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ABSTRACT
The work described in this thesis examines the renal 
excretion of nickel in humans and the Wistar Albino male rat. 
The renal clearance of nickel is characterized in two groups 
of electrolytic nickel-refinery workers. In the animal work, 
the mechanisms of nickel uptake in kidney tissue and its 
pathological consequences are investigated.
Multi-void 24-h urine collections were obtained from 26 
workers, as well as serum samples at the beginning and end of 
this sampling period. Nickel, microglobulin and
creatinine concentrations were measured in both body fluids. 
In addition, specific gravity, protein and qualitative 
indices of kidney disfunction (by Dip Stick) were assessed in 
urine. Examination of the functional dependence in 
individuals of urinary nickel, creatinine and specific 
gravity on urine flow-rate indicates that specific gravity 
adjustment of spot-nickel voids is more appropriate than 
employing creatinine. The systematic strategy devised in 
this study to overcome concentration-dilution effects for 
nickel has wide application in biological monitoring. It is 
demonstrated that if the specific gravity values of spot 
urine voids in a group of 20 individuals are between 1.010 
and 1.039, then the uncompensated uncertainty in 
specific-gravity adjusted urinary-nickel concentrations does 
not exceed + 10% (95% Confidence Level). Nickel clearance
studies and the determination of nickel in serum 
ultrafiltrates indicated that 24 + 6% of serum nickel is 
available for renal filtration, of which 65% on average is 
reabsorbed in the human kidney. It is concluded for the
nickel-refinery workers studied, that there was little
evidence of kidney dysfunction.
Studies with rat renal slices and isolated proximal
24-tubules showed that the uptake of Ni and its histidine
complexes is probably passive. Ni(His) 2  reduced the uptake 
of L-histidine and proline, but not of thymidine. The renal
Q
accumulation of nickel from nontoxic i.v. doses of Ni(IIis) 2
_ -j
(6 //g Ni kg ) was followed by rapid subcellular clearance 
during the 24-h period after injection. Autoradiography of 
the nephron illustrated that only the S3 segment of the
proximal tubule accumulated and retained nickel. There was 
no evidence of nephrotoxicity in the histopathological 
examination of these tissues. By contrast, high i.p. doses 
(3 and 6 mg Ni kg’ induced a decrease in Bowman’s space and 
minor changes along the entire length of affected nephrons. 
Compartmentalization of nickel within subcellular fractions 
of the rat kidney is interpreted in terms of an ’’Equilibrium” 
model for metal- ion uptake under steady state conditions 
(i.e., at fixed pH, redox potential, intracellular and 
extracellular ligand concentrations). Effectively, nickel 
distribution is determined by thermodynamic parameters such 
as complex stability.
The human and animal evidence support a passive mechanism 
of nickel reabsorption in the kidney. Simple pulmonary 
deposition and absorption considerations in man suggest that 
the dose of nickel acquired during an 8- h shift of work at a 
Threshold Limit Value (TLV) of 0.1 mg Ni m’^ is roughly
_ i
equivalent to the 6 //g Ni kg dose used in the rat study. 
Therefore, the absence of signs of significant nephrotoxicity 
in both the human and animal models appears to be consistent.
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CHAPTER 1 GENERAL INTRODUCTION
A PREFACE
In this thesis, experimental evidence is presented that 
describes the manner of nickel excretion by the human kidney. 
A rationale for volume correction of spot urine samples for 
use in biological monitoring of nickel workers is also 
addressed. These human studies are extended to an 
investigation of the uptake of nickel(II) salts and 
nickel (II)-histidine complexes in the rat kidney.
The health effects of exposure to nickel compounds may 
be divided into three categories: (i) nickel dermatitis; (ii) 
human cancers; and (iii) nickel carbonyl poisoning. These 
areas have been well-studied. In contrast, very little work 
has been done on the renal excretion of nickel in animals and 
humans. The objective of this thesis is to attempt to fill 
this void.
This thesis is divided into five chapters. The first 
chapter constitutes a general introduction to the sources, 
production, uses, toxicology and biochemistry of nickel. The 
second and third chapters report the results for the renal 
clearance and toxicity of nickel among electrolytic nickel 
refinery workers; empirical and theoretical treatments of 
adjusting spot urine nickel concentrations for urine flow 
rates are also presented. In Chapter 4 the uptake ancl 
distribution of nickel(II) salts and nickel(II)-histidine 
complexes in the rat kidney are investigated. Finally in
Chapter 5, the conclusions of Chapters 2 to 4 are used to 
help unify the work in this thesis, namely: the excretion of 
nickel(II) salts, the distribution of nickel(II)-histidine 
complexes within intracellular kidney compartments, and the 
biological residence time of nickel in animals and man.
B SOURCES. PRODUCTION AND USES OF NICKEL
(i) Sources.
Nickel (Ni) , atomic number 28, is the 24th element in 
the order of abundance in the earth's crust. It is a high 
melting (1453°C) metal with excellent corrosion- resistance 
and the ability to form many alloys (Tien and Howson, 1978). 
It is a widely known element because of its use in coinage, 
but has become more important for its many domestic, 
industrial and military applications. Although the pure 
metal itself can be used in many kinds of mechanical 
equipment, it is more commonly employed in the form of alloys 
such as nickel/chromium/iron known as stainless steel 
(Mackenzie, 1968). Nickel is known to occur in trace 
quantities in many foods such as fresh oysters, 1.5 ppm; 
wheat, 0.0 - 6.5 ppm; rye, 2.7 ppm; black pepper, 3.9 ppm;
cocoa, 5 ppm; tea, 7.6 ppm; baking powder, 13 ppm; and 
gelatin, 4.5 ppm; all of these values are based on 
fresh-weight (Schroeder et al., 1961).
The use of nickel dates from prehistoric times, when 
early man fashioned some implements from meteoric iron, which 
normally contains between 5 and 15 % nickel. Nickel was
first isolated by Cronstedt in 1751 from an ore containing 
niccolite (NiAs). An ore of this type had earlier caused 
copper and silver miners in Saxony considerable trouble 
because, although it resembled copper in colour, it yielded a 
brittle unfamiliar product. They referred to it as 
"kupfernickel", after "Old Nick" and his mischevious gnomes. 
Thus Cronstedt named this new element after this historical 
name. It was not until 1775 when Bergman first produced 
nickel in a fairly pure state that Cronstedt's work was 
widely accepted (Mackenzie, 1968; Mastromatteo, 1986).
The most important sources of nickel in Canada, and to a 
lesser extent in Finland, are the mixed sulfide ores 
(pentlandite, (Fe,Ni)S; nickel-bearing pyrrhotite, Fe^Sg to 
^e16^17’ anc^  nickel-bearing chalcopyrite, CuFeS2 ) • Minor 
deposits of these sulfide ores can also be found in Norway, 
China, India and the United States. The oxide ores, e.g. 
hydrous magnesium silicates, garnierite, (Ni,Mg)SiOg.nl^O and 
nickel- bearing iron oxide (laterite), are becoming more 
important sources of this metal. The oxide ores are found in 
New Caledonia, United States, Cuba, Phillipines, Indonesia, 
Brazil and Venezuela (Boldt, 1967). However, with the 
depressed market for nickel in the last few years, many of 
the projects in these countries have been severely restricted 
or temporarily terminated.
fii) Production.
The refining processes of the nickel-bearing sulfide 
ores found in Canada have the following main stages (Morgan, 
1979):
(a) Benef iciation. The ore is crushed and the
sulfide content is separated by mechanical, 
magnetic and flotation processes.
(b) Pyrometallurgy. The ore concentrates from the
previous step are passed to a furnace and
allowed to burn with the release of SO2  
(roasting). Various grades of
nickel- containing material can be placed into a 
furnace to melt the roasted concentrates 
(smelting). The molten material separates into 
an iron- rich silicate slag and a heavier 
sulfur-rich liquid called "matte". The liquid 
matte can be further treated with oxygen.
Silicious material is added to remove the iron 
and much of the remaining sulfur. The
separation of nickel and copper sulfides is
carried out mainly by controlling slow cooling, 
or leaching principles (matte separation).
After separation, the sulfides are then roasted 
to oxides. The nickel oxide may be sold 
directly or be reduced to metal and refined by 
the carbonyl or electrolytic process (Morgan,
1979). Details of these secondary refining
processes are discussed later.
(c) Hydrometallurgy/Leaching. This process may be 
used as an alternative to roasting methods. The 
ore (sulfide or laterite) or the metal
concentrate is leached to take nickel and other 
metals into aqueous solution. The metals are
then selectively precipitated (Duke, 1980). 
Ammonia is used in a pressure leaching method.
Iron forms insoluble ferric hydroxide, whereas 
nickel, copper and cobalt are taken into 
solution as amine complexes. The so-called
"pregnant" leach solution is heated to drive 
off the ammonia and the copper is precipitated 
as the sulfide. The remaining copper-free
solution is then reduced with molecular 
hydrogen resulting in the precipitation of pure 
nickel powder (Duke, 1980).
fiii") Uses.
Nickel is extensively used in electroplating, in the 
manufacture of steel and other alloys and in the manufacture 
of electronic devices. Very finely ground nickel is also 
used as a catalyst in the hydrogenation of oils. Nickel is 
also employed in coloured glass and for colour development in 
the ceramic industry. Many nickel compounds are released 
into the atmosphere during mining, smelting and refining 
operations. Coal-fired power plants also release nickel
compounds into the air. Because it is not profitable to 
recover nickel from this type of process, such releases will 
result in an increase in exposure to the general population as 
economic and energy considerations demand more coal to be 
consumed (Swaine, 1980).
Da Costa, in 1883, reported on the therapeutic effects 
of nickel salts. For example, nickel(II) sulfate was used in 
the treatment of rheumatism and nickel(II) bromide in 
reducing the frequency of epileptic attacks.
C NICKEL TOXICOLOGY
(1 ) NICKEL ESSENTIALITY
The data and rationale implicating nickel as an 
essential trace metal in man has been summarized by Cecutti 
and Nieboer (1981), and is reproduced below:
(a) the occurrence of nickel in human fetal 
tissues;
(b) the well-defined narrow range of nickel 
concentration in human body fluids (e.g. whole 
blood and urine) imply physiological or 
homeostatic control;
(c) the pathophysiological fluctuations in serum 
concentrations of nickel that occur in certain 
trauma states (e.g. myocardial infarction, 
acute stroke and accompanying severe burns);
(d) nickel deficiency symptoms in certain 
vertebrate species including rats, chicks,
swine, goats and sheep (among the more common 
were ultrastructural changes in the liver, 
reduced oxidative ability along with diminished 
activity of other key liver enzymes and 
impaired intestinal absorption of iron with 
concurrent indications of anaemia and of 
changes in iron metabolism and growth 
retardation);
(e) a number of eukaryotic and prokaryotic 
organisms have nickel-dependent enzymes (e.g. 
urease obtained from jack bean plants has been 
shown to be a nickel metalloenzyme and a number 
of enzymes requiring nickel as a cofactor have 
been isolated from bacteria which have been 
shown to involve the Ni(III)/Ni(II) redox 
couple) (Thauer et al.,1980; Thomson, 1982;
Xavier, 1986).
The very low dietary concentrations of nickel required 
for the demonstration of nickel deficiency in animals 
suggests that nickel deficiency in man is an unlikely problem 
(Cecutti and Nieboer, 1981). Thus, as pointed out by Nielsen 
(1984), its importance in human nutrition can only be 
inferred from animal studies. Extrapolation of experimental 
findings from animals to humans is difficult. Quite often it 
is necessary to link animal studies to observations that can 
be made in humans before the scientific community will accept 
a metal like nickel as essential in human nutrition. For
example, Spoerl and Kirchgessner (1977) detected an enhanced 
nickel retention during pregnancy of rats. The one paper 
that reports this trend in humans (Rubanyi et al. , 1982) 
reports serum nickel levels in control subjects that are 
approximately 100 times the currently accepted concentrations 
for occupationally-unexposed individuals. Thus, proof that 
this phenomenon occurs in humans remains to be demonstrated. 
If further investigations are able to confirm this, or other 
specific biological functions of nickel, then its acceptance 
as an essential metal in humans would be enhanced.
Nielsen (1971) was able to show that chicks on
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low-nickel diets had a much higher uptake of Ni into their 
liver, spleen, kidneys and aorta when compared to control 
animals. This has been interpreted as evidence for the
existence of a mechanism that regulates nickel absorption
according to need. For nickel to be kept in homeostasis, it 
is quite probable that there is a mechanism that will
conserve nickel when it is excreted via the kidney. The work
in this thesis may help to clarify this aspect (see 
Chapter 3). Absorption from food may also be expected to be 
regulated.
Although Nielsen (1984) considered only animal and plant 
studies, he concluded that: "it is reasonable to postulate
that nickel is required by humans".
Cii> ABSORPTION« DISTRIBUTION AND EXCRETION
(a) Absorption.
Inhalation and ingestion via mouth and gastrointestinal
tract are the major routes of nickel intake for man.
Although absorption through the skin (percutaneous) does not
appear to be a major source of nickel in man, it is of great
importance in such disorders as nickel dermatitis.
A typical Canadian consumes about 350- 580 /zg/day of
nickel. This wide range illustrates regional dependence
(Kirkpatrick and Coffin, 1974, 1977). Despite this large
intake of nickel, only 1-10% is absorbed from the
gastrointestinal tract in man and animals (EPA, 1978).
The most important route of nickel uptake, especially in
an industrial setting, is respiratory absorption. This has
been documented for workers in nickel refineries (including
nickel carbonyl plants) and electroplating shops. The
average person dwelling in an urban centre is exposed to
3approximately 0.025 //g Ni/m in air. The amount of nickel
3
inhaled annually would be about 0.2 mg, assuming that 20 m 
of air is breathed per day (Cecutti and Nieboer, 1981; 
Barrie, 1981).
Nickel has been found in most human tissues. However, 
it has been suggested that the highest concentrations of 
nickel occur in tissues exposed to exogeneous sources of 
nickel, like the lung, large and small intestines, and skin 
(Sumino et al., 1975). Large amounts of nickel have also
been found in the kidney, muscle and rib bone. An "average" 
70 kg person appears to have a total nickel content of 
0.5 mg (Bennett,1984).
Reliable methods are now available for the detection of 
nickel in body fluids and tissues. Until recently the 
accepted normal values were: whole blood (3-7 //g/L) , serum 
(1-5 y^g/L), urine (0.7-5.2 fig/V) , saliva (2.2 + 10.2 fig/V) , 
sweat (52 + 36 /xg/L) and feces (14.2 + 2.2 fig/g or 258
+ 126 //g/day) in healthy, industrially-unexposed persons
(Cecutti and Nieboer, 1981; Sunderman, 1983; Zober et al.,
1984). Recently, much lower values have been reported for
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nickel in serum of 0.46 + 0.26 fig L (Sunderman et al. ,
1984) and 0.28 + 0.24 fig L  ^ (Linden et al. , 1985; Sunderman 
et al. , 1986a), while in whole blood levels of 1.26 + 0.33 fig 
L~ ^  (Sunderman et al. , 1984) and 0.34 + 0.28 fig L" ^  (Linden 
et al. , 1985; Sunderman et al. , 1986a) were found.
Although lower serum and plasma nickel values are now 
commonly reported, urine concentrations appear to hold near 2 
fig/L. For example, Sunderman et al. (1986b), by direct
quantitation of urine diluted with dilute nitric acid, found 
urinary nickel levels to be 2.0 + 1.5 fig L (range 0.5 to 
6.0 fig L" ^ ) for four non-exposed healthy adults. The 
consensus is that part of this reduction in serum levels is 
due to better contamination prevention and the availability 
of atomic absorption spectrometers with modern background 
correction accessories (mostly by Zeeman technique). For 
workers occupationally exposed to nickel and its compounds,
values of plasma or serum concentrations up to 35 //g/L and 
urine levels up to 400 >czg/L have been reported (Nieboer et 
al., 1984a).
(b) Distribution.
The uptake, transport and excretion of nickel depends
not only on the mode of absorption but also on its chemical
form while being absorbed (see next section for a further
discussion of this). Blood is the main vehicle for the
transport of absorbed nickel. Although the exact division
between erythrocytes and the plasma or serum has not been
determined, serum and plasma reliably reflect blood burdens
and exposure (National Academy of Sciences, NAS, 1975;
Nieboer et al., 1984a). Nickel is transported in the body
via plasma where it is bound to both high and low molecular
mass carriers. The high molecular mass ligand is human
albumin, and possibly a nickel metalloprotein which is
believed to be an alpha- 2- macroglobulin, also called
nickeloplasmin (Sunderman, 1977; Nomoto, 1980; Scott and
Bradwell, 1983). The low molecular mass component has been
shown to be a nickel(II)-amino acid complex by in vitro 
63Ni-addition experiments. Of the 22 amino acids tested, the 
24-main Ni - binding amino acid was found to be L- histidine 
(L-His) (Lucassen and Sarkar, 1979). The exact distribution 
between these fractions has not been firmly established. The 
metalloprotein nickeloplasmin has not been well 
characterized, and there is some doubt about its importance
24-in the distribution of Ni in serum. Work by Nomoto et al.
(1971) and Sunderman et al. (1972) determined nickel
associated with albumin, nickeloplasmin and ultrafiltrable
components of rabbit and human serum. This early work
involved atomic absorption spectrometry measurements on the
fractions of serum that had been separated by ultrafiltration
and column chromatography. They found that approximately 40%
of nickel(II) present in rabbit serum was associated with
albumin, 44% with the nickeloplasmin fraction and 16% with
the ultrafiltrable fraction; whereas approximately 34% of the
nickel in human serum was associated with albumin, 26% with
nickeloplasmin and 40% was ultrafiltrable. Asato et al.
(1975) found the amount of ^ N i^+ (introduced by intravenous
(i.v.) injection) associated with the ultrafiltrable fraction
of rabbit serum to be 15%. Nomoto (1980) separated
alpha-2-macroglobulin by affinity column chromatography from
the serum of healthy humans who had no industrial exposure to
nickel. Using atomic absorption spectrometry he found that
43% of the total nickel content was bound to
alpha-2-macroglobulin. By comparison, Lucassen and Sarkar
2+
(1979) found that only about 0.1% of the total Ni in human 
serum was bound to the nickeloplasmin, with 95.7% bound to 
albumin and 4.2% to L-histidine in the ultraf iltrable fraction.
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They added NiC^ to 2.0 mL of serum and diluted to a 
constant volume of 2.5 mL before ultracentrifugation. The 
values reported are thus for nickel(II) added to serum and do 
not necessarily represent the endogenous nickel distribution.
Caution in interpretation is thus warranted since the added 
nickel resulted in concentrations about 35,000-fold higher 
than those observed naturally in serum. The in vitro 
distribution studies involving 22 amino acids were also 
carried out under these artificial conditions. There appears 
to be no agreement on the exact size of the ultrafiltrable or 
high molecular mass fractions of nickel(II) in human serum. 
The work described in Chapter 3 measures the actual 
endogenous low and high molecular mass fractions by 
ultracentrifugation and atomic absorption spectrometry in
serum of electrolytic nickel-refinery workers.
2+The binding of Ni to these protein and amino acid 
ligands allows its rapid transport throughout the body. 
Although the distribution of nickel in the human body is of 
great importance, relatively little is known in comparison to 
animal studies. Usually the nickel content in human tissue 
has been studied employing autopsy specimens. Most of the 
early data appears to be of questionable analytical 
reliability. Also many studies (e.g. Schroeder et al. 19.61; 
Tipton and Cook, 1963; Tipton et al., 1965) found that the 
nickel contents of some of the autopsy tissues were below the 
detection limits available at that time. However, these 
workers were able to illustrate the presence of nickel in 
lung, kidney, liver, heart, trachea, aorta, spleen, skin and 
intestine. Generally, the levels were found to be less than 
0.05 pg/g wet tissue. The skin, intestine and lung had 
higher levels with the highest concentrations accumulating in
the lung. Similarly, Sunderman et al. (1971) found that lung 
tissue from accidental death victims had the highest levels 
of nickel (0.016 /^ g/g wet tissue) of the tissues sampled. In 
more recent studies of post-mortem specimens from adults 
without known occupational or iatrogenic exposure to nickel 
compounds, the highest concentrations of nickel were found in 
bone, followed by lung, kidney, liver and heart (Nomoto, 
1974; Sunderman, 1984d; Zober et al., 1984; Kollmeier et al.,
1985).
Nickel concentrations in lung tissue obtained from 
random autopsy tissue of industrially non- exposed individuals 
are positively correlated with age (Sunderman, 1984d) with a 
correlation coefficient of 0.82. In another study, Kollmeier 
et al. (1985) found this trend with a correlation coefficient 
of 0.71. Recent and the earlier data has been summarized by
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the relationship: Lung Nickel (//g kg dry wt) = 3.25 Age 
(years) - 38.4, with r = 0.77 and P< 0.001 (Rezuke et al. . 
1987). No age-dependent increases of nickel were observed in 
bone, kidney, liver or heart (Sunderman, 1984d). In a 
preliminary study Morgan and Adams (1980) found elevated 
levels of nickel in post-mortem lung tissue of nickel 
refinery workers. Andersen and Hogetveit (1984) found that 
autopsied lung samples from former nickel refinery workers in 
Norway had nickel values ranging from 2 to 1360 ppm, 
depending on worksite classification. Therefore, it appears 
that lung nickel levels are related to industrial exposure. 
The discussion on cancer will illustrate the importance of
nickel accumulation in the lung.
The estimated body burden of nickel in healthy adults 
averages 7.4 //g/kg body weight, with the highest contribution 
(7.3 /4g/kg) coming from ingestion (including drinking water) 
and the remainder from inhalation (Bennett, 1984).
In comparison to the limited amount of human work, a 
large amount of information is available for acute and 
chronic animal exposure studies. Nickel(II) salts
administered parenterally to a variety of animals show the 
largest accumulation in lung, kidney, liver and endocrine 
gland, with relatively little nickel found in neural tissue 
(Mushak, 1980). Thus both animal and human data ilustrate 
high levels of nickel in lung and kidney.
(c) Excretion.
Many studies have been completed on the kinetics of 
distribution and clearance of injected nickel compounds in 
experimental animals. All of these studies show a relatively 
short half-life for water-soluble Ni(II)-salts of 24 h (or 
less). In rats and rabbits, Onkelinx et al. (1973) 
determined a two- compartment clearance model with fast and 
slow components. One day after injection, 78% of the dose is 
excreted in the rabbit, and in the rat it takes about 72 
hours. In both species, ^Ni^+ was rapidly cleared from the 
plasma or serum in the first two days after injection and 
disappeared at a much lower rate from three to seven days. 
This work also showed that most of the nickel is cleared by
the kidney (during the three days after injection of rats, 
78% of the dose was excreted in the urine and 15% was 
excreted in faeces presumably via bile). In contrast to the 
large amount of absorbed nickel excreted by the kidney, the 
excretion of total ingested nickel is mainly faecal, with 
only about 10% appearing in the urine, . for both dogs 
(Tedeschi and Sunderman, 1957) and humans (Horak and
Sunderman, 1973).
Asato et al. (1975) have studied the ultrafiltrates from
rabbits given i.v. injections of NiC^. They found that
the Ni(II)-ultrafiltrable complexes (i.e. low molecular mass
complexes) were rapidly cleared from the serum via urine.
Although the identities of all the ultrafiltrable
Ni(II)-ligands were not totally established, preliminary
24-studies indicated that Ni was preferentially complexed to 
the amino acids L-His, L-Cysteine (L-Cys) and L-Aspartic 
(L-Asp), both singly or as mixed-ligand species.
Biliary excretion of nickel has been known to occur in 
calves with a nickel-supplemented diet (O'Dell et al., 1971), 
and in rabbits (9.2% of i.v. ^Ni^+ injected dose) (Onkelinx 
et al., 1973). Recently, Marzouk and Sunderman (1985) have
found that biliary excretion of nickel in rats injected with 
single subcutaneous doses only amounted to approximately 0.3% 
of the total dose over a 24-h period. By contrast, bile may 
be an important excretion route of nickel for humans. Bile 
specimens obtained during the postmortem examination of 
gallbladders from five non-occupationally exposed subjects
averaged 2.3 + 0.8 /zg Ni L  ^ (Rezuke et al. , 1987). This 
level appears to be comparable to normal urinary nickel 
levels of 2.2 + 1.2 fig L" ^  (or 2.6 + 1.4 /zg d~ (Sunderman 
et al., 1986a). If there is no significant intestinal
reabsorption of the bile-nickel in the gastrointestinal 
tract, Rezuke et al. (1987) estimate that the net biliary
excretion of nickel in non- exposed persons averages 2- 5 /zg
-1 -1 d . This work suggests a net excretion of ~ 6 /zg Ni d for
the combined biliary and urinary routes.
One study by Hohnadel et al. (1973) indicates that sweat 
may be a major route of nickel excretion in humans. They 
determined nickel levels in the sweat collected from healthy 
subjects during sauna bathing for brief periods at 93°C to be 
52 + 36 /zg/L for men and 131 + 65 /zg/L for women. The 
importance of this route of excretion for electrolytic nickel 
refinery workers is unknown.
The role of hair as an excretory mechanism in man has 
inspired a large number of studies. Most of this interest 
has evolved from the possibility that nickel levels in hair 
may be used to assess overall nickel body burdens. This 
approach has not been successful, although hair may be an 
index to external environment exposure. In addition, there 
is controversy as to the correct collection and analytical 
procedures. Most of this debate is concerned with the type 
of sample to be collected, namely bulk hair sample 
(Sunderman, 1983) versus proximal (first centimetre) scalp 
hair (Nieboer et al., 1984a). Washing protocols are also
controversial; whether three consecutive washings with a 
non-ionic detergent (Sunderman, 1983) or with distilled water 
(Chittleborough, 1980) should be adopted. In spite of these 
problems, Nieboer et al. (1984a) came to the conclusion that 
human hair shows considerable promise as an environmental 
indicator of exposure, providing more research is done on the 
complexities of hair-nickel interactions.
It may be concluded from the above discussion that the 
major route of excretion of absorbed nickel in man and many 
animals appears to be renal. This is most likely the reason 
why urinary nickel is a reliable indicator of environmental 
exposure. Urine is also, the most convenient body fluid for 
biological monitoring because its collection is non- invasive 
and its nickel concentration is considerably higher than in 
plasma, serum or whole blood, which facilitates analysis 
(Nieboer et al., 1984a).
T i m  TOXIC EFFECTS OF NICKEL COMPOUNDS
fa^  Historical Aspects.
As early as 1889, dermatitis resulting from exposure to 
chemicals used in nickel plating has been reported by 
Blaschko (NIOSH, 1977). Eczema was more severe in those who 
had worked longest and the use of rubber gloves and 
protective creams was recommended to reduce such outbreaks. 
Originally considered to be an occupational problem, recent 
clinical and epidemiological reports suggest that 
non-occupational exposures to nickel can present significant
problems to the general population. In contrast, there has 
been a decline of incidents related to industrial exposure 
(Nieboer et al., 1984a).
In 1891 McKendrick and Snodgrass recognized the extreme 
toxicity of nickel carbonyl. They concluded that air 
concentrations of less than 0.05% v/v are dangerous. In 1902 
the first reports of nickel carbonyl poisoning due to 
industrial exposure occurred soon after the construction of 
the Mond nickel refinery in Clydach, Wales (Sunderman, 1977). 
From 1902 to the present there have been many case study 
reports of nickel carbonyl poisoning. Recently, Zhieheng 
(1986) has reviewed 179 cases that have occurred in China 
since 1961. All of the patients recovered including the six 
classified as severe. In North America and Europe there were 
19 deaths reported from 1903 to 1971 (Sunderman et al., 
1975). Lately, there has been a large decrease in accidental 
gassings, for example from 17 in 1971 to 2 in 1981 at the 
International Nickel Company (INCO) Clydach refinery (Nieboer 
et al., 1984a).
In Great Britain, the first indications of lung and 
nasal cancer of nickel workers were listed in the Annual 
Reports of the Chief Inspector of Factories for 1932 and 1949 
(NIOSH, 1977; Mastromatteo, 1986). In the 1932 report there 
were 10 cases of cancer of the nasal cavities and paranasal 
sinuses. However, in the 1949 report there were 47 cases of 
cancer of the nose and 82 cases of lung cancer. In a report 
to the Ontario Department of Health in 1959, Sutherland
estimated that during 1930-1957 workers at INCO's Port 
Colborne refinery had a 37-fold increase in risk of dying 
from cancer of the nasal cavities (Sunderman et al. , 1975). 
In the 1960’s, cancer of the respiratory tract was also 
recognized among workers at a sintering plant in Copper 
Cliff, near Sudbury (Sunderman et al., 1975)..
fb^ Effects on the General Population.
The population at large (i.e. those not exposed to 
nickel in their work place) are exposed to nickel in their 
everyday life due to the widespread use of this metal and its 
compounds. Nickel is found in food, water, stainless steel 
products (e.g. jewelry, cutlery, etc.), permanent magnets, 
radios, generators, turbochargers, high stress and high 
temperature copper-nickel alloys and Ni-Cd batteries. These 
lead to exposure by skin contact and gastrointestinal tract 
absorption. As mentioned, nickel is also found in the air 
mainly due to the combustion and incineration sources (e.g. 
coal and oil burning units such as utilities, commercial and 
residential dwellings and municipal and sewage sludge
incinerators). These anthropogenic sources account for the 
observation that the respiratory tract constitutes a
significant route of intake besides the diet.
Nickel dermatitis. Nickel sensitivity is found in
approximately 5% of the general population, with a tenfold 
higher incidence in women than men (Kieffer, 1979; Sun, 1980; 
Menne and Hjorth, 1982; Nieboer et al., 1984a). This type of
eczema is characterized by inflammation of the skin upon 
continued contact with nickel- containing items (Sunderman et 
al., 1975). Calnan (1956) described two patterns of nickel 
dermatitis: a primary outburst at the site of direct metal 
contact, and a secondary eruption or area of "spread" remote 
from the metal-contact site. Secondary distant eruptions are 
found in 75% of patients (Menne and Hjorth, 1982). The usual 
method for diagnosing individuals for nickel sensitivity is 
the "patch test". It involves placing a few drops of a
water-soluble nickel compound (e.g. 2.5% NiSO^ in either
water or petrolatum; Wilkinson et al., 1970) on a cotton
patch and taping it to an individual's skin. A positive test 
is considered to occur when inflammation develops under this 
patch after 24 to 48 h. This test is not very sensitive for
persons who produce only mild reactions to nickel, or who
display a very delayed reaction. Also the patch test itself 
has the potential of inducing nickel sensitivity in an 
individual. It can also cause local irritation or
non-specific (false) positives (e.g. due to the adhesive 
tape) and exacerbation of the dermatitis (Svengaard et al. , 
1978; Veien et al. , 1979). The patch test diagnosis of
nickel dermatitis can now be complemented with the lymphocyte 
transformation test. The lymphocyte transformation induced 
by NiSO^ in vitro has been shown to be beneficial in the
diagnosis of nickel sensitivity in dermatitis patients (Veien 
et al., 1979; Al-Tawil et al., 1981). This test is based on 
the fact that lymphocytes isolated from the nickel- sensitive
person undergo a lymphocyte to lymphoblast transformation 
after 7 to 8 days incubation in the presence of a Ni(II) 
salt. This transformation is monitored by an increased 
uptake of radiolabelled H- thymidine when cells proliferate 
during blastogenesis. Although this is a more difficult test 
to perform than the patch test, it may prove to be more 
specific and sensitive (Al-Tawil et al. , 1981). It is also 
less invasive than the patch test, in that it does not cause 
a primary eruption of the skin.
The mechanisms of sensitization are not completely 
understood. However, it is generally accepted to include the 
following phases: (1) diffusion of nickel through the skin;
(2) subsequent binding (conjugation) of the nickel(II) ion 
(the hapten) with protein(s) and/or other skin components to 
become the allergen; and (3) a cellular response to the 
nickel- macromolecular complex (Sunderman et al., 1975; Spruit 
et al., 1980; Adams, 1983). The allergen is believed to
initiate a cascade of biological reactions in regional lymph 
nodes, spleen and bone marrow, ultimately including 
stimulation and proliferation of effector T- lymphocytes 
(thymus- dependent lymphocytes) that recognize and react with 
the hapten. After a secondary challenge, effector cells upon 
contact with the allergen release chemotactic substances that 
cause the inflammatory skin reaction by inducing vascular 
permeability, attraction of mononuclear cells, and retention 
and proliferation of cells within the area penetrated by the 
hapten. It is clear that nickel dermatitis is a delayed,
cell-mediated hypersensitivity response.
Despite the suggestion by some investigators that there 
is an association between nickel dermatitis and atopy (or the 
hereditary predisposition to mount a humoral immunological 
reaction which is characterized by high plasma IgE titres), 
the expected correlation with serum IgE levels has not been 
generally observed (Nieboer et al., 1984b). In fact, atopic 
people are known to have a reduced predisposition to contact 
sensitization. However, very recently, Belda et al. (1985) 
found that the IgE levels in a group of nickel- sensitive 
individuals when compared to those in a non- allergic control 
population failed to provide evidence of a reduced tendency 
to elevated IgE levels in people with contact dermatitis. 
This suggests that IgE and IgG antibodies are most likely 
indirectly involved in the cellular response.
Other Health Effects. Although the general population is 
exposed to nickel by way of the lung, there have been no 
reports of respiratory hypersensitivity (i.e. asthma) nor 
respiratory cancer. Neither are there reports of nickel 
carbonyl poisoning in people not industrially exposed.
(c) Industrial Exposure.
Nickel Carbonyl (Ni(CQ)^). This is a very volatile 
colourless liquid (b.p. 42.6°C) that decomposes rapidly above 
room temperature unless held under a pressurized atmosphere 
of carbon monoxide (Antonsen, 1978). Exposure may arise from 
a variety of operations in refineries, manufacturing plants
and research laboratories. The Mond or Carbonyl process of 
nickel refining, discovered by Ludwig Mond and Carl Langer in 
1889, uses these properties to isolate pure nickel (Boldt, 
1967). At Clydach, Vales, refinery feed material (usually 
nickel(II) oxide from Canada) is passed into rotating kilns 
where it is treated with molecular hydrogen to reduce the 
nickel. It is then exposed to CO at room temperature to form 
nickel carbonyl gas. Subsequently, the gas is passed over 
nickel seed pellets, which have been preheated to 200-250°C 
to decompose the nickel carbonyl. The pure nickel metal 
deposits on the pellets and the CO is then recirculated.
Ni + 4C0 * Ni(C0)4 (1.1)
Nickel powder can also be manufactured by this process if the 
nickel carbonyl vapour is shock heated in a special 
decomposer (Morgan, 1979).
In addition to gassing in nickel refineries, nickel 
carbonyl exposure may also result from its inadvertent 
formation (i.e. when carbon monoxide, especially under high 
partial pressure, comes in contact with an active form of 
nickel such as nickel catalysts used in hydrogenation) 
(Kincaid et al. , 1953). Exposure in these circumstances is 
likely to be particularly hazardous because the presence of 
nickel carbonyl may not be expected or recognized as a 
hazard.
Nickel carbonyl is a very lipophilic compound. Hence,
when its vapour is inhaled, it passes through the lung's 
membranes very easily and causes nickel to be deposited in 
the lungs and other tissues. The clinical symptoms of nickel 
carbonyl poisoning have been divided into two phases. The 
first or immediate phase has symptoms similar to influenza: 
headache, vertigo, nausea, vomiting, fatigue and sometimes 
sternal pain and epigastric discomfort (Carmichael, 1953; 
Sunderman and Kincaid, 1954; Vuopala et al. , 1970; Sunderman 
Sr., 1970; NAS, 1975; Sunderman Jr., 1977). These early 
symptoms of the initial phase are usually mild and disappear 
within 24 hours. The second or delayed phase symptoms 
usually develop gradually 2 - 1 0  days following exposure. 
The second phase symptoms are similar to chemical pneumonia, 
as is apparent from the following quote from NAS (1975) : 
"Constrictive pain in the chest is usually the first symptom. 
This is followed by cough, hypernea, cyanosis, occasionally 
gastrointestinal symptoms and a profound weakness". In the 
most severe cases, death occurs 4 to 13 days after exposure 
(Armit, 1907; Carmichael, 1953; Sunderman and Kincaid, 1954; 
Sunderman, 1970; Sunderman, 1977). In a recent study, 
Zhicheng (1986) found the general symptoms to be very similar 
to those reported previously, and he was the first to 
document the occurrence of cardiotoxicity. Three of six 
severe cases had inflammation of the myocardium 
(myocarditis).
The lesions induced by nickel carbonyl exposure in lung 
tissue of animals and man are very similar. Autopsy
-26-
examination has also documented the occurrence of hepatic and 
adrenal cortical degeneration, as well as cardiac 
irregularities and liver enlargement. Brain and renal 
congestion are often observed (Sunderman Sr., 1981), although 
the loss of life is usually attributed to respiratory 
failure.
Convalescence in patients recovering from acute nickel 
carbonyl poisoning is usually quite long and is customarily 
characterized by fatigue on slight exertion. Commonly two to 
three months elapse before it is possible for a patient to 
return to work.
Studies of nickel carbonyl in mice and rats after 
inhalation or intraperitoneal administration have shown that 
nickel is deposited primarily in the lungs, and to a lesser 
extent in the heart, diaphragm, central nervous system, 
kidney, liver, adipose tissue and blood (Sunderman and Selin, 
1968; Oskarsson and Tjalve, 1979a; Tjalve et al., 1984). The 
pulmonary parenchyma is the principal target tissue 
regardless of the route of administration. It is known that 
Ni(CO)^ can cross the alveolar membrane in either direction 
without undergoing a metabolic change. After a review of 
the literature, Nieboer et al. (1984a) postulate the 
following mechanism of action in nickel carbonyl poisoning. 
The first step is the decomposition of Ni(CO)^ to produce 
metallic Ni.
Ni(CO)^ * Ni° + 4C0 (1.2)
This reaction may be promoted by haemoglobin which serves as
a receptor for the released CO. The second step is the
o 2+oxidation of the metallic Ni to Ni by a suitable oxidizing 
agent (Ox), perhaps aided by enzyme catalysts.
Ni° + Ox -» Ni2+ + Ox2' (1.3)
It is not clear whether the direct interaction of Ni(CO)^
o 2+with tissues or the resulting Ni or Ni is responsible for 
the severe tissue lesions.
It is currently thought that the toxic action of nickel 
carbonyl is not due to carbon monoxide (Armit, 1907; Kincaid 
et al., 1953). These studies have evaluated the relative
amounts of CO present as carboxyhaemoglobin. It was
concluded there was not a high enough level of CO in the
blood to account for the observed toxic action. Oskarsson
n 63and Tjalve (1979a) found from the tissue distribution of Ni
14and C-labelled nickel carbonyl that the toxic effect of
Ni(CO)^ appeared to correlate with the distribution of 
nickel. Thus the lung was the main depository.
Zhicheng (1986) has reported that individuals subjected 
to mild exposure were successfully treated with bed rest and 
symptomatic drugs like bronchodilators. Moderate cases also 
received oxygen, glucose, vitamin C and corticosteroids. The 
severe cases were treated with a series of drugs and other 
methods, such as limitation of water intake, administration
of oxygen, hibernation therapy, and parenteral administration 
of large doses of corticosteroids, dithiocarb, antibiotics 
and other drugs to help resolve pulmonary oedema, pneumonia 
and toxic myocarditis. This work confirmed that
corticosteroids are useful in the treatment of Ni(CO)^ 
gassing, and it was found that prompt help .(first aid) and 
comprehensive treatment are important for the recovery of the 
patients.
Currently accepted clinical practice in North America
and Europe is based upon the hypothesis that administration
of chelating agents, especially oral administration of
diethyldithiocarbamate (DDC), improves the prognosis
(Sunderman Sr., 1981). It is thought that the role of DDC is
2+to lower the body burden of Ni . Unfortunately, the
available data does not demonstrate an unequivocal increase 
in urinary nickel levels due to DDC chelation therapy. The 
clinical worth of DDC therapy is also clouded by the fact 
that in clinical cases it was given 3 - 4  days after exposure 
and that no controlled therapeutic trials have been conducted 
to evaluate the effectiveness of this chelating agent
(Nieboer et al., 1984a).
A novel mechanistic point of view arises from reports 
that DDC acts as an effective scavenger of free radicals, 
such as the superoxide anion (Nieboer, unpublished results). 
In the animal model, it protects tissue against radiation 
damage (Evans et al., 1982, 1983). The injury to the lung 
induced by Ni(CO)^ resembles that caused by other chemicals
like phosgene and paraquat that are known to have a toxic
mechanism involving redox reactions (Menzel and McClellan,
1980; Minchin and Boyd, 1983). A similar mechanism can be
postulated for Ni(CO)^ because it decomposes rapidly,
releasing Ni° which is assumed to be the source of electrons
2+when oxidized to Ni . If this mechanism proves to be 
operative, then it follows that it is crucial for DDC to be 
administered quickly after the exposure to nickel carbonyl.
This radical mechanism of nickel carbonyl toxicity may 
also explain differences found for the chelating agents DDC 
and D-penicillamine (D-PEN) in studies of Ni(CO)^ 
administered to animals. Both are known to act as free 
radical scavengers in animal models (Evans et al. , 1982,
1983). However, DDC is lipophilic, and can act as an 
intracellular radical scavenger, whereas the D-PEN is 
hydrophilic and presumably cannot act as an intracellular 
free radical scavenger. Animal studies have indicated that 
D- PEN is more effective than DDC in NiC^ poisoning, while 
the reverse has been observed for Ni(CO)^ (Horak et al. , 
1976; Baselt et al. , 1977). In fact, ^Ni- autoradiography 
has demonstrated that DDC enhances the deposition of nickel 
administered as NiC^ in lipophilic tissues (Oskarsson and
M
Tjalve, 1980). In vitro cellular nickel(II) uptake studies 
with a number of cell types have also confirmed such 
intracellular compartmentalization effects in the presence of 
DDC (Nieboer et al., 1984c).
After a review of the literature, Nieboer et al. (1984a)
concluded that high urinary levels of nickel generally 
reflect not only the extent of Ni(CO)^ exposure but also the 
clinical severity that may be expected. For example, a 
urinary nickel level of more than 100 y^ g/L on the day of 
exposure suggests that careful monitoring of the patient 
would be judicious even in the absence of initial symptoms. 
The urinary nickel action levels reported in the literature 
are based on an 8-h urine collection. However, as pointed 
out above and by Nieboer et al. (1984a) and Zhicheng (1986), 
more immediate treatment seems advisable. Therefore waiting 
for an 8-h urine collection before treatment is initiated may 
not be appropriate. This demonstrates the need to use spot 
urine samples that can be accurately and confidently 
corrected for concentration/dilution effects. This aspect is 
addressed in Chapter 2.
Cancer. The incidence of increased cancer risk associated 
with industrial exposure to nickel compounds shows nasal and 
lung cancers to be predominant. The incidence of these two 
cancers has been most strongly correlated with exposure to 
pyrometallurgical refinery intermediates (Cecutti and 
Nieboer, 1981; Nieboer et al., 1984a; Sunderman, 1984a).
It appears that inhalation of newly generated insoluble 
dusts and/or fumes composed mostly of nickel-sulphide and/or 
nickel- oxide mixtures produced in the pyrometallurgical 
refining processes are carcinogenic. Nickel and nickel oxide 
dusts have also been associated with welding, grinding and
polishing and the casting of alloys, although no excess 
cancer risk is known for the associated occupations. There 
has been no increased risk observed in the electrolytic 
department at INCO's Port Colborne plant, while there have 
been reports of cancer risk in the electrolytic refining 
processes employed at other locations, especially in Norway 
and the USSR. These apparently conflicting findings for 
electrolytic refining have been attributed to the possibility 
of mixed exposures of water- soluble and relatively
water-insoluble nickel compounds, or to engineering and 
operational differences which gnerate airborne nickel of 
different composition (Nieboer et al., 1984a). The
carcinogenicity of water-soluble nickel(II) salts is still 
controversial. There have also been isolated reports 
indicating slight elevations in kidney cancer, stomach cancer 
and cancer of the prostate. However these were not
consistent, nor statistically significant, and their
importance or the role of nickel exposure in these instances 
has to be clarified (Nieboer et al., 1984a; Roberts et al. ,
1984).
Vater-insoluble compounds (e.g. NigS2 > Ni powder and 
NiO) have all been demonstrated to be carcinogenic in animal 
studies, but water-soluble salts (e.g. NiC^, NiSO^) have no 
carcinogenic potential (Leonard et al. , 1981; Sunderman,
1984c). Nasal tissues biopsies of nickel workers have 
demonstrated that nasal epithelial dysplasia may precede 
nasal cancer (Boysen et al. , 1980a,b; Boysen and Reith,
1982). Recently, Boysen et al. (1984) have studied the
histological changes in nasal biopsy specimens and urinary 
levels of nickel in retired workers. They found that the 
presence of hyperplastic/polypoid nasal lesions was inversely 
related to the duration of retirement, possibly reflecting 
gradual regression of the mucosal swelling. Lower nickel
body burden, assessed by plasma and urinary nickel levels, 
showed a similar dependence. The nickel concentrations in 
the plasma and urine were significantly higher among former 
roasting/smelting workers than in former electrolysis and
non-process (control) workers. This is probably due to the 
slow release and excretion of nickel(II) from deposits of 
particulate nickel compounds that have accumulated in the
first group prior to retirement. This slow release of 
insoluble nickel compounds from lung tissue has also been 
demonstrated in intratracheal injections of rats with 
insoluble NiO when compared to soluble NiC^ (English et al.,
1981). In part, the carcinogenic potential of the different 
nickel compounds appears to correlate with the degree and 
speed with which the lung can . remove these materials 
(Sunderman, 1984b; Nieboer et al. , 1986). Clearance will, of 
course, depend on the solubility of the compounds in body 
fluids. The more soluble compounds will be released from the 
body more quickly than the insoluble compounds. This 
illustrates the importance of biological residence time and 
bioavailability in nickel carcinogenesis.
Animal inhalation studies support the carcinogenic
effects found in man (Ottolenghi et al., 1975; Wehner et al., 
1984). Ottolenghi et al. (1975) exposed Fischer 344 rats to 
airborne nickel subsulfide in concentrations of 0.97 mg 
nickel m’ (70% < l//m diameter) 6 hours/day, 5 days/week for 
78 - 84 weeks and found that the lungs were most affected.
Vithin two years after starting the experiment, 14 malignant 
lung tumors were found in the exposed group, compared to 1 
malignant tumor in the control group.
Among studies employing injection protocols are many 
reports that nickel subsulfide (Ni^S2 ) is a potent 
carcinogen. Sunderman and Hopfer (1983) have shown in animal 
studies that crystalline alpha-Ni^S2  and crystalline beta-NiS 
can cause 100% induction of sarcomas at the injection site, 
whereas Ni dust and amorphous NiS caused 55% and only 4% 
respectively. These results show that nickel compounds 
differ substantially in their carcinogenic potencies 
(Sunderman, 1984b). This work also suggests that compounds 
that have well defined crystal structures are the most potent 
carcinogens. Kasprzak et al. (1983) were able to show that 
colloidal Ni(0 H ) 2  is non-carcinogenic in rats, whereas 
"dried" and more crystalline forms appear to be carcinogenic. 
Thus crystal structure and surface properties of nickel 
compounds appear important to nickel carcinogenesis. More 
recent studies have suggested that surface passivity of solid 
nickel compounds (i.e. "smooth exterior, crystallinity, low 
surface charge, low surface activity with respect to protein 
adsorption and cell lysis, and moderate solubility) appears
to be predisposing to carcinogenicity” (Nieboer et al.,
1984d; Nieboer et al., 1986). Surface inactivity was
interpreted to reduce biological clearance and to promote
2+intracellular delivery of Ni .
A number of studies have been reported on the intrarenal 
(i.r.) injection of nickel subsulfide in rats. After i.r. 
administration of 5 mg of alpha- NigS2 ? the blood haematocrit 
increased within one week concomitant with intense 
stimulation of erythropoiesis (Hopfer et al. , 1980).
Sunderman (1984b) has pointed out a significant rank 
correlation (p < 0.0001) between the sarcoma incidences and 
the capacities of the Ni- compounds to induce erythrocytosis 
after i.r. injection to rats. This has been interpreted that 
somehow regulation of renal production of erythropoietin can 
serve as an index to carcinogenic activity of nickel 
compounds in rats. After i.r. injection of NigS2 ? renal
tumors developed only at doses of 5 and 10 mg/rat with 28 and 
75% incidences, respectively. It is thus possible to induce 
renal tumors by direct injection of the solid Ni^S2  into the 
target organ. However, these experiments do not demonstrate 
that the kidney is a target organ of Ni^S2  when the exposure 
route is by the respiratory system. Presumably only the
Ni(II) ion reaches the kidney.
From this work we see that in an animal model not only 
is it possible to induce lung cancer, as found in humans, but 
it is also possible to generate injection site tumors. The 
significance of the latter to the human situation is
difficult to assess (Environmental Protection Agency, (EPA), 
1986) .
Manganese dust has been demonstrated to inhibit the 
carcinogenicity of alpha-Ni^S2  when both were given as 
intramuscular (i.m.) injections in the same thigh (Sunderman 
and McCully, 1983). It is interesting to note that in rats 
that received injections of alpha- NigS2  in one thigh and Mn 
dust in the other, no reduction in the incidence of sarcoma 
was evident. This illustrates that interaction with other 
metal ions may alter the potency of nickel compounds.
In the somatic mutation model of nickel carcinogenesis
2+it is often assumed that the Ni ion interferes with the 
fundamental molecular processes of replication, transcription 
and translation (Cecutti and Nieboer, - 1981), perhaps by 
interaction with the DNA of cells and causing irreversible 
damage. Friedberg (1985) has stated that ”if the cellular 
response(s) to this damage involves the misrepair of lesions, 
or if DNA repair does not occur and the dominant response is 
a mechanism that is error-prone, then mutations may arise in 
the descendants of the affected cells. These mutations, 
affecting specific genes (or sets of genes) regulate the 
critical aspects of cellular growth and may express 
themselves phenotypically as neoplastic transformations”. 
Waksvilc et al. (1984) have shown increased incidence of 
chromosomal aberrations (breaks and gaps) but no incidence of 
sister chromatid exchanges in peripheral lymphocytes of 
retired nickel refinery workers who were exposed to furnace
dust of NigS2  and NiO or aerosols of NiC^ and NiSO^ for more
than 25 years. The relation of these observations to cancer
2+is unknown. Ni like other divalent metal ions has been
shown to be mutagenic in cultured Chinese hamster ovary cells
(Sunderman, 1984b). With respect to these in vitro assays,
the response of nickel(II) appears to be non-specific in that
both essential and toxic metals have been shown to be
mutagenic in these systems. Recently, the EPA (1986)
reviewed the testing of various inorganic nickel compounds
for mutagenicity and other genotoxic effects in a number of
test systems. Although it is suggested that the data
reported must be considered preliminary, it appears that
nickel may induce gene mutations in bacteria and cultured
mammalian cels. Nickel(II) also appears to be able to induce
chromosomal aberrations in cultured mammalian cells and
sister chromatid exchange in both cultured mammalian cells
and human lymphocytes. It also exhibits the ability to
induce morphological cell transformations in vitro and to
interact with DNA resulting in cross-links and strand breaks.
The EPA (1986) document concludes that it has been
demonstrated that nickel compounds can induce genotoxic
effects. However, the "translation of these effects into
actual mutations is not clearly understood".
The major postulate of nickel carcinogenesis at the
2+present time is that the Ni ion is the ultimate carcinogen
(Sunderman, 1984b and e). Work by Hansen and Stern (1983) is
2+frequently cited to support this "Ni ion hypothesis". They
examined the in vitro transformation potency of nickel
compounds employing BHK-21 cells (baby hamster kidney cell
line), and established a correlation between the cytotoxicity
and morphological cell transformation induced by nickel
compounds. The results are suggestive that bioavailability
2+and the intracellular level of Ni • may determine
carcinogenicity. However, the Hansen and Stern study (1983)
does not firmly establish the "nickel ion hypothesis" because
of large inter-experiment variability, lack of statistical
treatment of the results, and since no actual measurement of
the intracellular nickel content was made. Although it has
2+been demonstrated that Ni can interact with the genetic
machinery (see Section iii d), its exact role in mutagenicity
and cancer development has not been clarified.
In a recent study by Nieboer et al. (1986) , it was
pointed out that consideration must be given to a number of
factors that may mediate or modify the nickel ion hypothesis.
Among these are: the surface and other physicochemical
properties of relatively insoluble nickel compounds; the
2+concepts of the bioavailability of Ni , mode of entry and
24-
delivery of Ni or Ni(II)-complexes to cells and the nucleus
of the cell; the biological residence time of nickel and its
compounds; and the balance between the intracellular
24-compartmentalization of Ni and its extracellular
transport/excretion.
Farber (1981, 1984) has pointed out that cancer is a
multistage process. A number of steps have been recognized:
(1) initiation (a single or brief exposure to a carcinogen 
induces a permanent change in tissues recognized after 
promotion as focal proliferations, such as papillomas, 
nodules or polyps); (2) promotion (the process involving cell 
proliferation whereby tumor formation is accelerated in a 
tissue that has been initiated); and (3) progression (focal 
proliferation lesions resulting from a promoting environment 
become precancerous lesions before malignant behaviour is 
expressed). Chemical promoters of cancer appear to share an 
ability to produce radicals such as the superoxide anion 
(O2 " )? the hydroxyl radical (-0H) and the peroxy radical 
(RO2 ") from molecular oxygen (O2 ) (Marx, 1983). Since 
studies indicate that with the enzyme system 
xanthine/xanthine oxidase and with stimulated human 
polymorphonuclear lekukocytes (PMNs) the Ni(III)/Ni(II) redox 
couple participates in dioxygen radical biochemistry (Nieboer 
et al., 1986), it is tempting to postulate that Ni(II) may
also be involved in the promotion stage of carcinogenesis.
2+However, the direct participation of Ni in any of the steps 
outlined by Farber has not been demonstrated.
It is obvious from this brief review that nickel 
carcinogenesis is a complicated process.
Nickel Induced Asthma. Very few well-documented cases have 
been reported of workers who have experienced asthma due to 
exposure to nickel. The first case of asthma that was 
clearly attributable to inhalation of nickel salts was
reported by McConnell et al. (1973) for a metal plater. They 
concluded from skin and haemoglutination tests that 
circulating antibodies to nickel were involved. The second 
case was reported by Malo et al. (1982) for a young worker in 
an electroplating factory. They showed the presence of 
nickel-specific IgE antibodies. Block and Young (1982)
described a third case of a metal polisher. All three 
workers had nickel dermatitis. They also had positive
reactions to prick testing with nickel sulphate solution (in 
concentrations of 1 mg/mL or 10 mg/mL). Sunderman and 
Sunderman (1961) have reported an incident of nickel- related 
asthma due to exposure to nickel carbonyl in a patient with 
Loeffer's syndrome (excess cellular infiltration of the 
lung). Recently, Davies (1986) found evidence of three cases 
of occupational asthma (out of 53 studied) due to exposure to 
nickel salts in the manufacture of a nickel catalyst. 
However, these cases were identified by clinical observation 
with only strong circumstantial evidence to support the 
diagnosis.
Novey et al. (1983) found a metal plating worker who 
upon inhalation challenge developed acute asthma to chromium 
sulfate and a biphasic asthma- like response to nickel 
sulfate. They were able to show specific IgE antibodies to 
the challenge materials (industrial solutions of chromium 
sulfate and nickel sulfate) but not to another metal, gold, 
which the patient could tolerate. They concluded that this 
work supports the postulate that bronchial reactivity can be
specifically induced by fumes of metallic salts, even in a 
previously nonallergic individual, and that an IgE type I 
immunopathogenic mechanism is involved. An antibody with 
nickel specificity has been characterized in the serum of a
patient (Dolovich et al., 1984; Nieboer et al., 1984b). This
2+ 24-antibody recognized Ni bound to the natural Cu -binding
site of human serum albumin (HSA) as illustrated by the high
titres of radiolabelled nickel ( Ni) that coprecipitated
2+
with IgE and IgG antibodies. By contrast, Cu bound to this 
site was not recognized by the antibodies.
As pointed out by Davies (1986), it is surprising that 
so few cases of nickel induced asthma have been described. 
He makes the comment that since serum antibodies with nickel 
specificity can now be identified, it should be easier to 
investigate and positively diagnose nickel asthma.
fd^ Biochemistry of Nickel
(^Including Determinants of Reactivity)
Introduction. Nieboer and Sanford (1985) have illustrated 
the great variety of determinants of metal- ions that 
facilitate the understanding of their biochemistry, toxicity 
and therapeutic uses. This review of nickel biochemistry 
will use many examples from cancer studies and other areas 
such as enzyme reactions to provide interesting information 
on metal- ion parameters that have widespread implications for 
all endogenous and exogenous metal ions.
Absorption. The mode of entry into the body that a chemical 
has may determine its toxic (or beneficial) effect. The
relatively small amount of nickel that is absorbed via the
gastrointestinal (G.I.) tract has been interpreted in two
ways: (1) as evidence that nickel is an essential element
with uptake as part of its homeostatic control; or (2) as
evidence that this is in effect a detoxification mechanism
2+that serves to exclude, at least in part, the Ni -ion from
2+the human body. Indeed, it appears that Ni interacts with 
constituents of foods and beverages in a differential manner 
causing a variable uptake in humans because of diet (Solomons 
et al., 1982). A recent study by Foulkes and McMullen (1986)
go 2+
found a two- step mechanism for the absorption of Ni from
the lumen of perfused rat jejunum. The first step was found
2+to be linearly dependent on concentrations up to 20 fM Ni
with saturation being approached between 20 and 100 /zM. They
also found that this step was inhibited by a foodstuff namely
2+dried skim milk. The absorption of Ni from the G.I. tract
2+probably results from an equilibrium of Ni with various
2 - i -food components which limit the amount of free Ni that can 
be absorbed. The absorption of low molecular mass 
Ni(II)-complexes in the G.I. tract was not investigated. The 
second step, the movement from the jejunum mucosa into the 
body was shown to be different for Cd^+ and Ni^+ . For Cd^+ , 
high retention in the mucosa occurred with subsequent slow
24-
movement to the body. Ni (Foulkes and McMullen, 1986) and 
2-hZn (Bonewitz et al. , 1983) show little tendency to be
24-retained in the mucosa. This indicates that Ni acts more
24-like the essential ion Zn than the non-essential and toxic
2+ 2+Cd ion. Thus the uptake of Ni appears to resemble that
of an essential metal with a means of limiting uptake to
2+partially regulate body levels. It is well known that Ni
can penetrate the skin and produce allergic skin reaction.
However the incidence of any G.I. tract irritation is very
low, with no reports of cancer due to nickel. This is in
contrast to the high prevalence of respiratory cancers in
nickel workers and dermatitis in the general population.
Cellular Uptake. Because of the high incidence of lung
cancer for workers exposed to insoluble nickel compounds,
most of the work on cellular uptake of nickel has centered
around the phagocytosis and solubilization of such compounds.
Costa and Mollenhauer (1980) have shown that crystalline
nickel subsulfide is actively phagocytized by cultured
Chinese hamster ovary (CHO) and Syrian hamster embryo (SHE)
cells. In contrast, no active phagocytosis was observed in
cells exposed to amorphous nickel monosulfide nor to
water-soluble nickel(II) salts. Phagocytized particles were
solubilized to a form capable of entering the nucleus and
interacting with nuclear macromolecules (Costa et al., 1981).
The kinetics of solubilization may be expected to play some
role in the toxic action of nickel compounds. For example,
2+in a study with Ni -hydroxides and NiSO^, Kasprzak et al. 
(1983) found an inverse relationship between carcinogenic 
activity and dissolution kinetics in human serum, artificial 
lung fluid and ammonium acetate buffer. By contrast, 
Sunderman (1984c) found that the sarcoma incidence at two
years after i.m. injection of various nickel compounds (14 mg 
Ni/rat) was correlated (p = 0.02) with their nickel mass 
fractions, but not with dissolution half-times in serum or 
renal cytosol, nor with in vitro phagocytic indices assessed 
for rat peritoneal macrophages. He also found a significant 
rank-correlation (p < 0.0001) between the carcinogenic 
activities and the potencies of the compounds to induce 
erythrocytosis of rats two months after i.r. injection of 
nickel compounds (7 mg Ni/rat). By comparison to the slow 
solubilization of crystalline nickel subsulfide, the highly 
lipid- soluble nickel carbonyl and aerosols of soluble nickel 
salts are absorbed by the body very quickly through the 
lungs. As already indicated, nickel absorbed or ingested as 
soluble nickel compounds has a much shorter half- life than 
tissue deposits of insoluble compounds (such as in the 
lungs).
Cellular uptake of soluble Ni(II) salts may be mediated
by the presence of extracellular and intracellular ligands.
2+The uptake of Ni by cultured cells (human B-lymphoblasts,
human erythrocytes and rabbit alveolar macrophages) has been
shown to be promoted by DDC presumably because of the
lipophilicity of the resulting Ni(DDC) 2  complex. L-His and
HSA at physiological concentrations, like the exogenous
ligands D-PEN and EDTA, inhibited the uptake of physiological 
2+levels of Ni (Nieboer et al. , 1984c). Preincubation with
2+DDC has also been shown to increase the uptake of Ni by 
human peripheral mononuclear leukocytes (mostly lymphocytes
with approximately 15% monocytes) (Menon and Nieboer, 1986).
They interpreted the predominant incorporation and subsequent
cytosolic accumulation rather than in the cell pellet
(consisting of the plasma membrane, nuclei, mitochondria,
lysosomes and cell debris) in terms of the "Equilibrium"
model of metal ion uptake by cells (Williams, 1981). This
model proposes that the distribution of metal ions among the
various compartments of a cell under steady state conditions
(i.e. at fixed pH, redox potential, intracellular and
extracellular ligand concentrations) is determined by
thermodynamic parameters such as the pKa values of ligands,
the binding constants of the metal-ligand complexes, and
their solubilities in aqueous and lipid phases. This
"Equilibrium" model may be envisioned to mediate cellular
24-uptake, distribution and clearance of Ni
Biological Role of the Nifll^ Ion. Ingested nickel is
presumably taken up as the Ni(II) ion. Intracellular
dissolution of particulates of a nickel compound in
phagocytic cells is also believed to result in an increased
availability of nickel ions. Nickel(II) released from, for
example, alveolar macrophages, is likely available to the
24-surrounding tissue. Presumably once inside the cell, Ni 
then has the potential of interacting with a large selection 
of intracellular ligands (from amino acids to proteins to DNA 
etc.). Subsequently it is most likely transported to various 
parts of the cell (e.g. to the nucleus) and, in part,
transported out into the blood stream, from which it can be
delivered to other tissues or be excreted via the kidney.
2+Thus absorbed Ni now has the potential of participating in
some of the many biological roles of metal ions (Fig. 1.1).
Reactivity of the Nickel(II) Ion. A system of classification
has been proposed by Nieboer and Richardson (1980) that
separates the binding preferences of metal ions into class A
(oxygen- seeking), class B (nitrogen/sulfur-seeking) and
borderline (or ambivalent). A survey of crystallographic
data for metalloproteins and metalloenzymes is consistent
with these designations (Blundell and Johnson, 1976; Nieboer
and Richardson, 1980). The charge-to-size ratio (Z /r) is a
measure of the ability of metal ions to participate in ionic
or class A interactions, while the - product of
o
electronegativity and size (Xmr) reflects covalent-bonding or
class B tendency. These covalent and ionic indices plotted
in Figure 1.2 allow a graphical display of the metals in each
of these three categories (Nieboer and Richardson, 1980;
Nieboer and Sanford, 1985).
2+The Ni ion is borderline in its binding preference.
Thus in addition to its affinity for class B (nitrogen and
sulfur) ligands, it tends to bind to class A (oxygen) sites.
2+Consequently, Ni can compete effectively with class A ions
for their binding sites and at the same time seek out other
2+non-oxygen centres. A prime example is the tendency of Ni
2+ 2+to bind with oxygen sites even better than Ca and Mg 
2+Ni behaves as a partial antagonist in the response observed
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Figure 1.2 Classification of metal ions according to 
binding preferences: Class A, oxygen-seeking; Class 
B, nitrogen/sulfur seeking; Borderline,
intermediate or ambivalent.
Z = formal charge; r = ionic radius; 
xm = me"kal i°n electronegativity
For fixed covalent index, stability increases with 
ionic index; and conversely for fixed ionic index, 
stability increases with covalent index.
Consequently, endogenous ions such as Mg2+ and Ca2+ 
are readily displaced by ions above them in the
figure (e.g. Pb2+ and Cd2+) and to their right
(e.g. Al^+ , Be2+ and La^+).
Reproduced from Nieboer and Richardson, 1980.
2+for Ca -dependent processes in excitable tisues such as
2+muscle and nerve cells. On the other hand, Ni closely 
2+mimics Ca in generating action potentials, but cannot 
2+replace Ca in generating the myosin- actin interaction (see
24-Table 1.1). Ni has also been shown to have ambivalent
action on the contractile activity of isolated rat uterus
_ y
(Rubanyi and Balogh, 1982). In low concentrations (10 to
_ c
10 M), NiC^ increased the basal tone (sustained
24-
contracture) probably by enhancing the influx of Ca and/or
2+
inhibiting mitochondrial sequestration of Ca In high
- 4 - 3doses (10 to 10 M), NiC^ depressed spontaneous
contractions by antagonizing the influx of Ca^+ into uterine 
smooth muscle cells.
24-Complex Formation is very rapid for Ca (forward rate 
constant, k£ = 10^ - 10^ s " , which is faster than for Mg^+
(k^ = 105 s'1) and for Ni^+ (k£ = 10^ s'1) (Nieboer, 1981).
24- 24-Ni complexes also tend to be more stable than those of Ca
and Mg^+ . Substituton of Ni^+ for Ca^+ and Mg^+ can lead to
activation or inactivation of enzymes (Nielsen, 1974, 1980;
Nieboer et al., 1984a). Other examples, in addition to those
mentioned earlier, of the replacement of essential metal ions
2-fby Ni are given in Table 1.1. Recently King et al. (1985)
2+found that Ni dramatically activates the
calmodulin-dependent phosphoprotein phosphatase in a
2+time-dependent and irreversible manner. The Ni ion, like
24- 2+the endogenous divalent metal ions Mn and Mg maintains
Table 1.1
REPLACEMENT OF ESSENTIAL METAL IONS BY Ni2+
Biological system* Effect*
A. Ni7 +/Ca7 + antagonism
1. Enzymes
Human'salivary a-amylase +
Staphylococcal nuclease -
2. Excitable tissues
Frog skeletal and cat heart muscles:
Uncoupling of:
Excitation +
Contraction —
Uterine contraction in rat:
Low levels +
High levels -
3. Exocytosis
Epinephrine in frog adrenal +
Prolongs transmitter release in frog +
neuromuscular junction 
Amylase (rat parotid) —
Growth hormone (bovine pituitary) —
B. Ni2 +tMg7 + antagonism 
Enzymes
Phosphoglucomutase (rabbit muscle) +
Ribulose diphosphate carboxylase +
Yeast enolase —
Pyruvate kinase (rabbit muscle) —
Avion myeloblastosis virus and E. coii —
DNA polymerases
C. Ni7 +!Zn7 *  antagonism 
Enzymes
Carboxypeptidase A (bovine) +
Aspartate transcarbamoylase (E. coli) +
Alkaline phosphatases (E. coii) —
Carbonic anhydrase B (human) —
*A decrease In enzyme activity of >70% relative to the native enzyme was considered Inhibitory. 
* Activation or stimulation +; inhibition - .
Reproduced from Nieboer et al. 1984d.
the phosphatase's structural stability. They speculate that
2+the irreversible activation of the phosphatase by Ni in the 
presence and absence of calmodulin indicates that the effect
may be toxic by interfering with normal cellular regulation.
2+ 2+ Ni has been implicated in the inhibition of Ca
requiring hormone release. For example, Dormer et al. (1973)
studied three different Ca^+- requiring hormone systems in
detail: the release of the salivary enzyme amylase from the
parotid gland; the release of insulin from mouse pancreatic
islets; and the release of growth hormone from bovine
2+pituitary slices. In all of these cases the presence of Ni
inhibited the release of hormone or enzyme under conditions
which would have been expected to cause stimulation.
As pointed out in the Cancer section of this chapter, Mn
dust inhibits the carcinogenic response of alpha-Ni^S2  when
both were given as i.m. injections in the same thigh
(Sunderman and McCully, 1983). This can be explained by the 
24-fact that Mn might be expected to be a good replacement for 
2+ 2+Ni (Mn has borderline character; is slightly larger than 
2+Ni ; and both prefer octahedral complexes) providing that
2+the redox properties of Mn do not become critical. In
vitro and in vivo studies indicate that the presence of Mn
dust retards the dissolution of of NigS2  (Sunderman et al. ,
1976a; Hopfer and Sunderman, 1978). Presumably, the
simultaneous dissolution of both Ni^S2  and Mn dust (at the
2 +  24-same injection point) sets up a competition of Mn and Ni 
for the same binding sites. In normal tissue, manganese is
generally present at higher concentrations than nickel (up to
2+15X) (Sumino et al., 1975). Mn deficiency occurs in cattle 
grazing on peat pasture that lacks this element, but human 
deficiency is not known (Passmore, 1976). Manganese 
compounds do not appear to be carcinogenic.
Geometric preferences of metal ions may play.important roles
in biochemical reactions. This is illustrated by the
2+ 24-differences between Zn and Ni . They are both borderline
24-ions and form complexes of comparable stabilities. Most Zn
metalloenzymes require a tetrahedral arrangement of ligands
24-which is common for Zn stereochemistry, while the majority 
of four- coordinate complexes with Ni^+ are square planar
24-
(Nieboer et al., 1984d). In Table 1.1, some Zn -enzymes are
24-inhibited, as expected, by Ni substitution. The enzymes
24-that are activated by Ni substitution presumably do not
24-strictly require the tetrahedral geometry favoured by Zn
As discussed in the absorption, distribution and
24- 24-excretion section of this chapter, there is a Cu /Ni
binding site on HSA. This primary and natural complex of 
2+Ni is characterized by a square pyramid with both nitrogen
and oxygen binding sites (see Fig. 1.3) (Glennon and Sarkar,
1982; Sarkar, 1984; Dolovich et al., 1984). This illustrates
the borderline character of both Cu^+ and Ni^+ . Both Cu^+ 
24-and Ni have almost the same ionic radii and are capable of
5-coordinate square pyramid geometry (Cotton and Wilkinson, 
24-1980). Cu exhibits stronger binding to this site than does
2+Ni , which could have been predicted by the larger class B
2+character possessed by Cu ; the log (association constant)
for Cu^+-HSA is 16.1 and 9.5 for Ni^+-HSA (Glennon and
2+ 2+ Sarkar, 1982). Not surprisingly, Cu can replace Ni bound
to HSA. However, the human body is capable of generating
2+specific antibodies that only recognize Ni . bound at this
24-
natural Cu binding site (see Nickel Induced Asthma section 
of this chapter).
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Figure 1.3. Proposed structure of the nickel-transport 
site of human albumin.
Reproduced from Sarkar, 1981.
The binding of nickel to proteins after intraperitoneal 
(i.p.) injection, and in vitro incubation of NiC^ with 
isolated fractions obtained from the lung and liver of
untreated mice, was investigated by Herlant-Peers et al.
(1983). They found, in both in vivo and in vitro studies,
that all cellular fractions (except the nuclear fraction)
contained several nickel-binding proteins. In vivo
63 2+incorporation of Ni into lung fractions (especially the
mitochondrial and microsomal) showed consistently higher
concentrations of label than did the liver fractions. This
investigation not only illustrates that the lung is a target
organ for nickel-retention (and possible toxicity), but also
2+demonstrates that Ni is preferentially bound to the
mitochondrial and microsomal fractions. Several proteins are
implicated in the transport and metabolism of nickel in the
cell. Thus we see that cells are able to compartmentalize
nickel within them. A number of other studies have
2+illustrated a similar ability of Ni to bind to low and high
molecular mass components of rat, cow and human renal cytosol
(Sunderman et al., 1981; Sunderman et al. , 1983; Abdulwajid
and Sarkar, 1983; Templeton and Sarkar, 1985; Templeton and
Sarkar, 1986). The significance of renal intracellular
compartmentalization will be discussed in Chapters 4 and 5.
Ni-transport proteins may be expected to mediate
delivery of nickel to the nucleus of a cell. Once Ni^+ is in
the nucleus it can cause potentially detrimental effects. 
2+Mg is the counter ion to negatively charged phosphate 
groups and thus stabilizes genetic material (Eichhorn, 1981). 
It is also needed to regulate the incorporation of the proper 
nucleotides in both DNA and RNA synthesis (Spiro, 1980).
o . o .
Ni has the ability to displace Mg (both have
2+approximately the same radii and Ni will bind to an oxygen
ligand better than Mg ). Replacement of Mg by Ni is
known to decrease the fidelity of DNA synthesis (Sirover and
2+Loeb, 1976). Ni has also been shown to bind to DNA and RNA
polymerases and appears to deactivate them (Sirover and Loeb,
2+1976) , probably by displacing Zn . Thus it is not 
surprising that DNA lesions have been observed in nuclei 
isolated from rat tissues (kidney, liver and lungs) following 
i.p. injection of nickel carbonate (Ciccarelli and Vetterhahn,
1982). Recently Ciccarelli and Vetterhahn (1985) have found
Rq Q .
that Ni became bound to chromatin, polynucleosomes (DNA +
histone octamer protein complex), and to deproteinized DNA,
both in isolated intact nuclei and in vitro incubation of
2+chromatin fractions. The amount of Ni bound depended on
2+the concentration of Ni , the presence of chromosomal
proteins and the binding sites on DNA which provide a stable
2+ 2+ coordination environment for Ni . As DNA containing Ni
2+was isolated from chromatin, Ni appears to interact
directly with the stable binding sites of the DNA molecule in
this molecular moiety (Ciccarelli and Vetterhahn, 1985). The 
24-binding of Ni to chromatin and to DNA in isolated whole
nuclei was much slower than in vitro incubation of isolated
chromatin, indicating that accessibility of the DNA binding
sites was influenced by the presence of the nuclear membrane.
2+This illustrates the possibility of Ni being genetoxic and 
DNA its molecular target. Additional details on the
-genotoxic and mutagenic potential of nickel compounds are
provided in the Cancer section of this chapter.
It has been speculated that conformational changes in
oligodeoxynucleotides from the normal right-handed B- helix to
the left-handed Z-helix may have a role in the nickel(II)
carcinogenic process (Boutayre et al., 1984; Rich et al. ,
1984). In a recent study, Rossetto and Nieboer (1987) have
shown that conformational changes with poly d(G-C)*poly
2+d(G-C) support the theory that interactions of Ni with DNA
are not specific. They found that all 20 metal ions tested,
including several whose compounds are non-carcinogenic,
promote the conversion of the B-helix to a Z-helix. Thus, 
2+although Ni can interact with DNA, it may not be specific 
and hence may not be the ultimate carcinogen postulated in 
the somatic mutation model of cancer induction, unless 
preferential intranuclear compartmentalization occurs. This 
is in agreement with the non-specific mutagenic potential of 
nickel(II) that was pointed out earlier in the Cancer 
section.
Studies with the enzyme system xanthine/xanthine oxidase
3 1 o+
and with human PMNs indicate that the Ni /Ni redox couple 
can participate in dioxygen radical biochemistry (Nieboer et 
al. , 1986; 1987a and b). This redox property of nickel
suggests that it may have the ability to act as a chemical 
promoter of cancer (see Cancer section).
A large number of parameters and processes have been 
shown to be of importance in nickel biochemistry/toxicology:
namely, ion size, preferred geometry, binding preferences, 
isomorphous and non- isomorphous replacement of endogenous 
metal ions, complex stability, redox properties, lipid 
solubility, insolubility; and mode of entry, cellular 
uptake, phagocytosis, solubilization, membranes,
compartmentalization, target organ, and molecular target. 
Surface passivity of solid nickel compounds, biological 
clearance, biological residence time and bioavailability were 
identified as possible determinants of reactivity in the 
discussion of nickel carcinogenesis (see Cancer section).
From this brief review of nickel biochemistry/toxicology 
it is obvious that the subleties of the inorganic chemistry 
and solution chemistry of nickel(II) provide it with 
agonistic and antagonistic roles.
(e} Other Toxic Effects of Nickel
Reproductive and Developmental Effects of Nickel. Since 
nickel has been demonstrated to cross the placenta, there has 
been concern over its reproductive and developmental effects. 
Because these effects of nickel have not been demonstrated in 
humans (EPA, 1986), they will not be reviewed in this thesis.
(f) Nephrotoxic Effects of Nickel
There are some reports of nephrotoxicity in humans 
attributed to nickel exposure. Such observations are very 
rare in comparison to the well-documented nephropathies 
induced by uranium, cadmium and lead (Nieboer et al. , 1984a).
Gitlitz et al. (1975) reported proteinuria in persons who 
chronically drank water from a well contaminated with nickel, 
and Sunderman and Horak (1981) observed a significant 
relationship between increased urinary concentration of 
beta-2-microglobulin and hypernickeluria in nickel workers. 
However, Vail and Calnan (1980) found that there was no 
evidence of proteinuria in 17 nickel process workers in an 
electroforming plant during an outbreak of occupational 
dermatitis. It is important to note that other than in two 
cases of nickel carbonyl poisoning (Sunderman, 1977), no 
other cases of severe proteinuria, nor any other markers of 
significant renal disease have been reported despite years of 
collecting urine specimens (Nieboer et al., 1984a).
Gitlitz et al. (1975) have studied the biochemical and 
ultrastructural changes induced in the rat kidney after a 
single i.p. injection of a water-soluble nickel salt. They 
concluded that an acute reversible nephropathy is associated 
with nickel. Their work indicates that NiC^- induced 
nephropathy results mainly in glomerular damage, with renal 
tubular damage being less prominent and with focal tubular 
necrosis occasionally seen. Sunderman and Horak (1981) found 
that two days after injection of NiC^ in rats (6mg/lcg b.w.), 
excretion of protein in the urine was increased four-fold, 
urine N-acetyl-D-glucosaminidase (NAG) activity was doubled, 
and the excretion of selected amino acids was increased 
ten-fold. A dose-response relationship was demonstrated for 
these three indices, with urinary protein being the most
sensitive index of NiClg- induced nephrotoxicity.
Because there is relatively little known about the renal 
excretion of nickel in man and animals, the present study was 
initiated in an attempt to fill part of this void. This work 
will assess the renal function of electrolytic refinery 
workers for clearance of nickel, and urinary markers of 
nephrotoxicity. The uptake and distribution of nickel in the 
kidney of an animal model will also be investigated.
CHAPTER 2 A SYSTEMATIC APPROACH TO ADJUSTMENT OF URINARY 
NICKEL CONCENTRATIONS FOR RATES OF URINE FLOW
A INTRODUCTION
It is widely recognized that the volume of urine 
excreted varies widely with collection time. Even during 
short time periods, urinary flow rates are variable. Yet
urine analysis is commonly used in all branches of medicine 
and particularly in the biological monitoring of workers. A  
number of strategies have been used to overcome these
concentration-dilution effects on the analyte concentration 
of interest. Practices currently used include: (i) the 24-h 
collection; (ii) collection over a shorter but timed period 
(e.g., an 8-h collection); and (iii) the standardized,
untimed specimen (the spot sample), such as the first void in 
the morning, and preshift or postshift specimens. The spot 
samples are often adjusted (normalized) to a constant 
specific gravity or are expressed per mole or gram of 
creatinine. However, results are also frequently reported 
without any adjustment (Pryde 1982). Thus practices for 
adjusting urinary concentrations in spot samples for 
different flow rates are inconsistent.
For urinary nickel spot samples, Tola et al. (1979) 
found that specific gravity normalization was more effective 
than creatinine adjustment in reducing the variability in 
nickel concentrations. Bernacki et al. (4D78) chose to
reject urine specimens with a specific gravity (p ) below 
1.012. However, Hagedorn-Gotz et al. (1977) and Adams (1980)
were able to reduce considerably the variation in individuals
exposed to nickel carbonyl by creatinine normalization, as
illustrated in Figure 2.1. Here, the uncorrected
urinary-nickel values have a large variation with a probable
but not systematic decrease over a four day period. When
these nickel values were adjusted to a creatinine
_ i
concentration of 1.6 g L , a reasonably smooth decay curve 
with less variation was the result. With reference to 
Figure 2.1, subsequent to the initial time point of exposure 
there appears to be a gradual increase in nickel levels. 
After a maximum was achieved, a slow and relatively smooth 
decrease in nickel levels occurred. Thus, from this 
information it appears that nickel reaches a maximum in the 
urine approximately 24-h after exposure. It is evident that 
volume standardization increased the toxicological 
information about this Ni(CO)^ exposure incident. Most 
researchers report unadjusted nickel levels, perhaps because 
specific guidelines are not available and because data for 
other urinary analytes often indicate that neither specific 
gravity nor creatinine normalization reduces the standard 
deviation from that found in unadjusted results (Graul and 
Stanley, 1982).
It is widely held that the 24-h urine collection 
obviates the concentration-dilution problems since amounts of 
analyte per unit time are measured (Pryde, T982). However, 
there is evidence that concentrations in 24- h collections 
adjusted for specific gravity are a better index of exposure
.  Point of 
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Figure 2.1. Nickel concentrations in urine samples from a 
worker accidently exposed to nickel carbonyl.
Reproduced from Adams (1980).
than 24-h excretion rates (Elkins and Pagnotto, 1965). In 
the occupational setting, the single spot sample has been 
accepted as the most practical and convenient. Although 24-h 
collections are preferable in a clinical setting, a single 
spot or grab sample is commonly used for practical reasons. 
When 24-h collections are taken, it is common to express the 
analyte of interest in the amount excreted per day. With 
untimed spot samples, the common practice is to normalize the 
analyte concentration with creatinine rather than correct to 
a fixed specific gravity. —
In this chapter a systematic approach to urinary nickel 
adjustments is outlined to provide more rigorous treatment to
this problem. The two cohorts examined involved
International Nickel Company of Canada (INCO) employees 
working in electrolytic refining, one at Port Colborne 
(Ontario, Canada) and the second at Thompson (Manitoba, 
Canada). The nature of the electrolytic processes are now 
briefly summarised.
The secondary refining of nickel by electrolytic 
processes takes impure nickel (see Chapter IB ii) to produce 
very pure nickel (>99.9%), while recovering impurities such 
as Fe, Co, Cu and precious metals (e.g., Au, Ag, and Pt) . 
The following description is based on Boldt (1967), Mackenzie 
(1968) and Morgan (1979). The generalized flowchart for the 
two common electrolytic refining processes (electrorefining 
and electrowinning) is illustrated in Figure 2.2. The major 
difference depends on the type of anode utilized. At Port 
Colborne the majority of the anodes were made by the 
reduction of nickel oxide (~74% Ni) to impure metal with 
petroleum coke as the reducing agent and then cast into 
anodes. These anodes were then placed into tanks containing 
electrolyte at ~60°C as depicted in Figure 2.2. This yields 
an electrolytic process (electrorefining) that does not have 
a net cell reaction as illustrated below in Equations 2.1 and 
2.2.
2+Ni (anode) ^ Ni (in anolyte) + 2e (anode) (2.1)
Ni^+ (catholyte) + 2e" (in cathode) ^ Ni(cathode) (2.2)
Concrete —  
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///////////////////
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Figure 2.2 General flowchart illustrating the principles of 
secondary refining by the electrolytic processes 
electrorefining and electrowinning. Adapted from 
Mackenzie, 1968.
However, at Thompson the anodes are cast from nickel matte 
(~207o S) directly from the converter (smelter). This results 
in an electrolytic process that has a net cell reaction 
(electrowinning). These anodes are then placed into tanks 
containing electrolyte as depicted in Figure 2.2. The 
principal anode reaction is:
Ni3S2 * 3Ni2+ + 2S + 6e 
while at the cathode:
3Ni2+ + 6e* * 3Ni
resulting in a net cell reaction of
Ni3S2 ^ 3Ni + 2S (2.5)
Around each cathode is a canvas- covered compartment that is
used to divide the cell so that elements like Cu and Pb 
(lower in the electromotive series than Ni) in the anolyte 
will not plate out on the cathode. The anolyte passes from 
the anode part of the cell containing such elements as Co, 
Cu, Fe, Pb, and As while the Ag, Au, and Pt group of metals 
remain undissolved and are recovered from the slime that 
deposits at the bottom and sides of the tank. Iron is 
usually removed by first aerating the anolyte to obtain the 
ferric ion which is precipitated as the ferric hydroxide. 
Coprecipitation of Pb and As also occurs. Cobalt is 
precipitated as the cobalt(III) hydroxide after oxidizing 
with (e.g., Cl2). Copper is removed by the addition of
metallic nickel causing the precipitation of metallic Cu or
(2.3)
(2.4)
addition of H2S to precipitate the copper as CuS. After
removal of impurities, the electrolyte is pumped into the
compartment around the cathode. The higher level of the
catholyte creates a hydrostatic pressure so that there is
continual flow of electrolyte out of this compartment into
the anolyte, not allowing any mixing of the anolyte in the
catholyte compartment. The pure electrolyte around the
24-cathode that now contains "pure" Ni is plated out on the 
cathode with a purity of ~99.937o.
From this description of electrolytic refining processes 
it is obvious that both groups of workers in this study are 
exposed mainly to soluble nickel. However, anode casting and 
the purification steps do result in exposure to particulates 
containing nickel and/or other elements.
B MATERIALS AND METHODS
For convenience and to avoid duplication, both the 
determination of nickel in urine and sera are described in 
this section, although the reporting of the serum nickel 
levels is delayed until Chapter 3.
(i) MATERIALS
fa^  Chemical reagents
Pertinent information about the routine chemical 
reagents used are summarized in Table 2.1.
(b) Laboratory Solutions fAuto Analyzer)
Sodium Chloride (0.9% w/v)♦ To prepare 1 L of sodium 
chloride solution, 9.0 g of NaCl was placed in a 1 L 
volumetric. Approximately 500 mL of ultra-pure water (DDV; 
Table 2.1) were added and mixed until completely dissolved. 
Prior to dilution to volume, 0.5 mL of the detergent Brij-35 
were added.
Sodium Hydroxide TO.5 M) . Approximately 800 mL of DDV were 
added to a 1 L volumetric flask containing 20.0 g of NaOH and 
allowed to dissolve. It was then brought to volume.
Saturated Picric Acid. Approximately 14 g of picric acid 
were added to a 1 L volumetric flask and DDV added to the 
mark. The mixture was periodically agitated during 4-h 
equilibration period. The solution was then filtered into a 
polyethylene (PE) bottle and stored in the dark.
Stock Creatinine Standard (1 m g /m L ). Exactly 1.0 g of 
creatinine was transferred to a 1 L volumetric flask. This 
was dissolved and brought to volume with 0.1 M HC1.
(c) Laboratory Solutions fNickel Determination)
Potassium Phosphate Buffer. To prepare 250 mL of buffer, 
17.0 g of anhydrous KH2P0^ and 21.8 g of I(2HP0^ were added to 
~ 150 mL of DDV. The beaker was covered with Parafilm and 
allowed to sit overnight. The resulting solution was 
transferred to a 250-mL volumetric flask and-brought to the 
mark with DDV. To this 0.1 g of APDC was added. The 
resulting solution was extracted a number of times with CHCl^
Table 2.1a 
CHEMICAL REAGENTS
Chemical Reagent Source Grade Comments
Ammonium pyrolidine 
dithiocarbamate 
(APDC)
^2 * microglobulin 
Test Kits
Barbital IV 
(Sodium diethyl- 
barbiturate)
Barbital 
(5,5- diethyl 
barbituric acid)
Bri j- 35
Bromothymol Blue 
CHClg
Coomassie 
Brilliant Blue
Creatinine
DD HC1
HC1
BDH,
Toronto, 
Canada
Pharmacia
Montreal
Fisher
Fisher
Technicon
BDH
BDH
Bio- Rad 
BDH
Spectrosol
RIA-1 
/?2 ~ micro
and
RIA-2
Purified
Purified
AnalaR 
G- 250
AnalaR
Double
Distilled
HC1
J.T. Baker Analytical 
Reagent
For atomic absorption 
spectrometry.
Determination of
/?2 ~ microglobulin in
serum and urine by
radioimmunoassay
(RIA)
Used to obtain optimum 
bubble pattern and 
maintain low noise in 
creatinine determination 
(0.5 mL per litre of 
saline solution).
5- fold concentrate
Double distilled
constant boiling mixture 
(6 M HC1) of reagent 
grade HC1.
J.T. Baker Ultrex 607o (w/v)- solution.
Table 2.1a continued
Chemical Reagent Source Grade Comments
Human Serum 
Albumin
Sigma Albumin
Human
Fraction V
Used for total 
protein standards in 
Bio- Rad determination
k2hpo4 BDH ACS Assured
k h2pq4 BDH ACS Assured
nh4oh Merck,
Toronto, 
Canada
Ultrapure 13.4 M solution
Nickel Powder Alpha 
cat. no. 
0063
Used for nickel 
standards Spherical 
5 [m  diameter.
NaCl BDH AnalaR
NaOH BDH Analytical
Reagent
4- Methylpentane- 
2-one (MIBK)
BDH Laboratory
Reagent
For atomic absorption 
spectroscopy.
Picric Acid BDH AnalaR
Pb(N03)2 BDH AnalaR Used for lead standards.
Ultra- pure water 
(DDV)
Prepared by demineral- 
izing laboratory 
distilled water (Corning 
LD- 2a demineralizer) and 
distilling it in a 
Corning Mega-Pure still.
a. Some of the items listed in this Table are employed for
the work described in Chapter 3.
until there was no trace of yellow in the CHClg layer. The 
purified buffer solution and the last CHClg extract were 
tested for nickel content. The buffer was transferred to a 
polyethylene bottle the cap sealed with Parafilm; storage was 
in the dark. The final pH of the solution was 6.7. 
Bromothvmol Blue Indicator Solution. Into a 60 mL screw- cap 
polyethylene drop-dispenser bottle, 20 mg of bromothymol blue 
and 1 mL of dilute NH^OH solution were added. The contents 
were diluted to 50 mL with DDV and stored in a wash bottle. 
The delivery tube was capped and the bottle was wrapped with 
Parafilm. It was stored in the dark.
APDC (27c w/v). 0.5 g of APDC was added to a 50 mL Falcon
Tube (not acid washed). This was dissolved in 25 mL of DDV 
and extracted with MIBK until the last two extractions were 
colourless (usually three extractions were required).
Stock Nickel Standard flOOO mg/L^. Into an acid washed 
150-mL beaker, exactly 0.50 g of nickel powder (spherical 5 
fmi diameter) was added. Approximately 5 mL of HNO^ (Ultrex) 
were added and the mixture was stirred under low heat until 
dissolution was complete. The cooled solution was 
transferred to a 500 mL volumetric flask and brought to the 
mark with DDV. The solution was stored in a Parafilm-wrapped 
screw-capped polyethylene bottle. This solution was stable 
for ~ 1 year.
Nickel Intermediate Standard (1 mg/mL). Vitlr a fixed volume 
50- fiL Eppendorf pipettor (calibrated for delivery with 
water), 50 /jL  of the nickel stock standard solution was
-70-
transferred to a 50 mL (acid-washed) glass volumetric flask 
and diluted to volume with 1% DD HC1 (0.12 M HC1). This 
solution was kept for up to six weeks.
(d) Decontamination of Plastic and Glasswares
In Table 2.2, details are provided about the glassware
and plasticware employed. The protocols to prevent 
extraneous additions during collection, handling and 
analytical procedures were patterned after Nieboer and Jusys 
(1983). Throughout the cleaning of wares, plastic gloves 
were worn and special effort was taken to avoid contact with 
stainless steel items (e.g. fume-hood linings and sinks). 
All wares used in the procedures for nickel were first washed 
with a hot non-ionic detergent solution, rinsed with DDV and 
then subjected to acid-washing. Items were first placed in
acid-washed snap-capped polyethylene canisters and soaked in
6 M HC1 in a batch fashion for 2 to 7 days on a plastic tray 
in a fume hood cupboard. In the case of large items (e.g., 
500-mL PE bottles) the 6 M HC1 was poured directly into the 
contianers, and the tops screwed on tightly so as to ensure 
direct contact with the screw cap. After decantation of the 
HC1, the wares were rinsed at least three times with DDV. 
This was followed by a soaking for 2- 7 days in dilute 
double-distilled (DD) HC1 (~ 1M HC1) until use. At that 
time, they were then rinsed several times with DDV and dried 
in an aluminium oven at 110°C on plastic coated test- tube
Table ,2.2a
PLASTICVARE
Descriotion Source Comments
Vide mouth 
bottles
Nalgene, 
Fisher
Polyethylene (PE) screw 
cap bottles (500 mL); 
collection bottles for 
urine voids.
Centrifuge
tubes
Corning 
25319-15, 
Fisher
Polypropylene (PP) screw 
cap centrifuge tubes 
(15 mL); for storage of 
serum.
Centrifuge
tubes
Falcon
2098,
Becton-
Dickinson
Polypropylene (PP) screw 
cap centrifuge tubes 
(50 mL); for storage of 
urine.
Centrifuge
tubes
Falcon
2059,
Becton-
Dickinson
Polypropylene (PP) 
snap- cap round bottom 
tubes 17x100 mm; for 
determination of 
nickel in serum.
Syringes Sarstedt Serum Monovette 
syringes (polypropylene 
10 mL) with separation 
aid; for collection 
of blood.
Needles Intravenous
Cannulae
6745
Becton-
Dickinson
I. V. catheter 
(polyethylene cannulae 
with teflon needle hubs) 
20G 5 cm length with 
23G inner needle; for 
collection of blood.
Ultracentrifuge
tubes
Beckman
339573
Threaded- top polycarbonate 
tubes with a plug, 0- ring 
and noral cap (maximum 
speed 650000 RPM) .
a. Some of the items listed in this Table are employed for
the work described in Chapter 3.
racks. The 500 mL PE urine specimen bottles, the 50-mL 
Falcon tubes and the 15-mL Corning centrifuge tubes were 
allowed to air- dry after vigourous shaking to remove excess 
water by inverting on a clean lab bench covered with 
absorbent bench paper (Canlab) placed on paper towels. After 
drying, all wares were wrapped with Parafilm, placed in 
sealed plastic bags and stored in boxes until use.
The syringes used in blood collection required special 
treatment. They were subjected to the same acid washes 
described above except that this was done in smaller batches 
and special care was taken to ensure that they were 
completely filled with the wash or rinse solutions. After 
removal from the last DDV rinse, they were dried by 
lyophilization while being held in an acid-washed glass jar. 
Subsequently, the tops and bottoms of the syringes were 
wrapped with Parafilm and stored in sealed plastic bags until 
use.
(ii) DONOR POPULATIONS 
(a) Nickel.
This study was carried out on 26 subjects occupationally 
exposed to nickel at INCO’s electrolytic refining operations 
in Port Colborne (Ontario, Canada) and Thompson (Manitoba, 
Canada). A single multi-void 24-h collection involving 
twenty workers was conducted at Thompson. The study group 
consisted of workers from each of three shifts (day shift, 
7am - 3pm; afternoon shift, 3pm - 11pm; midnight shift, 11pm
- 7am). The Port Colborne collection had two components.
The first 24-h multi-void collection (day shift, 7am - 3pm)
was made just prior to a one-month layoff and the second
multi-void 24-h collection was made on their return to work. 
The mean + SD age of the Port Colborne donors was 48 + 12 
years while for Thompson it was 4 5 + 8  years.
(b') Lead.
This study was carried out on one subject who was
occupationally exposed to lead when cutting lead- chromate 
painted surfaces. The subject was 50 years old.
(iii.j METHODS
(a) Urine Collection Procedures
Each individual urine void during the 24-h collections 
was made directly into a separate acid-washed 500 mL PE
bottle. The time of each void was recorded on the form
_ -t
provided (Table 2.3) so that the flow rate in mL min could 
be calculated from the urine volume and the elapsed time 
between voids. Particular care was taken to inform the
donors as to the importance of chance contamination from 
hands and clothing, and recording the correct time of each
void. In Table 2.4, the instructions given each donor for
specimen collection are reproduced. All samples were weighed 
in the 500 mL preweighed polyethlene collection bottles and 
wrapped with Parafilm before transport to the laboratory. 
The urine was not acidified, but was transported by car to 
the analytical laboratory as soon as possible (Port Colborne)
Table 2.3
24- HOUR URINE COLLECTION RECORD
Company/Location ___________________________________ _
Donors Code ______________
Employee Identification Number _ _ _ _______________
Dates from _____________  to___________________
Sample Code Number Time of Collection
TO BE COMPLETED AT END OF 24-HOUR COLLECTION;
Numbers of urine samples returned: _________________
Numbers of empty sample bottles returned: __________
COMMENTS; ___________________________________________
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Table 2.4
INSTRUCTIONS FOR 24- HOUR URINE COLLECTION
These instructions must be followed to avoid 
contamination of the specimen, to assure proper collection 
and to avoid the mixing up of samples.
1. Use the urine collection bottles in sequence (for 
example: A1, A2, A3, etc.)
2. A new bottle must be used for each urination.
3. All urine must be collected for each urination (even if 
a second bottle is required). Make sure vour bladder is 
completely empty.
4. Please record the time of each urination on the 
collection record.
5. Never rinse out any of the collection bottles with soap 
or water (each bottle has been specially treated).
6. Never add any tap water to the urine.
7. Your hands must be washed before giving the urine 
sample.
8. Males are asked to lower pants before urinating.
9. Collection bottle must not come in contact with any 
clothing.
10. After urine has been collected, screw the cap on 
tightly.
11. At work, all urine specimen collection should be done in 
the Nurses’ Station.
12. All bottles (used and empty) must be returned.
or frozen for transport by air to Hamilton (Thompson). Each 
void was analyzed for nickel, creatinine and specific gravity
(p) •
( b )  Serum Collection Procedure
Blood samples were collected using the IUPAC reference 
procedure (Brown et al. , 1981). The shallow depression at 
the bend of the elbow (antecubital fossa) was cleansed with 
an ethanol swab and allowed to dry by evaporation. A 
tourniquet was applied while a polyethylene intravenous 
catheter was inserted into an antecubical vein. The stylus 
of the catheter was removed, and blood (>3 mL) was allowed to 
flow through the plastic catheter to remove any nickel 
contamination in the catheter. This blood was discarded. A 
polypropylene syringe (with separation beads) was used to 
collect 10 mL of blood. After collection, the handle of the 
syringe was removed and the open tip of the syringe was 
wrapped in Parafilm. The blood was allowed to clot for 50 to 
90 min at room temperature in the syringe held in an upright 
postition by a plastic coated testube rack. The syringe was 
then centrifuged at 900 g for 20 min. The serum was 
transferred with an acid-washed Pasteur pipet to an 
acid-washed 15 mL acid-washed PP centrifuge tube, wrapped 
with Parafilm, and transported as soon as possible by car 
(Port Colborne) or was frozen for air transport to Hamilton 
(Thompson). Samples were kept frozen until they were 
analyzed for nickel.
(c) Determination of Urinary Nickel
On arrival at the laboratory, urine samples were mixed 
to resuspend any solids and a representative aliquot was 
transferred to a 50-mL Falcon tube and stored in a cold room 
at 4°C until analysis. Urinary nickel was determined by 
direct extraction (without digestion) of nickel into a MIBK 
layer for detection by electrothermal atomic absorption 
spectrometry (EAAS). Verification of this method relative to 
the IUPAC nickel reference method (Brown et al., 1981)
indicated comparable accuracy and precision (Jusys et al. , 
1982). Care was taken to avoid contaminating the samples and 
measures to assure low blank values as recommended by Nieboer 
and Jusys (1983) are incorporated in the analytical 
procedures described below.
The nickel working standards were prepared fresh daily
by pipeting accurately with a 2-mL graduated Mohr pipet
(500 /zL, 1000 //L, 1500 //L, 2000 jjL)  of the nickel
intermediate standard solution into 50-mL glass volumetric
flasks. This constituted standards of 10, 20, 30 or
- 140 jjbg L used for urine with high nickel concentrations.
For samples with low urinary nickel values the working 
standards were prepared by pipeting accurately with a 1 mL 
Mohr pipet 200, 400, 800, or 1200 j jL  of the intermediate
nickel standard into a 100-mL glass volumetric flasks. This 
resulted in standards of 2, 4, 8 or 12 //g L . All of the 
working standards were brought to volume with DDW.
Exactly 2 mL (calibrated Gilson pipettor) of standards
or blanks (DDV) were transferred to acid-washed test tubes. 
For urine samples with low amounts of nickel exactly 2 mL was 
transferred to acid-washed glass centrifuge tubes. When high 
urinary nickel was anticipated, the urine samples were 
diluted with DDW and 2 mL transferred to glass centrifuge 
tubes.
Prior to extraction,bromothymol blue indicator solution 
(3 drops) was added to each tube. Then 50 /jL  (from a fixed 
volume 50- //L Eppendorf pipettor) of phosphate buffer was 
added. The solutions were adjusted to a pH 7 by dropwise 
addition of dilute NH^ (1:3 v/v). Following this, 0.5 mL 
(Gilson pipettor) of 2% (w/v) APDC solution was added. The 
resulting mixture was vortexed for 10s and allowed to stand 
for 5 min. From a calibrated automatic dispenser, 1.0 mL of 
MIBE was then added and vortexing for 35s followed. When the 
aqueous and MIBK phases had separated on standing (standards 
and blanks) or after centrifugation (15 min at 1000 g) of the 
urine samples, the MIBK layer was transferred to sample cups 
and analyzed for Ni by EAAS. Instrumental settings and the 
temperature- control program employed are summarized in Table 
2-5.
(d) Determination of Urinary Lead
The approach adopted was identical to that of the direct 
extraction of urinary nickel except that the graphite furnace 
temperature control program was altered because of the
Table 2.5
INSTRUMENTAL PARAMETERS AND SETTINGS FOR Ni ANALYSIS BY EAAS
A AA Spectrometer Parameters 
(Perkin- Elmer Model 703)
1. Lamp Current 25 mA
(Hollow cathode)
2. Wavelength 232.0 nm
3. Slit Width 3 (0.2 nm)
4. 1^ 2 Background Corrector OFF
5. Peak Integration Time 5s
6. Signal Absorbance
7. Mode Peak Height
8. Recorder Int
B AUTOMATIC SAMPLER
(Perkin- Elmer Model AS-1)
1. Sample Size 20 /zL
C GRAPHITE FURNACE PARAMETERS 
(Perkin Elmer Model HGA-500)
Stepa Temp(°C) Ramp(s) Hold(s) Read Base Line
1 Drying 150 20 10 off off
2 Ashing 900 40 20 off on at 52s
3 Atomization 2600 0 5 on off
4 Conditioning 2700 0 2 off off
5 Conditioning 30 20 10 at 18s off
_ i
a. Internal argon flow was held at 300 mL min except in Step 3,
_ i
where it was 50 mL min
Table 2.6
INSTRUMENTAL PARAMETERS AND SETTINGS FOR Pb ANALYSIS BY EAAS
A AA SDectrometer Parameters 
(Perkin- Elmer Model 703)
1. Lamp power 10 watts
(Continuous discharge)
2. Wavelength 283.3nm
3. Slit width 4
4. D2  Background Corrector On
5. Peak Integration Time 3s
6. Signal Absorbance
7. Mode Peak Height
8. Recorder Int
B AUTOMATIC SAMPLER
(Perkin- Elmer- Model AS-1)
1. Sample size 20 /zL
C GRAPHITE FURNACE PARAMETERS
Step Temp(°C) Ramp(s) Hold(s) Read Baseline
1 Drying 110 10 30 off off
2 Ashing 650 10 30 at 20s at 35s
3 Atomization 1800 1 6 on off
4 Conditioning 2500 1 2 off off
5 Conditioning 30 20 10 at 32s off
a. Internal argon flow was held at 300 mL min"* except in Step 3. 
where it was 40 mL min" *.
relatively high volatility of lead. The instrumental 
settings and the temperature- control program employed are 
summarized in Table 2.6. The standards were made up with 
Pb(N0g)2 (Analar). Both samples and standards were treated 
in the same manner as in the determination of urinary nickel.
(e) Determination of Serum Nickel
The analytical procedure was adopted from Sunderman et 
al. (1984) and details are described below. The working 
standards and blanks were made up in an identical manner to
_ -j
the low standards (2, 4, 8 and 12 //g L ) used in the urinary 
nickel determination.
The serum was thawed at room temperature and 2.0 mL 
(1-mL Gilson pipettor) were added to 10-mL Falcon centrifuge 
tubes (model 2059). While the serum was being vortexed, 
100 /jL  (100 fiL fixed-volume Eppendorf) of concentrated HNOg 
(Ultrex) was added directly to the tube. The vortexing was 
continued for one min. Then each Falcon tube was stoppered, 
wrapped with Parafilm and placed in a water bath for 10 min 
at 70°C. After this incubation, the samples were then 
centrifuged for 30-40 min at 2300 rpm. One mL of protein- 
free supernatant was transferred to a 15-mL glass centrifuge 
tube and two drops of bromothymol blue indicatior were added 
to the supernatant. Phosphate buffer (25 fiL) was then added, 
followed by ~ 3 drops of concentrated (Ultrex, 13.4M) NH^ and 
~ 4 to 7 drops of dilute (1:3 v/v) NH^ until the colour 
changed from a light yellow to a light blue-green. If there
were any signs of haemolysis, no phosphate buffer was added 
but instead 50 fjiL of concentrated NH^ (13.4M) was added after 
neutralization to bring the pH above 9.0. Then 0.25 mL of 2% 
APDC solution was added, and the sample was vortexed for 10s. 
The mixture was allowed to stand for 5 min and then 0.5 mL of 
MIBK was added prior to vortexing for 35s. When the aqueous 
and MIBK phases had separated (no centrifuging was 
necessary), the MIBK layer was transferred to acid-washed 
polyethylene sample cups and analyzed for Ni by EAAS. 
Instrumental settings and the temperature- control program 
employed are summarized in Table 2.5.
Blanks (DDW) and standards were treated the same as 
serum samples, except that they were not centrifuged and were 
extracted into 1 mL of MIBK after the addition of 0.5 mL of 
27c APDC solution.
(f) Determination of Serum and Urinary Creatinine
These were measured by the Jaffe reaction employing a 
single-channel Technicon Auto Analyzer. This method was 
compared to an established continous- flow Jaffe micromethod 
used in the Clinical Chemistry Laboratory at the 
Chedoke-McMaster Medical Centre (Ryan and Walker, 1980) and 
against the manual Jaffe method according to Adams (1980).
The sera were run directly, while the urines were 
diluted by a factor of 33.33 with 0.02 M HC1. The working 
standards were prepared by adding 1, 3. 5, 7 and 10 mL of the 
stock standard (1 mg mL ) to a 100-mL glass volumetric flask
and bringing to volume with 0.02 M HC1 to give a final
- 1concentration of 1, 3, 5, 7 and 10 mg L
The samples and standards were placed in a series of 
sample cups on the rotating tray of the Technicon 
Autoanalyzer Sampler II. A sample of DDV was inserted
between each sample to reduce "carry over". The sample is
removed by a probe which is activated by a pump (Fig. 2.3).
The sample is separated by air bubbles ("slugs") and passed 
through a dialyzer at 37°C which allows creatinine to pass 
from the sample stream to the DDV stream on the other side of 
the dialyzing membrane but impervious to high-molecular-mass 
compounds. Saturated picric acid is mixed with 0.5 M NaOH
CREATININE N-llk  
PUMP I - MANIFOLD #116-A070-01
Ta F U v u t l
Pmm Wa(M
Iw 1 *1 F1 . J
V
Waata
14 Tam a
. m
RECORDER CO LO RIM ETER T IM E  D E L A Y  
SOS m .  C O IL
IS  mm  F /C  1 0 *4 1 1 1
40 f t .
14 MMB
01
1144203-01  O IA L T Z E R
14 T w m  
1 1 4 4 1 0 3 4 0 T a  f a a t k r  I I  
W a.ii R t c t t t t c l t '
SAMPLER II
4 0 /H r .
• 8  SAMPLE
1 1 4 4 2 0 7 4 0
.0 4 *  P ICR IC  ACID
04S NaOH
.073 WATER
.001 PROM P /C
Waata
Figure 2.3. Continuous-flow analyzer man if oJLd employed in 
creatinine analysis. The tubes with numbers eight and 
nine were switched in order to attain a good bubble 
pattern in tube nine. Reproduced from Technicon Auto 
Analyzer Methods Manual.
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and then comes into contact with the sample from the dialyzer 
(see tubes 10 and 12, Fig. 2.3). Next the stream is passed 
through a 12m time-delay coil for colour development. From 
where it passes through a debubbler, to a 15-mm flowthrough 
UV/VIS cell where the absorbance is measured continuously at 
505 nm.
(g) Determination of Specific Gravity
Specific gravity was measured on a hand-held, 
temperature-compensated, refractometer (American Optical 
Corporation). A small drop of urine was placed on the lower 
glass surface of the meter. The upper glass surface (hinged) 
was lowered on the drop bringing the two surfaces firmly in 
contact. The meter was held toward a light source allowing 
light to pass through the sample and prisms. The specific 
gravity was read directly from a scale at the point where a 
sharp line of contrasting light and dark area formed.
(h) Determination of Osmolality
This parameter was measured by the Clinical Chemistry 
Laboratory of the Chedoke-McMaster Hospital by freezing-point 
depression of centrifuged urine samples using an Advanced 
Instruments Osmometer Model No. 68-L.
C RESULTS
(i) NICKEL CONCENTRATIONS IN BODY FLUIDS 
(a) Urinary Nickel.
The smallest concentration of nickel that could be 
detected with 95% probability [i.e., detection 
limit = x(blanks) + 2 .3cr(blanks) ; Nieboer and Jusys, (1983)]
_ i
was 1.1 //g L corresponding to four blanks per experiment. 
The blank was assessed to contain (mean + SD) 0.4 + 0.3
_ -i
fig L of Ni (4 experiments, 4 blanks per experiment). The 
run to run precision had a coefficient of variation (CV = 100 
SD/X) of 8.9 percent based upon 11 experiments employing the
_ i
same urine sample with a concentration of 52 + 5 fig L 
fb^  Serum Nickel.
_ i
Recovery tests were performed by adding 5 fig L to each
sample. The recovery of nickel averaged 101 + 11 percent
(range 86 to 116; n=6). The smallest concentration of nickel
that could be detected with 95 percent probability was 
-10.39 fig L corresponding to four blanks per experiment. The
_ i
blank was assessed to contain 0.14 + 0.11 fig L of Ni. The 
run to run precision had a CV of 12.8 percent based on seven 
experiments employing the same serum sample. The serum 
nickel concentration from an unexposed donor was 0.38 ± 0.17 
fig L" ^  (n=14, range 0.19 to 0.73).
(c) Urinary Lead.
_ -t
The recovery tests were performed by adding 10 fig L to
-86-
each sample. The recovery of lead averaged 105 + 9 percent 
(range 93 to 120; n=4) .
fii) 24-h COLLECTIONS
As illustrated in Figures 2.4 to 2.7, there are wide 
variations in urine output during the day, and this must
obviously result in fluctuating analyte concentrations. In 
general, the urinary analyte levels (nickel, creatinine and 
specific gravity) have an inverse relationship with urine
_ -i
flow rate, V, (in mL min and calculated from the urine
volume and the elapsed time between voids). As the urine
flow rate changes (increases or decreases), the analyte 
concentration varies in the opposite direction. There 
appears to be no relationship between the variation of these 
analytes and the particular work shift that an individual is 
on, nor on the time of collection. Because of the variations 
observed, it is mandatory that for untimed urine samples some 
manner of adjusting to a standard flow rate needs to be 
sought.
The relationships developed by Araki (1980) for lead,
<5- aminolaevulinic acid, coproporphyrin, creatinine, total
solutes and urinary volume open up a more systematic approach
to volume correction. Urinary nickel, creatinine and total
solutes were found to conform to the relationship in Equation
2.6 by Araki (1980) ~~
b •
U° = l^V 1 (2.6)
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where LL is the concentration of Mi" in the urine, V is the
urine flow (mL min" ^ ) , U? is the urinary concentration of i
at a flow rate of 1 mL min , and is the volume exponent
or power coefficient. Typical regression analysis plots of
log(lL) versus log(V) for the individual voids from a single
donor participating in the 24-h collections at Port Colborne
and Thompson are illustrated in Figures 2.8 to 2.12.
Estimates of b^ and U? are summarized in Table 2.7. The
averages of the power coefficients bN ., b^ 1 and b^OTTi.-, areiii p~ i osmoi
comparable, whereas that for ^creat substantially
different. Thus it appears that creatinine has a different
flow-dependence than nickel, total solids and osmolality.
The dependence of the magnitude of the power coefficient
b^ on donor is illustrated in Figures 2.13 to 2.16. In
Figure 2.13, the magnitude of the volume coefficient b^
versus donor is plotted. The bcrea.£ values are arranged in
decreasing values from left to right. From this diagram it
is evident that the b^^ and b^_ ^  values are consistently
smaller than those for creatinine, although it is not clear
how close the values of bM . and b^ are to each other. InJNi p- 1
Figure 2.14, the ^creat values are plotted against an 
arbitrary scale for individual donors so that a linear fit of 
this data is obtained. Is is clear from this plot that b ^  
and b  ^values are roughly arranged in a linear manner below 
that of the bcrea .^ line. Figures 2.15 and ^.16 depict the 
linear fit of b ^  and b^ _ ^  coefficients with respect to this 
arbitrary donor scale. A comparison of the regression
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Figure 2.8. A scatter diagram showing the linear 
relationship between log(Uj^) and log(V) for one donor
from the first Port Colborne collection. The regression 
parameters are indicated in the figure (p<0.005).
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Figure 2.9. A scatter diagram showing the linear 
relationship between ^°S(Ucrea^) and log(V) for one
donor from the first Port Colborne collection. The 
regression parameters are indicated in the figure
(p<0.001).
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Figure 2.10. A scatter diagram showing the linear 
relationship between 1°S(U i ) and log(V) for one
donor from the first Port Colborne collection. The 
regression parameters are indicated in the figure
(p<0.001).
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Figure 2.11. A scatter diagram showing the linear 
relationship between log(Up^) and log(V) for one donor.
The regression parameters are indicated in the figure
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Figure 2.12. A scatter diagram showing the linear 
relationship between log(uosmoi) and log(V) for one
donor from the first Port Colborne collection. The 
regression parameters are indicated in the figure
(p <0.001). -
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Figure 2.13. Dependence of the magnitude of the volume 
power coefficient on donor. The t>crea^ values
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corresponding bNi (-A-A-) and b^ _ ^  (-■-■-) values for
each donor are also plotted. As explained in the 
footnotes to Table 2.7, b- values were obtained by
regression analysis plots of log(U^) versus log(V). The
subscripts T and P represents the Thompson and Port 
Colborne collections respectively.
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Table 2.7 
VOLUME EXPONENTS (bi) AND URINARY 
CONCENTRATIONS (U°) AT UNIT URINE FLOW RATESa
Parameter^
Port Colborne 
(First Collection)0
Thompson
Group** Overalle
bNi — — 0.7 ± 0.2
V i
— — 0.7 ± 0.2
bcreat — — 1.0 ± 0.2
bosmol 0.7 ± 0.1 — —
U°Ni 28 + 6 fig L 60 + 30 pg L’1 —
(range) (29-33) (19-123) —
Ucreat 1.26 ± 0.06 g L ' 1 1.27 ± 0.18 g L"
1 _
ip - 1 0.0217 ± 0.001 0.018 ± 0.003 —
U° , osmol 743 + 4 m mol kg’ ^ — —
n
The parameters found for one 24-h multi-void collection from 
a worker exposed to lead are: bp^ = 0.9; Up^ = 40 //g L"^.
bThese parameters are defined in Equation 2.6, namely:
bi _ 1
U^ = U^V . Here, V is the urine flow (mL min~ ; calculated 
from the urine volume and the elapsed time between voids), 
U^ is the concentration of Min in the urine, U? is the
_ -i
urinary concentration of i at a flow rate of 1 ml min , 
and b^ is the volume exponent or power coefficient.
Only the data for three workers had a wide enough range of 
V values for linear regression analysis.
^Data for eight workers had a wide enough range of V to allow 
linear regression analysis. _
0  Q
Average for both groups; like U^ values, b^ values were 
obtained from plots of log U^ versus log V.
parameters describing the fitted lines clearly ilustrates
that bcreat > V l  * bNi-
As expected, there is a significant variation in the
flow rates of the individual voids of each donor throughout
the 24-h collection period (Fig. 2.17). By comparison and as
illustrated in Figure 2.18 there is a smaller but still
substantial variation in flow rate in the 24-h collections.
The most frequently observed flow rate for both types of
_ i
collections is centered around 1.0 mL min . The average 
values of the flow rate for individual voids and the 24-h
collections are summarized in Table 2.8: overall averages of
-1 - 1 1.6 + 1.5 mL min and 1.2 ± 0.5 mL min for untimed spot
samples and 24-h collections, respectively. In both cases,
the Thompson collections have a lower flow rate than the Port
Colborne collections. It is also noticeable that the
variance as judged by the magnitude of the standard deviation
is 2.5 to 3 times smaller for the 24-h collections in all
instances.
In Figures 2.19 to 2.21, urinary nickel (^Ni^ anc^  
creatinine (^creat) levels are compared. For arbitrary 
groupings of donors, a rough correlation exists between these 
two parameters, although the absence of a single relationship 
implies the variation of an underlying independent 
variable(s). A similar conclusion is reached from an 
examination of plots of urinary nickel versus total solutes 
(U^ _ as illustrated in Figures 2.22 to 2.24. The data in 
Figures 2.23 and 2.24 do suggest an improvement for the
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Figure 2.19. A scatter diagram showing the relationship
for selected donors in thebetween UNi and Ucreat
Thompson cohort.
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Figure 2.20. A scatter diagram showing the relationship 
between and ^ e ^ for selected donors in the
Thompson (Cp K p  F^ ,) and Port Colborne (Ep) cohorts.
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Figure 2.21. A scatter diagram showing the relationship 
between and Ucrea .^ for selected donors in the
Thompson (Ip K p  P,p) and Port Colborne (Ap) cohorts.
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Figure 2.22. A scatter diagram showing the relationshi 
between and U  ^ for selected donors iu_ the Tliompso
cohort.
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Figure 2.23. A scatter diagram showing the relationship
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Figure 2.24. A scatter diagram showing the relationship 
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Table 2.8
OBSERVED FLOW RATES
Collection Flow Rate
_ i
(mL min ) 
MEAN ± SD
na
Thompson
Individual Voids 1.3 ± 1.1 123
24- h Collections 1.1 ± 0.4 20
Port Colborne
Individual Voids 1.9 ± 1.8 87
24- h Collections 1.3 ± 0.6 12
Thompson
and
Port Colborne
Individual Voids 1.6 ± 1.5 210
24-h Collections 1.2 ± 0.5 32
Q
the number of individual voids or 24-h collections.
correlation Uj^ versus U  ^ commpared to UNi versus Ucreat 
for individual donors, as indicated by the splitting of the 
data into separate donor curves.
The plots in Figures 2.25, 2.27, 2.28 and 2.30
illustrate that the normalized ratio ^Ni^creat *ms
considerably more uncompensated contribution from urine flow
rate than Uj^/U This is more difficult to assess for the
data in Figures 2.26 and 2.29, although this generalization
appears to hold (compare data for donors Ep and Cp in these
two graphs). Certainly, there is less random scatter in the
- 1U p- normalized and for V > 1 mL min greater urine
flow independence is also achieved.
When U^i/Ucrea^ is plotted against for the 24- h
collections in this study (Fig. 2.31), two apparently linear 
responses result. Such data separation has also been 
observed in other studies for both spot and 24-h collections 
(see Table 2.9). The placement of data points on lines A and 
B is not determined by collection site. However, this 
grouping appears to reflect different mean urine flow rates:
. i
line A data has a mean flow rate of V = 1.7 + 0.4 mL min , 
while line B data has a lower flow rate, namely V = 0.8 + 0.2 
mL min"^. This dependence is further illustrated in Figure 
2.32 where UNi/Ucreat is plotted versus Ucreat/Screat. Here 
the data corresponding to lines A and B of Figure 2.32 
respectively occur below and above ^ e -^ /S = 100. When
the Uj^/U ^ data are plotted against the amount of nickel
excreted in 24-h ( E ^ ) , the clear separation into two groups
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Figure 2.25. A scatter diagram showing the relationship 
between UNi/Ucreat and V for selected donors in the
Thompson cohort. —
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Figure 2.26. A scatter diagram showing the relationship 
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The regression equations are:
U-
Curve A: Ni
Uere at
1.7Un . - 3.0 r = 0.99 (p<0.001)
13 donors
U
Curve B: Ni
Ucreat
= 0.67Un - + 0.52 r = 0.99; (p<0.001) 
1 15 donors
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vanishes as illustrated in Figure 2.33.
By contrast to creatinine normalization of the 24-h 
collections (Fig. 2.31), when the same data is adjusted 
employing the total solids (p-1 ) and plotted against as 
before, no grouping is evident (Fig. 2.34). Furthermore, 
when Uj^/U  ^ is plotted against for the 24-h collections 
(Fig. 2.35), a plot similar to that observed for creatinine 
adjustment is obtained (compare Figs. 2.33 and 2.35).
D DISCUSSION
(i) CURRENT PRACTICES OF URINE ADJUSTMENTS 
AND THEIR LIMITATIONS
The focus in this section will be on the urine flow 
dependence of urinary nickel, creatinine and specific 
gravity. Recommendations for flow adjustments of urinary 
nickel concentrations will also be made. The interpretation 
of these data in relation to measures of kidney function will 
be presented in Chapter 3.
Observed urinary nickel levels for non- occupationally
exposed individuals agree with recent literature data:
- 1 - 1  namely, serum = 0.46 + 0.26 pg L ; urine = 2.0 + 1.5 fig L
(Sunderman et al., 1984, 1986b). For exposed individuals, the
observed concentrations fall in the lower end of the ranges
_ -j
reported by reputable laboratories (serum < 35 fig L ; urine 
< 400 fig L’ ;^ Nieboer et al. (1984a)).
As illustrated in Figures 2.4 to 2.7, the wide variation 
in flow rate has an inverse relationship to the analyte
concentration (nickel, creatinine and specfic gravity). 
Although all these analyte concentrations vary in a similar 
manner, the question that needs to be answered is: which
analyte (creatinine or specific gravity) most closely 
resembles nickel in its excretion pattern? As mentioned in 
the introduction, 24-h collections of urine are thought to 
eliminate the concentration/dilution effects associated with 
spot samples. The expected large deviation in flow rates is 
evident in the spot urine collections (see Fig. 2.17). 
However, the data in Figure 2.18 and Table 2.9 illustrate 
that for 24-h collections there is still a significant 
variation in urine flow. Thus, it is reasonable to ask if 
24-h collections (without any further adjustments) are the 
best sampling strategy.
Figures 2.19 to 2.24 illustrate one possible approach to 
deciding what type of normalization is most appropriate for a 
particular analyte. In these plots of versus Ucrea .^ or
U i') "the objective is to determine which of urinary 
creatinine or urinary total solids most closely resembles 
urinary nickel. This is the strategy that was taken in a 
recent paper by Sunderman et. al. (1986b). The plots from 
this paper are reproduced in Figure 2.36. Sunderman et al. 
(1986b) concluded that normalization by either creatinine or 
specific gravity have approximately equal validity for nickel 
elimination in urine, based upon the successful correlations 
between nickel concentrations and creatinine concentration or
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specific gravity of urine specimens from healthy individuals. 
They recommend that "the results of nickel analyses of random 
spot urine specimens should be reported as unadjusted nickel 
concentrations, with optional provision of supplemental 
values factored on the basis of creatinine and/or specific 
gravity, according to the preference of the responsible 
physician". This study was done on subjects who were not 
industrially exposed to nickel. Hence the maximum nickel
_ i
values were below 6  fig L , possibly making this study 
invalid for any recommendations made for biological 
monitoring of nickel workers. Lauwerys (1983) recommends 
that analyses of dilute spot urine specimens (creatinine
-j
concentration < 0.3 g L or specific gravity < 1.010) 
should, whenever possible, be repeated on a different 
specimen.
From the data presented in the present study (Figs. 2.19 
to 2.24), it can be seen that the relationships between 
and Ucrea .^ or U  ^ are not necessarily linear for a single 
donor when varies over a much wider range than studied by 
Sunderman et al. (1986b). This leads to the speculation as to 
whether this approach is valid and whether a more 
satisfactory approach is feasible. The systematic, and 
internally rigorous, mathematical approach described in the 
remainder of this chapter is to some extent empirical, but 
will be shown in Chapter 3 to be rooted in the mathematical 
relationships of renal clearance.
For convenience, the remainder of this discussion will
be divided into four parts. The first three sections will 
develop some theoretical aspects of urine normalization and 
apply them to adjustments by creatinine and specific gravity 
of urinary nickel levels. The final part will discuss the 
implications of the new approach for biological monitoring.
fii^ THEORETICAL CONSIDERATIONS
As described in Section 2C, Araki (1980) found a
relationship described in Equation 2.6 between a number of
urinary analytes such as lead, creatinine, total solutes and
coproporphyrin and urinary flow rate 
b-
U i V  1  =  u i  ( 2 - 6 )
where U- is the concentration of analyte ”in in the urine, V
is the urine flow, U? is the urinary concentration of i at a
_ i
flow rate of 1 mL min and b^ is the volume exponent or 
power coefficient. For 8  individuals exposed to lead, Araki 
found that separate plots of log IK versus log V gave an 
average b^ value for lead of 0.75; for total solutes, 0.63; 
for osmolarity, 0.73; and for creatinine, 1.01.
In the present study, a linear relationship was observed 
for plots of log IK versus log V for the analytes creatinine, 
specific gravity (i.e. total solids), osmolality, lead and 
nickel (see Figures 2.8 to 2.12). The results from the 
regression plots using Equation 2.6 are summarized in Table
2.7. They are in close agreement with those found by Araki
(1980). The regression coefficients b^ for creatinine, 
solutes and osmolality are almost identical with Araki’s
assignment (see Table 2.7). The value for lead in this study 
is also close to Araki’s mean value. Thus both studies 
corroborate the validity of the relationship in Equation 2.6. 
The mean values for bj^ and are identical (both
0.7 + 0.2), whereas bcrea-k is much larger (1.0 + 0.2). It is 
obvious from the data depicted in Figures 2.8 to 2 .1 2 , that a 
number of factors contribute to successful correlations of
log versus log V. There must be a resonable spread in V
- 1 - 1  values (at least AV > 1 mL min , although AV > 2 mL min is
preferable) and an adequate number of data points (eg.,
n> 4). An even distribution of V values throughout the range
studied is also mandatory (i.e. no grouped data). In the
present study, the data from three donors were rejected for
flow rate analysis because of errors made in the timing of
the voids. However, data corresponding to these donors were
included in the 24- h collections used later in this chapter
and in Chapter 3. Futhermore, there were four donors who
gave only 3-timed voids in a 24-h collection and this was
considered to provide too few data points for regression
analysis. Since no special steps were taken to hydrate the
donors, it is not surprising that 14 failed to have an
adequate spread in V values. Because of these limitations,
only data from 11 of the 32 donors were suitable for
examining the dependence of analyte concentrations on urine
flow rates.
As shown in Figure 2.13, there is a similarity between 
b ^  and b^ _ ^  and they both appear to be different from that
- 130-
of b„ . However because of the scatter in the data, it is creat ’
not clear how close individual values of bM - and b^  ^ are toN i />  1
each other. This dependence is more clearly illustrated in 
Figures 2.14 to 2.16, where this data was arbitarily arranged 
so that the creatinine data formed a straight line. It was 
found that the nickel and solutes coefficents approximated 
straight lines both of which were below the creatinine line 
with almost identical slopes and intercepts (i.e. 
bNi = "0*0239(donor) + 1.02; r = 0.67 ;
b^_^ = - 0.0251(donor) + 1.05; r =0.78). These values are 
different from those found for the creatinine data 
(bcreat = ‘0*0322(donor) +1.44; r =1.00). For all donors for 
which b^ values are available, these equations yield 
bNi/bcreat=0*7 and bj^ j_/b ^=1. This illustrates the almost 
identical relationship that bj^ and b^ _ ^  have to each other, 
and implies that specific gravity (solutes) adjustment of 
nickel levels in spot urine samples for urine- flow dependence 
is more appropriate than creatinine corrections.
Vhen b^ = 1.0, the excretion rate of the analyte (amount 
excreted per unit time) is independent of secretion or 
reabsorption (i.e. is creatinine- or inulin-like) and simple 
dilution effects regulate its concentration. Under these 
conditions, Equation 2.6 reduces to Equation 2.7.
V.u. = U? (2.7)
If b^ is not equal to 1.0, the analyte excretion rate (i.e., 
UV) is dependent on either secretion or reabsorption. 
Evidence will be presented in Chapter 3 to show that nickel
- 131-
is reabsorbed in the kidney in a similar manner to urea.
Equation 2.6 can be rearanged to give Equation 2.8.
-b.
Ui = UiV 1 (2 -8)
Volume normalization usually compares the concentration of
the analyte of interest (U^) with that of an endogenous
reference compound (Ug). Usually this endogenous reference
compound has well-defined excretion parameters. Using
Equation 2.8, the general equation for urine normalization
becomes Equation 2.9.
o
U. U- b9- b1
tr = -o v (2-9)
This expression illustrates the principle of volume 
normalization. The concentration quotient U^/Ug becomes 
flow-rate independent only when b^- b2  = 0  (i.e. b^ = b2 ),
t>2 “ Q
since under this condition V = V = 1 for all values of
V. In all other cases (i.e. b^ =£ ^2 ^ 5 -ratio has
not been completely compensated for differences in the flow 
rate between different urine specimens. This leaves the term 
still with a functional dependence on V like the 
uncorrected quantity U^. Thus a functional relationship 
between these quantities is expected and the analyte of 
interest (U^) may be over- or under- compensated by the 
reference analyte (U2 ), depending on whether b^ - b2  > 0  or
^1 " ^ 2  < *^ —
fiii^ CREATININE NORMALIZATION
For creatinine normalization of urinary nickel levels, 
Equation 2.9 may be written as in Equation 2.10
UNi USi bcreat- bNi (2.10)
Ucreat Ucreat
V
The mean value for bcrea{- for both the present and Araki's 
studies is 1.0, and thus Equation 2.10 reduces to
% i „ i- t>w .
  US-V (2 .1 1 )
Ucreat” Ucreat ^
which can be rearranged to give
U°
creat 1-bNi (2.12a)
Ni y “ Ni
creat
= Uj^V0 - 3  (2.12b)
with bj^ = 0.7. The uncompensated volume dependence results
in overcompensation of the urinary nickel levels for V > 1 mL
- 1 - 1  min and undercompensation for V < 1 mL min . A plot of
U^f/Ucreat versus ^or ‘t^ ie 24-h collections (Fig. 2.31)
can be resolved into two lines A and B. This illustrates
that even for 24-h collections there is still a residual flow
rate dependence that has not been resolved by creatinine
normalization. Curve A is consistent with 24-h collections
_ 1
that have flow rates larger than 1 mL min resulting m
over-compensation by creatinine normalization. The mean + SD
_ i
of the flow rates for line A is 1.7 ± 0.4 mL min , while
_ 1
that of curve B is 0.8 + 0.2 mL min which thus is closer to
_ i
1 mL min . Table 2.9 summarizes additional data obtained
from three other studies. The three curves represented by
all the data in Table 2.9 are shown in Figure 2.37, where
curves A and B are those from the present study (Fig. 2.31),
and curve C is the mean of relationships 6  and 7 in Table
2.9. These data illustrate the three cases that appear to
occur with creatinine normalization. Curve B represents data
- 1that is reasonably close to a flow rate of 1 mL min , 
whereas curve A represents data that have flow rates above
_ i
1 mL min ; and it is reasonable to postulate that curve C 
represents data with flow rates less than 1 mL/min. The flow 
rate associated with curves A, B and C can be estimated from 
the slope (^/^creat’ Eqn. 2.16a below) and employing the
average value for U^rea _^ (1.27 g L"^; Table 2.7). For Curve
- 1 - 1  A, V=2.2 mL min ; Curve B, V=0.85 mL min and Curve C,
_ i
V=0.43 mL min . The flow rates for Curves A and B are in 
close agreement with the average values of the actual flow 
rates quoted earlier. This again supports the argument that 
the average flow rate associated with curve C is much less
_ i
than 1 mL min
The studies which form the basis of Relationships 6  and 
7 in Table 2.9 did not provide any data on urine flow rates.
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Table 2.9
EXPERIMENTAL RELATIONSHIPS 
OBSERVED FOR CREATININE NORMALIZED NICKEL IN BODY FLUIDS
Observed Relationship8 ’^
Correlation
Coefficient
Sample
Number
n Reference
(i)
(2)
(3)
(4)
(5)
UNi
Ucreat
UNi
Ucreat
UNi
Ucreat
UNi
Ucreat
UNi
U
1 *7 UNi"~ 3 , 0  0 , 9 9
0.67UNi+ 0.52 0.99
0.62UNi- 0 . 2 2  0.90
0.65UNi+ 1.73 0.91
0.65UNi- 3.0 0.98
creat
13 Current study 
Line A
15 Current study 
Line B
20 Jusys et al., 
1982
143 Bernacki
et al., 1978
t
26 Hagedorn- Gotz 
et al., 1977
(6)
(7)
UNi
Ucreat
UNi
U
= 0.36UNi- 0.09
= 0.32UNi+ 7.2
creat
0.99
0.91
8  Jusys et al. 
1982
8  Hagedorn- Gotz 
et al., 1977
a - 1 - 1UNi are expressed in //g L , with Ucreat in g L *
The average value for the slopes of lines 2 to 5 is 0.65 
and for lines 6  and 7 is 0.34.
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Figure 2.37. A composite diagram showing three posssible 
linear relationships between e ^ and Uj^. Curves
A and B are from the present study, while- curve C is the 
mean of the observed relationships 6  and 7 in Table 2.9.
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Thus, it is not possible to assign curve C a definitive V 
value. However, Figure 2.32 illustrates that all the data of 
curve A in Figure 2.31 lie below Ucrea .^/Screa .^ = 100, while 
curve B data have values above this arbitrary value. In 
terms of renal clearance, C/V = U/S (see Chapter 3B) , the
ratio Ucreat/Screat is viewed as the renal
creatinine-concentration factor. As shown in Chapter 3, the
average value for ^crea^/^ f°r workers corresponding to
the data in Figure 2.32 is 98, with an average Ccrea-fc of 1 2 2
- 1 — - 1 - 1  mL min and V=1.24 mL min . For V < 1.2 mL min ,
_ i
^creat^creat > *00; an(* conversely for V > 1.2 mL min
Thus this plot is an independent verification that the data
_ 1
on curve A have a flow rate greater than 1 mL min and those 
on Curve B less than this reference value. The observation 
of three lines in Fig. 2.37 may therefore be interpreted to 
indicate that creatinine correction of Uj^ results in 
inherent uncompensated urine flow-rate contributions. This 
can be illustrated in the following manner.
For creatinine and nickel, Equation 2.8 may be written 
and rearranged as in Equations 2.13 and 2.14.
Ucreat = Ucreat ^  (2 ‘13)
% i  = UNiV Ni t2 '14)
If both sides of Equation 2.14 are multiplied by V,
Equation 2.15 results.
1 b
VUNi = U°NiV Ni (2.15)
Therefore when combining Equations 2.12a and 2.15, 
Equation 2.16a results with Equation 2.16b as a special case.
^creat ^creat
5 —  UNiV (2.16a)
UNi
5--- % i  (V = 1) (2.16b)
^creat ^creat
Thus the slope of a plot of Uj^/U ^ versus is
1 /U^reat anc* ‘term ^Ni^ e:^ ecrt *s an estimate of the
_ i
uncompensated volume dependence. Assuming V = 1 mL min
(c.f., Eqn. 2.16b), the slope of curve B gives
Ucreat = ^ w h i c h  is not very different from
Ucreat = 1* 3 g L~* that was found from the regression plots
according to Equation 2.6 (see Table 2.7). By contrast, the
slopes of curves A and C of Fig. 2.37 yield 0.6 and 
_ ^
2.9 g L , respectively, which differ considerably from the
_ i
regression value of 1.3 g L
A plot of % i / U crea .^ versus U ^ V  is expected to reduce 
the separation in the data observed in Figure 2.31 and Figure 
2.37. This indeed is the case, because as shown in Figure 
2.33 a single straight line is obtained for such a plot with 
Ucreat = min which is in reasonable agreement with
Ucreat = S obtained from the regression plots of
Equation 2.6. Thus, the term in Equation 2.11
illustrates vividly the presence of a residual-, uncompensated 
flow-rate dependence for creatinine adjustment of urinary 
nickel concentrations.
(iv) SPECIFIC GRAVITY NORMALIZATION
Equation 2.17 is used to normalize urinary analytes to a 
specific gravity of 1.024 in North America and to 1.016 in 
Europe (Levine and Fahy, 1945; Elkins and Pagnotto, 1965; 
Elkins et al. , 1974; DHEW, 1974; Pryde, 1982; Sunderman et 
al., 1986b)
U?'(at p  = 1.024) = 0.024 IK/ (p±- 1.000) (2.17)
o 'where IK is the observed analyte concentration, IK is IK 
normalized to a specific gravity of 1.024 and p^ is the 
observed specific gravity for the sample. In order to treat 
specific gravity in a manner similar to creatinine 
normalization, it is necessary to develop a relationship with 
total solutes.
Density measures the mass of a substance per unit 
volume, while specific gravity is the ratio of its mass to 
that of an equal volume of water at 4°C. Because water at 
4°C has a density of 1.000 g mL"^, density and specific 
gravity thus defined are interchangeable. The following is a 
derivation of a formula for urinary solutes using the 
definition of specific gravity and the interchangeability of 
density and specific gravity which results in the weight (V) 
of water being numerically equal to its volume (V) at 4°C.
^solute + ^solvent)
p± =  ----- :----------------------- ( 2  • is)
(wt. of equal volume 
of water at 4°C) —
^solute + ^solvent) 
Pi = -------- y----------- (2.19)
V ¥solute solvent
P i  =  y  +  y  ( 2 . 2 0 )
p  ^= solute concentration + 1 . 0 0 0  (2 .2 1 )
pi = U^ _ 1 + 1 . 0 0 0  (2 .2 2 )
U 1 = pi - 1.000 (2.23)
where U  ^ denotes the urinary solute concentration in
_ i
g mL In this derivation, changes in volume due to
dissolution of solutes (i.e., dV / dn the partial molar volume 
for both the solvent and solute) have been ignored. 
Multiplication of the right-hand side of Equation 2.23 by 
1 /(1 -^) roughly corrects for this, with (3 = dV/<9ng 0  lute ^or 
the solute (Barber and Wallis, 1986). An approximate
correction can thus be made to Equation 2.23 using 
5V/5ngo^u^e = (3 = 17.82 mL m o l = 0.32 mL g~ ^  NaCl,
realizing that approximately independent of
solute concentration and assuming that all solutes in normal 
urine are similar to NaCl (Bromberg, 1980). This
consideration suggests that U  ^ is being underestimated by 
about 30%. Although the (3- correction is of unknown magnitude 
when considering all urine solutes, it may be assumed to be a 
constant and thus need not be considered further. By 
comparing Equations 2.17 and 2.23 it can' be seen that
specific gravity adjustment is the same as normalization by 
urinary solute concentration (also called total solutes).
Creatinine normalization led to three curves when 
%i/^creat was P^0^ ^  against and this was interpreted
that in creatinine normalization, uncompensated flow-rate 
residuals remain after normalization. If solute
normalization is better for urinary nickel levels, then a 
plot of Uj^/U  ^ versus should not give two lines as
seen in creatinine adjustment (Fig. 2.31). Figure 2.34 is a 
plot of Uj^/U  ^ versus Uj^ for the same nickel data as in 
Figure 2.31. This results in a straight line (r = 0.93) 
instead of two lines seen in the creatinine data. Also, a 
plot of Uj^/U  ^versus (Uj^V) (Fig. 2.35) is a straight
line, but is somewhat less strongly correlated (r = 0.89). 
The derivation of a relationship similar to Equation 2.16a 
but for specific gravity normalization shows that the curve
in Figure 2.35 should have a slope that is volume dependent
b - 1
(slope = V 5 and presumably this explains the
slightly poorer correlation coefficient. The values for U^_^ 
from Figures 2.34 and 2.35 are 0.023 and 0.018 g mL" 1, 
respectively which are in close agreement with those found 
from the regression plots employing Equation 2.6 (0.022 and
_ i
0.018 g mL for the two groups of nickel workers studied; 
see Table 2.7). These results again indicate that urinary 
solute normalization is more appropriate for~urinary nickel 
than creatinine adjustment.
In conclusion, the close agreement between b^^ and b^ _ ^
values (Table 2.7) along with the above mathematical and 
graphical verifications provide evidence that urinary solute 
correction is the most appropriate normalization procedure 
for nickel.
fv^ BIOLOGICAL MONITORING
(a) Definition, Uses and Pratices.
There are many definitions of this term. Waritz (1979) 
defines it as the ’’analysis of some biological fluid, such 
as urine, blood, tears, or perspiration, or analysis of some 
body component, such as hair or nails to evaluate past 
exposure to a chemical”. These measurements may be carried 
out not only on body fluids and tissue (biopsies) of exposed 
populations during their normal life, but also on tissues 
taken during surgery or postmortem examination (Zielhuis, 
1978). Olishifski (1983) includes in biological monitoring 
the objective of determining excessive absorption of a 
contaminant, while Lauwerys (1983) and Zielhuis (1978) 
include an assessment of the internal exposure (ie. the 
internal dose) to a chemical agent. This may relate to the 
amount of chemical recently absorbed, the amount stored in 
the body (body burden), or the amount of the active chemical 
species bound to a site of action. Ross (1984) has pointed 
out that biological monitoring provides an avenue for 
assessing the extent of environmental and occupational 
exposures and has the potential for early detection of toxic 
lesions at preclinical and reversible states. Nieboer et al.
(1984a) have essentially a similar perspective: ’’collection
and analysis of biological samples for the purpose of
determining exposure and health risk”. The health risk 
assessment would be based on a toxicological outcome 
measurement (e.g., proteinuria).
Whatever the definition and goals of biological
monitoring, it will involve the analysis of various 
biological samples (eg. blood, serum, urine, hair, biopsy or 
autopsy tissue, saliva, expired air etc.). The most favoured 
body fluids used in nickel biological monitoring are serum, 
plasma and urine (Stoeppler, 1980; Stoeppler, 1984; 
Sunderman, 1984d). Urine is generally preferred to serum 
(plasma) because its collection is non-invasive. Collection 
of blood for nickel analysis requires venepuncture with a 
plastic intravenous cannula to avoid nickel contamination 
from needles. In addition, nickel concentrations are higher 
in urine than in serum, enhancing analytical accuracy and 
precision. Urinary nickel has the potential of early 
detection of toxic lesions at the preclinical state. For 
example, the Nieboer et al. (1984a) review of the data
suggesting that high urinary levels of nickel generally
reflect not only the extent of Ni(CO)^ exposure, but also the 
clinical severity that may be expected. A urinary nickel
_ i
level of more than 1 0 0  //g L on the day of exposure suggests 
that careful monitoring of the patient would be judicious 
even in the absence of initial symptoms. Nieboer et al. 
(1984a) also reported significant dose-response relationships
between total ambient nickel levels (both soluble and 
insoluble) and nickel in the urine and plasma (serum). This 
illustrates that urinary nickel is an appropriate medium for 
biological monitoring.
It is common to have timed 24- h urine collections when 
it is pratical (e.g., in hospital patients and for research 
purposes). However, it is not feasible for routine 24-h 
urine collections to be requested in the biological
monitoring of industrial workers (Levine and Fahy, 1945;
Elkins et al., 1974; Lauwerys, 1983; Aitio and Jarvisalo,
1985) . This has led to the common use of spot or grab
samples of urine. In fact, spot samples may have a distinct 
advantage over 24-h colections. This is illustrated in the 
exposure of workers to nickel carbonyl. As pointed out on 
pages 29 and 30 of Chapter 1 , immediate treatment of nickel 
carbonyl poisoning seems advisable and waiting for the 
traditional 8 -h urine collection before initiating treatment 
may not be appropriate. Therefore, the collection of a
reliable spot urine specimen may allow almost immediate 
treatment of the patient.
fb) Need for Urine-Flow Corrections.
A major objection to the use of urine as the fluid of 
choice is that it is subject to wide variations in analyte 
concentration because of dilution effects. -Hence, this has 
led to the standardization by specific gravity or creatinine. 
The approach taken by some investigators to volume correction
has been somewhat empirical. Elkins et al. (1974) compared 
(in a graphical manner) the fluctuations of lead samples 
adjusted to a specific gravity of 1.024, to 1.8 g of 
creatinine or to mg Pb/osmol. They found that all adjusted 
values are better than unadjusted ones, but there was no 
general superiority for one of the normalizations 
investigated. Levine and Fahy (1945) compared the
coefficient of variability for unadjusted urinary lead levels 
and the same urinary leads normalized to a specific gravity 
of 1.024. A decrease in variation of adjusted urinary lead 
excretion was found for a series of spot samples taken from 
subjects recovering from lead poisoning. Tola et al. (1979) 
corrected urinary nickel samples to a specific weight of 
1.018 because this proved to result in the least variation.
The average coefficient of variation (CV = 100 SD/X) 
found in the present study for the uncorrected urinary nickel 
(Uni) levels in the individual voids collected over a 24-h 
period from each donor is 39 + 21% (32 donors) . These same 
samples when normalized by creatinine (Uj^^/Ucrea _^) yielded 
CV = 27 + 17%. For adjustment by solute (i.e., Uj^/U )^ , it 
was 24 + 1 2 %. The solute-adjusted samples had the lowest 
average CV and were statistically different (p<0.01) from the 
uncorrected samples, indicating that solute (specific 
gravity) normalization is the most appropriate. It is 
interesting to consider the Thompson and Port“Colborne groups 
separately. For the Thompson study, the specific gravity 
corrections gave statistially significant reduction in CV
(p<0.01), while the creatinine did not. By contrast for the 
Port Colborne cohort, neither creatinine nor specific gravity 
adjustment yielded a significant improvement (p>0 .0 1 ), 
although the lowest CV value occurred for specific gravity 
correction. It is just this type of inconsistency that has 
marred the practices of urinary corrections, and emphasizes 
the need for a different perspective.
An interesting approach has been taken by Barber and 
Wallis (1986), who applied specific gravity, osmolality and 
creatinine corrections to the same set of urinary mercury 
data. They investigated the reproducibility of the corrected 
mercury concentration in a spot sample to predict a person's 
24-h mercury excretion. Osmolality and specific gravity 
corrections were almost identical and creatinine was most 
effective by a small but statistically significant amount. 
They state that "it was not the purpose of this paper to 
recommend which correction is most appropriate", but they 
hoped that their work "will assist the physician in making a 
choice". Graul and Stanley (1982) emphasized that the 
adjusted concentration of a spot sample need not be 
representative of the 24-h concentration. Presumably 
agreement is only possible for substances that are excreted 
at a constant rate such as creatinine. Consequently, the 
approach suggested by Barber and Wallis is of limited 
applicability. It will be demonstrated in the next section 
that the perspective outlined in sections (ii), (iii) and 
(iv) above for nickel may be generalized for any analyte.
(c) Standardization to Unitary Flow Rate.
A more general approach to this problem can be developed 
using Equation 2.9.
ui „b„-b-J V 2 - 1  (2.9)
or
U2 U2
U i U? AK
— 1 = VAb (2.24)
U2 U2
For creatinine adjustment, the power coefficient term 
(Ab=b2 ~ b^) in Equation 2.9 becomes ^crea-t"^Ni anc* so^u"te 
corection it is b ^-b^. A plot of versus V (see
Figs. 2.25 to 2.30) will give a measure of Ab and ^
or It is evident from the data in Figures 2.25 to
2.27, that the creatinine adjusted curves tend to increase 
rapidly at low flow rates and level off to a relatively 
constant % i / U crea .^ value at high flow rates. By contrast, 
the solute- adjusted ratio U^.j/U  ^ curves with negative Ab 
values tend to decrease rapidly at low flow rates and the 
curves level off to a relatively constant  ^ value at
high flow rates (see Figs. 2.28 to 2.30). In general, the 
solute curves appear to level more quickly that the 
corresponding creatinine plots. It is also obvious from 
these figures that the exact shape is donor dependent.
The shapes of the curves in Figures 2.25 to 2.30 can be 
rationalized by examining the family of theoretical curves
- 147-
plotted in Figure 2.38. Here (the uncompensated volume 
residual in Equation 2.24) has been plotted against V for 
various values of Ab and V. When Ab>0, the curvature is very 
similar to the creatinine-normalized curves for nickel (Figs. 
2.25 to 2.27), whereas when Ab< 0  the curves resemble some of 
the solute normalized curves (Figs. 2.28 to 2.30). It is 
apparent from Figure 2.38 that as Ab approaches zero, the 
curves tend to flatten out rapidly. It is also clear from 
the point of convergence depicted in Figure 2.38, that the 
uncompensated (residual) volume factor, approaches unity
when Ab — i 0 or V — > 1.0. Based upon the b values summarized 
in Table 2 .1 0 , the mean value for Ab = t>crea .^ - b^^ = 0.31 and 
Ab = b^ _ bj^ = 0.005. Thus on the average, — > i for 
specific gravity correction of urinary nickel, in contrast to 
creatinine normalization.
It is of interest to compare the relationship between 
the family of curves in Figure 2.38 and Equation 2.10. The 
right- hand side of this equation corresponds to the product 
(U^/U^V^k, an(i thus is dependent on the individual donor. 
This follows since u!j* and are characteristic of a
particular individual. A perusal of the Ab values in Table
2 . 1 0  indicates that b^ also exhibits a strong dependence on 
the individual donor. There are a number of consequences
-148-
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Figure 2.38. The family of curves for the uncompensated
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residual flow factor (V ) at various flow rates (V) and 
selected values of the power coefficient difference Ab.
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that follow from this. First of all, the position with 
respect to the Y-axis of the curves for plots of U^/l^ versus 
V (as in Figs. 2.25 to 2.30) is determined by U^/U^, while, 
the degree of curvature in these plots is determined by Ab. 
Secondly which corresponds to an endogenous metabolite, 
depends on a number of personal factors (e.g. diet, activity, 
kidney function). In addition U°, which corresponds to a 
xenobiotic or its metabolite, depends upon exposure and body 
burden. It is not obvious what determines the b^ value for 
an individual, although dependence on kidney function must 
play a role (e.g. degree of tubular absorption or secretion). 
Nevertheless, for urinary excretion of metabolites such as 
nickel, creatinine and specific gravity common patterns of 
excretion may be discerned when examining group data, 
although considerable deviation from the average response can 
occcur in any particular individual. As discussed later, 
this has implications for biological monitoring.
Consideration of the residual volume factor opens up an 
interesting perspective on normalization strategy. In Tables
2 . 1 1  and 2 . 1 2  and in Figure 2.39, numerical and graphical 
presentations are provided for the flow rates at which the
At
uncompensated flow factor (V ) deviates from unity by a 
predetermined amount. In addition, urinary creatinine 
concentrations, solute concentrations and specific gravity 
values corresponding to boundary flow rates and Vmax)
are provided. It is clear from Figure 2.39, that the range 
of flow rates at which the residual flow factor does not
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Ab
1.1 1.2
+0.8
maxmin
+ 0.4
- 0.2
maxmin
Ab
0.9 0.8
Figure 2.39. The boundary flow rates (V . o and V □) ° m m  max '
for various Ab values at which the uncompensated
residual flow factor (V^) deviates + 1 0 % (broken lines) 
or + 20% (solid lines) irom unity. The data plotted 
corresponds to that in columns 1 to 3 of Tables 2 . 1 1  and 
2 .12.
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Table 2.11
BOUNDARY VALUES OF SELECTED URINARY PARAMETERS 
CORRESPONDING TO VAb = + 0.1 FOR SELECTED Ab VALUES
Ab
v a 
min
(mL min" *)
V b max
(mL min’1)
U . -C creat ,mm
(g L'1)
U . d creat,max
(g L'1)
U . -C p-1 ,min
(g mL" 1)
U d p-1, max
(g mL" 1)
P • 8 ' m m ^max
0.1 0.35 2.59 0.49 3.61 0.010 0.042 1.010 1.042
0.2 0.59 1.61 0.79 2.14 0.014 0.029 1.014 1.029
0.3 0.70 1.37 0.92 1.81 0.016 0.026 1.016 1.026
0.4 0.77 1.27 1.00 1.64 0.017 0.024 1.017 1.024
0.5 0.81 1.21 1.05 1.56 0.018 0.023 1.018 1.023
0.6 0.84 1.17 1.08 1.51 0.018 0.023 1.018 1.023
0.7 0.86 1.15 1.10 1.47 0.018 0.022 1.018 1.022
0.8 0.88 1.13 1.12 1.44 0.018 0.022 1.018 1.022
-0.1 0.39 2.87 0.44 3.24 0.010 0.039 1.010 1.039
-0.2 0.62 1.69 0.75 2.04 0.014 0.028 1.014 1.028
-0.3 0.73 . 1.42 0.89 1.75 0.016 0.025 1.016 1.025
-0.4 0.79 1.30 0.97 1.60 0.017 0.024 1.017 1.024
-0.5 0.83 1.23 1.03 1.52 0.017 0.023 1.017 1.023
-0.6 0.85 1.19 1.06 1.49 0.018 0.022 1.018 1.022
-0.7 0.87 1.16 1.09 1.45 0.018 0.022 1.018 1.022
-0.8 0.89 1.14 1.11 1.42 0.020 0.022 1.020 1.022
a Vmin = tbe flow rate (V) at which V+Ab = 0.9 or V" Ab = l.l
b Vmax = the flow rate (V) at which V+Ab = 1.1 or V" Ab = 0.9
C Ui,max = UiVmii; with bCreat = ^  V  l = °-7
d 'b '
Ui,min “ UiVmax; witb bcreat = 1’0’ b/>l = 0-7
0
pmin“ Up-l,min+ 1; ^max = U/o-l,max+ 1
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Table 2.12
BOUNDARY VALUES OF SELECTED URINARY PARAMETERS 
CORRESPONDING TO VAb = ± 0.2 FOR SELECTED Ab VALUES
Ab
y a 
min
(mL min’*)
V b max
(mL min" *)
U . .c creat,min
<g v  b
U . d creat,max
(g l- b
U . .c p-1 ,mm
(g mL" 1)
u . .p-1 ,min
(g mL" *) ^min ^max
0.1 0.11 6.19 0.20 11.50 0.006 0.094 1.006 1.094
0.2 0.33 2.49 0.51 3.83 0.011 0.044 1.011 1.044
0.3 0.48 1.84 0.69 2.64 0.013 0.033 1.013 1.033
0.4 0.57 1.58 0.80 2.22 0.015 0.030 1.015 1.030
0.5 0.64 1.44 0.88 1.98 0.016 0.027 1.016 1.027
0.6 0.69 1.36 0.93 1.83 0.016 0.026 1.016 1.026
0.7 0.73 1.30 0.97 1.73 0.017 0.025 1.017 .1.025
0.8 0.76 1.26 1.00 1.66 0.017 0.024 1.017 1.024
-0.1 0.16 9.31 0.14 7.91 0.004 0.072 1.004 1.072
-0.2 0.40 3.05 0.42 3.16 0.009 0.038 1.009 1.038
-0.3 0.54 2.10 0.60 2.34 0.012 0.031 1.012 1.031
-0.4 0.63 1.75 0.72 2.01 0.014 0.028 1.014 1.028
-0.5 0.69 1.56 0.81 1.83 0.015 0.026 1.015 1.026
-0.6 0.74 1.45 0.87 1.71 0.015 0.025 1.015 1.025
-0.7 0.77 1.38 0.92 1.64 0.016 0.024 1.016 1.024
-0.8 0.80 1.32 0.96 1.58 0.017 0.023 1.017 1.023
1.2
0.8
a V . = the flow rate (V) at which V+^b = 0.8 or V ^bmin x 7
b V = the flow rate (V) at which V+^b = 1.2 or V ^  max v '
‘bi
c U. = U?V ; with b _  , =1.0, b^ 1 = 0.7 i,max i m m  creat p-1
, -b-
d U- • = U?V with b _  . = 1.0, b^ 1 = 0.7i,min l max’ creat />- 1
^min- ^/>l,min+ ^max “ b/>l,min+ *
differ from unity by more than + 1 0  or +2 0 % is strongly 
dependent on Ab. As Ab increases, the boundary values Vm^n 
and V _ approach each other. For example, providing a 10%
IUcLX
_ 1
error is acceptable V . = 0.59 and = 1.6 mL min whenr m m  max
_ i
Ab=0.2; compared to V . = 0.84 and V = 1 . 1  mL min when’ m m  max
Ab=0.6. The corresponding boundary concentrations follow a
similar pattern (see Tables 2 . 1 1  and 2.12). Thus once the b^
values are known for both the metabolite of interest and the
reference substance, it is possible to recommend
concentration ranges of the reference material for which
uncorrected spot samples do not differ from U° by more than a
predetermined percentage. Taking nickel and creatinine as
examples (Ab = 0.3), for an uncertainty of +1 0 % as shown in
Table 2 . 1 1  these "boundary values" are: V . =0.70 and
J m m
Vmax = 1 ' 3 7  mL min" 1; Ucreat, min = ° ’ 9 2  and
Ucreat, max = 1 '81 6  L'1} and pmin= 1.016 with pm a x = 1.026.
Similarily for a +20% error: V . = 0.48 and V = 1.84 mL 
J ~ m m  max
“i"'1; Ucreat, min = ° ' 6 9  and Ucreat, max = 2 ' 6 4
p . = 1.013 and p =1.033. If these error levels are' m m  'max
acceptable, rejection of specimens with specific gravity or 
creatinine concentrations outside of these ranges would 
assure that on the average (U°reat/^creat^ approximates 
U°i or Vl/V2 = U°/U°2.
A slightly more sophisticated approach is possible when 
taking into account the uncertainty in the Ab value. 
Equation 2.24 can be interpreted in terms of Ab + SD as shown 
in Equation 2.25.
Here, SD is the standard deviation corresponding to the mean
of the observed Ab values. It is evident from the data in
Table 2.10, that for specific gravity and nickel Ab + SD has
the value 0.005 + 0.24. Now the data in Tables 2 . 1 1  and 2 . 1 2
and Figure 2.39 can be employed to establish specific gravity
ranges for which i SD w j^_l no^ <fiffer from unity by more
than 1 0  or 2 0 %, regardless of inter-personal variation in b^
values. Thus when Ab = 0 and SD = + 0 .2 , p . and p „ are—  7 ' m m  ' m a x
calculated to be 1.014 and 1.029 respectively for a +10%
deviation from unity of ± SD^ Rejecting samples outside 
of this specific gravity range assures that specimens from 
individuals with Ab quite different from Ab are still 
properly compensated within the preselected allowable error.
A normal distribution is assumed for the statistics 
employed in the remainder of this chapter. Boundary values 
for the urinary parameters in Tables 2 . 1 1  and 2 . 1 2  can be 
selected based upon a preselected confidence level (CL) of Ab 
which corresponds to Ab + t(SD/Vn~ ) when considering small
sampling theory, with t = Student t factor and n the number
of donors (McClave and Dietrich, 1985). Taking nickel and 
creatinine as examples (Ab = 0.3 + 0 .2 ), for 2 0  subjects the 
95% confidence limits of Ab would be 0 . 2  to 0.4. It is 
obvious from the data in Figure 2.39 that of these two Ab 
values, Ab = 0.4 imposes the greatest restriction and thus
determines V . and . To facilitate a comparison of them m  max
relative effectiveness of creatinine and specific gravity
adjustment protocols, it is helpful to consider the boundary
concentrations for both these metabolites. The pertinent
urinary parameters for +10% uncertainty as shown in Table
2.11 are: U____+ „• = 1.00 and U , = 1.64 g L ^;creat,mm creat,max °
similarly, Pm^n= 1*017 and Pmax= 1*024. By comparison for 
nickel and specific gravity, the 95% confidence limit of Ab 
for 20 donors is -0.1 to +0.1. The corresponding urinary 
boundary parameters for +10% uncertainty (Table 2.11) are:
U . = 0.49 and U = 3.24 g if1; p . = 1.010creat, m m  creat, max & ’ * m m
and p Q = 1.039. Thus if the spot voids are within the above
SlaX
boundary values, we would expect that at the 95% confidence 
level the mean flow rate for the group of 2 0  individuals 
would fall within the range predetermined by an error of + 1 0 % 
in the residual flow factor. For urinary nickel correction, 
the range of both Ucrea .^ and p is larger when specific 
gravity adjustment is employed than for creatinine. This 
illustrates an important advantage of using specific gravity 
to correct values: namely, the number of samples that
would have to be rejected at the 95% confidence level to meet 
the +10% error specification is fewer. For the 144 voids 
collected from the 20 donors in the Thompson study, 63% of 
all the specimens fall outside of the confidence interval 
specified if creatinine adjustment were adopted; while for 
specific gravity correction only 15% of the specimens would 
have been rejected. Similarly, creatinine normalization
would require the rejection of 50% of all the first voids in 
a shift compared to only 6 % for specific gravity adjustment. 
For the larger group of both cohorts studied (Port Colborne 
and Thompson; 32 donors) creatinine adjustment would result 
in 62% of the 242 voids collected falling outside of the 
confidence interval; while for specific gravity adjustment 
15% of the specimens would have been rejected.
For a much smaller group of 3 donors, the 95% confidence 
interval for Ab increases to -0.3 to +1 . 0  for creatinine and 
-0.7 to +0.7 for specific gravity correction. This results 
in much narrower ranges for values of Ucrea .^ and specific 
gravity that allow for a + 10% error. The range of Ucreat 
would be 1.14 to 1.41 g L"^, while p = 1.019 to 1.022 for 
creatinine correction. Specific gravity correction would 
have Ucrea .^ = 1.10 to 1.47 g L" ^  and p = 1.018 to 1.022. 
These narrow ranges would result in a large number of voids 
being rejected. For small groups it may prove more 
advantageous to collect 24-h urine specimens (but see below). 
As illustrated above in groups larger than 2 0 , the accepted 
range of urinary parameters would only broaden further 
minimally. Groups of 2 0  or more would facilitate biological 
monitoring since only a small number of voids would require 
rejection to have the mean flow rate falling within the 
acceptable confidence limits. Similar arguments as above can 
be employed for a +2 0 % acceptable uncertainty-in the residual 
flow factor. The corresponding urinary parameters are 
compiled in Table 2 .1 2 .
Unlike creatinine, specific gravity can be easily
measured with a hand held refractometer shortly after
collection. If the specific gravity observed falls within 
the predetermined uncertainty, the specimen can be accepted 
for further processing (i.e., nickel analysis). By contrast 
if it is outside this range, then the specimen should be
rejected and another obtained.
It is appropriate to mention that specific gravity
adjustment may be influenced by fluctuation of salt intake 
and yields erroneous results in the presence of glucosuria or 
proteinuria (Sunderman et al., 1986b). Nephrotoxic metals are 
capable of producing the above symptoms (Hook and Hewitt, 
1986) and hence may interfere with specific gravity
measurements. However, even though nickel may interfere with 
amino acid excretion (see Chapter 4) the amount of renal 
abnormality observed in workers of this study is minimal (see 
Chapter 3). Because of these limitations, along with the 
fact that the above arguments for normalization presume 
normal kidney function, it seems appropriate that spot urine 
voids be screened for diagnostic markers of abnormal kidney 
function (e.g. presence of glucose and protein). This can be 
conveniently achieved in a semiquantitative manner with 
"dip- sticks" (see Chapter 3). If there is evidence of any 
urinary abnormality, a 24-h collection seems advisable.
The above approach to normalization can be generalized 
for any urinary analyte of interest. As Tn the case of 
nickel, the appropriate b^ value of the exogenous substance 
or its metabolite should be determined before a normalization 
protocol is designed. Such evaluation of b^ and of Ab + SD
will allow the setting of appropriate ranges of creatinine or 
specific gravity for the accepted error level. As will be 
shown in Chapter 3, the choice of an endogenous substance for 
normalization is basically determined by the need to match 
the renal excretion pattern (i.e., clearance) of the 
xenobiotic with that of the reference metabolite. Since such
A K
matching assures that Ab = 0  and thus V - 1 , the
standardization process effectively corrects the urinary 
concentration to the value that may be expected at V = 1
i A h
mL min’ since V = 1  under this condition. An alternative 
approach to urinary normalization is thus to adjust the 
analyte of interest to a flow rate that approaches
_ i
1 mL min . This perspective is especially important when a
small number of donors is considered. For example, when
n = 3 then for nickel with specific gravity adjustment
0.81 and V n = 1.23 mL min’1, at the 95% confidence m m  max ’
level for a 10% error. For a 20% error, the flow rates would
_ i
be 0.69 to 1.44 ml min . In the case of 4 people, Vm^n =
_ -i
0.73 and V = 1.37 mL min , for a 10% error; while they max
have values of V = 0.54 and V = 1.84 for 2 0 % error.m m  max
Unfortunately, urine flow rates are not available for untimed 
spot specimens. However, as illustrated in Figure 2.17 and 
Table 2.8, the flow rate distribution for 24-h collections is
_ i
centered about 1 mL min and shows a smaller variation when 
compared to individual voids (c.f., data in~Fig. 2.17 and 
Table 2.8). Therefore by taking a 24-h collection, the flow 
rate is automatically closer to the ideal or hypothetical
_ i
state of 1 mL min . Of the 32 24-h collections summarized
in Table 2.1, 17 fall within the range mentioned above of
Vmin = 0*73 to Vmax = 1.37 mL min" * (10% uncertaintly range),
and 25 fall within the values V„- = 0.54 to = 1.84m m  m a x
_ 1
mL min (20% uncertainty range). This confirms the 
plausibility of the recommended approach. It also follows 
from the rationale employed that for spot samples, any 
correction is better than none, providing |b^ | »  |Ab| (c.f., 
Eqn's 2.6 and 2.24; also see Fig. 2.38).
Using the above approach, it is not obvious what the 
protocol for a single donor should be. However, using the 
standard sample score = (observation - mean)/SD (Moore, 1979) 
and a percentile table it is possible to estimate boundaries 
for an individual 24-h or spot-sample collection. For the 
data in this study (Fig. 2.18) the flow rate (V) for a 24-h 
collection is expected to be within the range of 0.5 to 2.0
- 1  —  i
mL min 8 6  percent of the time (V = 1.2 ± 0.5 mL min ). 
(These boundaries are selected to keep the uncompensated 
residual to a reasonable magnitude; see Figure 2.38.)
Using the standard score, it can be estimated for individual 
24-h collections adjusted by specific gravity, that the Ab 
term will be in the range -0.4 to 0.4 95% of the time (Ab = 
0.0 + 0.2). From these ranges of V and Ab, it is possible to
A V*
calculate that the uncompensated volume residual term (V )
will have an error of between -24 and 32%. Therefore the
standard score predicts a maximum error of- ~ 30% can be
expected for an individual using a 24-h collection corrected
by specific gravity if V is within the boundary values of 0.5 
_ i
and 2.0 mL min . This would seem an acceptable error and
rejection rate (i.e., corresponding to 5/32 (16%) of 24- h 
specimems in the present study). Similarly for the same
boundary values of V and the 95% confidence interval for Ab, 
the rejection rate for the 2 1 0  spot- sample voids depicted in 
Figure 2.17 would be 64/210 (30%). This indicates that if a 
30% error is acceptable then a specific-gravity adjusted 
urinary nickel concentration in a spot sample is a suitable 
measure of nickel excretion in a single individual, providing
the specific gravity value falls between p  - 1.015 (at V =
- 1 - 1  0.50 mL min and Ab = 0.4; or V = 2.0 mL min and Ab =
-0.4) and p = 1.026 (at V = 2.0 mL min’  ^and Ab = 0.4; or V = 
- 10.50 mL min and Ab = -0.4). Consequently, it may be 
concluded that specific-gravity adjustment of urinary nickel 
concentrations in spot samples when combined with appropriate 
flow-rate restrictions (expressed in terms of specific 
gravity range) provide a suitable estimate of U°Ni/tJ0 p_ ^  at 
a specified error and confidence interval.
The question of whether to normalize, and if so with 
what, should not be left to the discretion of the individual 
investigator. As pointed out above, any correction in most 
cases would be better than none; however if this work is to 
be used in a meaningful manner it is essential that 
investigators be consistent and a normalization protocol have 
general acceptance and implementation. Only when this 
happens will it be possible for urinary data T o  be compared, 
to be emloyed as indices of exposure and to be useful in risk 
assessments.
CHAPTER 3 RENAL CLEARANCE OF NICKEL AND BIOCHEMICAL INDICES 
OF KIDNEY FUNCTION IN ELECTROLYTIC REFINERY WORKERS
A INTRODUCTION
As indicated in the general introduction to this thesis 
there are a small number of reports of nickel induced 
nephrotoxicity in humans. Proteinuria has been reported for 
people who chronically drank water from a well contaminated 
with nickel (Gitlitz et al., 1975). Sunderman and Horak
(1981) reported a significant association between increased
urine concentration of P ^  microglobulin (Z^ - p)
- 1 1 ( > 240 /ig L ) and hypernickeluria ( > 100 /ig L ) for 30
electrolytic nickel refinery workers (p < 0.05 Mann-Whitney U
_ i
test) with the largest P<£ p  concentration of 450 pg L 
These urinary p^- p  levels were not, however, reported per 
mole or g of creatinine as is common in cadmium studies. 
Recently, Elinder et al. (1985a) reported unadjusted urinary
_ i
p <2 p  levels of between 40 and 20100 pg L for 19 workers 
exposed to cadmium. High levels of P^ p  appear to be quite 
common in cadmium workers and are taken as a marker for 
kidney tubular damage. Lauwerys (1983) considered renal 
function of Cd- exposed workers to be abnormal when total 
protein in the urine exceeded 250 mg/g-creatinine. Vail and 
Calnan (1980) found that there was no evidence of proteinuria 
in seventeen nickel-process workers in an electroforming 
plant during an outbreak of occupational dermatitis. Other 
than two cases of nickel carbonyl poisoning (Sunderman,1977), 
no other reports of proteinuria, or of other markers of renal
disease have been reported with workers exposed to nickel. 
Recently, there has. been one report of IgA nephropathy 
associated with dental nickel alloy sensitization (Strauss 
and Eggleston, 1985). These authors suggest that their 
patient may represent an example of nickel- induced 
sensitization associated with IgA glomerulopathy. There are 
also isolated reports indicating slight elevations in kidney 
and prostate cancer in nickel workers. However, these are 
not consistent, nor statistically significant, and their 
importance has yet to be clarified (Nieboer et al., 1984a; 
Roberts et al., 1984). The apparent lackof renal damage attributed 
to nickel is in direct contrast to the well established 
nephrotoxic and specific damage caused by a number of other 
metals such as uranium, cadmium, lead and mercury (Nieboer 
and Sanford, 1985). Metal-ion induced kidney damage is 
specific for individual metals.
In contrast to the inconclusive evidence of renal damage 
in humans, there is much better evidence of nickel-induced 
nephropathy in animal studies. For example, poisoning of 
dogs and cats by nickel nitrate was reported to produce acute 
renal injury with proteinuria and hyaline casts. Inhalation 
or injection of nickel carbonyl was found to cause transient 
azotemia, with pathological evidence of glomerular and 
tubular damage in various species including man (Sunderman et 
al., 1975; Gitlitz et al. , 1975; Sunderman, 1977; Sunderman 
and Horak, 1981). Acute nephropathy developed in rats after 
single ip injection of NiC^ with a 4-fold increase in 
urinary total proteins, 2-fold increase of urine NAG activity
and a 20- to 25- fold increase of valine excretion (Sunderman 
and Horak, 1981). Mathur and Tandon (1981) also found 
significant elevation of urine and plasma a - amino acid 
levels in rats 7 days after ip injection of NiSO^'GI^O. A 
more detailed outline of renal damage found.in animal studies 
will be presented in Chapter 4.
There has only been one detailed study of the renal 
excretion of nickel by humans. Mertz et al. (1970) looked at 
the renal excretion of Ni under varying conditions of 
diuresis in adults of both sexes with normal and impaired 
kidney function. Great variability in Ni excretion was 
observed within the individual experimental groups that could 
not be related to different functional states of the kidneys. 
However, nickel excretion was shown to be dependent on urine 
flow rates.
It is interesting to look at the work done by 
Tossavainen et al. (1980) to describe the excretion pattern 
of 4 electroplaters exposed to water- soluble nickel sulphate 
and chloride. Air, urine and plasma samples were collected 
during one workweek immediately after the workers’ summer 
vacation. Urine and plasma samples were taken at 0700 and 
1600 h each day of the week. Air samples were collected with 
personal samplers for the am and pm periods during the work 
shift from Monday to Friday inclusive. The urinary nickel 
levels were corrected to a specific gravity of 1.018. They 
were able to fit this experimental data to a mathematical 
model that employed a simple linear one- component kinetic 
model with one input and one output variable. It was assumed
that the nickel uptake is proportional to the ambient nickel 
level and can be described as a series of consecutive doses 
during the workweek. Elimination was also assumed to be 
governed by first order kinetics (see Figure 3.1). This 
model gave estimates of elimination half-time ranginS
from 17 to 39 h for nickel in the urine and 20 to 34 h for 
nickel in the plasma. These values are in good agreement 
with those reported in Chapter 1 for exposure to soluble 
nickel salts. Both the mathematical model and the 
experimental data indicate that the urine (or plasma) 
concentrations increase significantly not only during the 
work day, but also gradually during the workweek.
The research described in this chapter investigates 
urinary nickel excretion pattern(s), its renal clearance and 
evidence for renal damage in electrolytic nickel refinery 
workers. It will also look at the change in urinary nickel 
levels after a one month lay- off and its fluctuations during 
a workshift.
B THEORETICAL CONSIDERATIONS OF RENAL CLEARANCE 
(i) INTRODUCTION
The following derivations are based on the classical 
treatment of clearance of an analyte (i) as depicted in 
Equations 3.1.and 3.2.
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Figure 3.1. Urinary nickel concentrations (adjusted to a 
specific gravity of 1.018) for suject A during a work 
week. Bar diagrams represent nickel concentrations in 
air (am and pm ). Reproduced from Tossavainen et 
al. (1980). The model used to predict the urinary 
concentration due to exposure may be summarized by the 
following expression:
UNi = k3 + klCair ’ klCairexP[- k2<T‘
- 1-Here is the urinary nickel concnetration (//g L~ ) ;
k^ = a scaling constant relating air and urinary
- 1 3concentration [(//g L )/(//g m" )] and k2  a scaling 
constant related to biological half- life T ^ ^  ( k 2  = 
In2 /T^y2); -*-s the- measured air concentrationair
(mg m ); t^ = the time of onset of exposure; T = the
time of observation and kg = constant baseline
concentration (dietary uptake and body burden). Up^ is
determined by a term which is independent of the
biological half- life (2 nd from right) and another (1 st
from right) which depends on it. Changes in C . can beair
accomodated in the above formula by adding similar terms 
for the new values of Ca^r (positive or negative) and
summing the various contributions.
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(amount cleared from serum) =
lLV(amount excreted in urine) (3.1)
(3.2)
where
_
CL = clearance of analyte (i) in mL min (the
hypothetical volume of plasma or serum that has 
theoretically been completely cleared of 
analyte (i))
IL = urine concentration of the analyte (i) with the 
same units as the plasma or serum
_ i
V = urine flow rate in mL min
(or P^) = the serum or plasma concentration of the
analyte (i) with the same units as in the urine.
It is common for metals to have only a fraction of the total
amount in the serum available for filtration through the
glomerulus of the kidney. For example, serum calcium is
recognized to have three distinct fractions: (a)
protein-bound, (b) low molecular-mass complexes, and (c) free 
2+Ca (Veissman and Pileggi, 1974). These authors state that 
the total amount of ultrafilterable calcium (free ion and low 
molecular-mass complexes) is 60.5%. When the fraction of a 
metal that is ultrafilterable (os) is included in the
clearance expression, Equation 3.2 becomes:
(3.3)
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and Equation 3.1 should be written as in 3.4.
IKV (amount excreted) = aiCKSi (amount cleared) (3 .4 )
The clearance now represents the volume from which the 
ultrafilterable component of substance i is removed and <^CK 
is the hypothetical volume from which all of substance i is 
removed.
d i }  FRACTIONAL CLEARANCE
In Chapter 2  it was shown that nickel specific gravity 
(solutes) and creatinine adhere to Equation 3.5
coefficient. The parameters IK and V are as previously
Equation 3.9 is obtained by combining Equations 3.5, 3.6 and
where U? is the urinary concentration of i at a flow rate of
_ i
1 mL min and b^ is the volume exponent or power
- 1defined. When V = 1 mL min Equation 3.3 becomes
where C? is the clearance of the metal at a flow rate of 
- 11 mL min . If both sides of Equation 3.4 are divided by 
1 bV , Equation 3.7 is obtained.
which reduces to
(3.7)
(3.8)
3.8.
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bi V 1
UjV = «iCiV Si u? ajCVs. (3.9)
therefore,
b.-1
CiV 1 = c? (3.10)
or
„  l-b4 
cA = C°V 1 (3.11)
Considering two analytes 1 and 2, Equations 3.12 and 3.13 
then follow.
cl = clv
o b2 
2 = C2V
(3.12)
(3.13)
The general equation for the relative clearance (RC) for any 
analyte 1 being normalized by a second analyte 2 is
RC1,2 x
1-b.
V
1- b<
(3.14)
,b2" bl (3.15)
For creatinine-normalization of urinary nickel Equation 3.15 
takes the form 3.16, which constitutes the fractional 
clearance; Equation 3.17 represents the relative clearance 
for specific-gravity adjustment.
CT"Ni
^ N i , creat 'creat
C°Ni
creat
ybcreat bNi (3 .1 6 )
CNi
RCNi,/9-l _ C
P- 1
C°LNi
C°
V 1
VVl" bNi (3.17)
The expression in Equation 3.16 denotes the fractional 
clearance because creatinine is used as an estimate of the 
glomerular filtration rate (GFR) (see Section 3C). 
FCNi crea-£ thus represents the fraction of filtered nickel 
appearing in the urine.
fiii^ SERUM/URINE RELATIONSHIP
Equation 3.4 can be rearranged to highlight the serum
term as in Equation 3.18
uiv
8i = ~ a C ~ (3 -18)1
or
S. = — Ti—  U.v (3.19)
i aL _• ll
or
Si = -5C7- Ei (3 '2°)
where U^V = E^ = excretion rate or excretion per unit time
C REVIEW OF LABORATORY METHODS FOR SERUM CREATININE 
AND SPECIFIC GRAVITY DETERMINATION
A review of the literature indicates that there is not a 
definitive method to determine concentrations of creatinine 
in serum. The most common approach employs Jaffe’s reagent 
which is know to be nonspecific in that colour develops with 
noncreatinine chromogens such as cepha antibiotics, the 
hypoglycemic agent acetohexamide (Kroll et al. , 1987),
acetone and glucose (Cook, 1975). Kroll et al. (1987) also 
postulated that a co-planar charge-transfer complex is formed 
between Jaffe's reagent (picrate) and creatinine (or other 
ketones) which accounts for the observed reactions with 
noncreatinine chromogens. Three approaches have been
followed in attempts to improve the specificity of the 
creatinine assay: (1) modification by adsorption with Lloyd’s 
reagent; (2) use of alternative methods to the Jaffe reaction 
such as high pressure liquid chromatography (HPLC) (Okuda et 
al. , 1983) and (3), use of creatinine- splitting enzymes
(Cook, 1975). Two of these alternative methods highlighted 
in the current literature are briefly described. The 
"proposed selected method" of Haeckel (1981) is a 
modification of that by Jaffe (1886) . This method uses 
Fuller's earth (kaoline containing a hydrated 
aluminum/magnesium silicate; also referred to as Lloyd’s 
reagent) to eliminate interference by other chromogens. The 
second approach by Jaynes et al. (1982) employs an enzyme 
assay. The change in absorbance at 340 nm represents the 
utilization of NADH in a coupled-enzyme assay for creatinine.
Rapoport and Husdan (1968) compared three different 
sample pretreatments before colour development by the Jaffe 
method. These included: (1) deproteinization of serum which 
results in a small amount of non- creatinine chromogen being 
detected; (2) adsorption of creatinine on Lloyd's reagent; 
and (3), dialysis as part of a Technicon Auto-Analyzer unit. 
They found that the Auto-Analyzer method gave the best
correlation between creatinine clearance and the clearance of 
inulin. The residual amount of noncreatinine chromogens 
measured in plasma by this method appears to balance the 
creatinine appearing in the urine due to tubular secretion. 
This compensation is illustrated in. the following 
mathematical formula employed in the calculation of clearance 
of endogenous creatinine (Duarte et al., 1980).
Creatinine clearance =
(mL/min)
■I ” 1Urine creatinine(filtered + secreted) mg dL x V ml min
— —-
Plasma (creatinine + noncreatinine chromogens) mg dL
Simultaneous measurements of inulin clearance, the 
actual creatinine clearance (creatinine determined in absence 
of other chromogens), and the clearance of creatinine 
assessed by the Auto Analyzer/dialysis method have 
demonstrated that for normal glomerular filtration rates 
(GFR), actual creatinine clearance overestimates GFR by a 
mean amount of 46%, while creatinine clearance by Auto 
Analyzer/dialysis overestimates by 8% (Anderson et al., 
1970). Since creatinine is the only known endogenous 
substance in the body whose clearance approximates the 
clearance of inulin (Duarte et al., 1980; Epstein, 1977),
this makes its use for the estimate of GFR practical for the 
current study. Because the Auto Analyzer/dialysis approach 
gave results closest to that of the true GFR as measured by 
inulin clearance, this method was selected for the
measurement of serum and urine creatinine.
The two most common methods of measuring urinary 
specific gravity is by a urinometer and refactometry 
(Faulkner and King, 1976). The urinometer method involves 
the measurement of specific gravity by a hydrometer in a 
cylinder containing urine. A number of disadvantages are 
associated with this method: (i) it is time consuming, (ii) a 
large volume of urine is needed, (iii) requires correction 
for large quantities of protein and glucose, and (iv) needs 
to be corrected for temperature (Faulkner and King, 1976). 
By contrast, measurement of urinary specific gravity by a 
temperature compensated refractometer (American Optical 
Corporation) overcomes many of the above problems. This 
method is rapid, only requires a small drop of urine and does 
not need to be compensated for temperature. However, large 
amounts of protein and or glucose will still interfere. 
Refractometry is based on the linear relationship between 
refractive index and the total concentration of dissolved 
solids (Glover and Goulden, 1963). Such relationship even 
occurs for a complex solution such as urine (Rubini and Volf, 
1957). Deviations from linearity are negligible for urinary 
specific gravity values below 1.035, which corresponds to the 
upper end of the range normally encountered (Cannon, 1974). 
Because of its simplicity, speed of measurement and general 
acceptance in Clinical Chemistry laboratories, the 
refractometric method was chosen for the measurement of 
urinary specific gravity.
D MATERIALS AND METHODS
The same serum and urine samples considered in Chapter 2 
also form the data base here. Thus a number of the 
laboratory solutions and procedures are the same as described 
in Chapter 2. Therefore they will not be described in detail 
here and the reader is referred to Chapter 2.
m  MATERIALS
(a) Chemical Reagents
Pertinent information about the routine chemical 
reagents used is summarized in Table 2.1.
(b) Laboratory Solutions (Auto Analyzer)
Details about the source and preparation of solutions 
are described in Chapter 2.
(c) Laboratory Solutions fNickel Determination)
Full details of the preparation of these solutions are 
described in Chapter 2.
(d) Laboratory Solutions fTotal Protein Determination^ 
Veronal Buffer ( p H = 7.4). Stock buffer solution contained 
0.015 M barbital, 0.0045 M sodium barbital and 0.77 M NaCl in 
DDW. Before use it was diluted four-fold (100 mL to 400 mL) 
with DDV giving a final pH of 7.4.
Stock Total Protein Standard (4.5 mg mL~ ^ ) . Into a 50 ml
beaker, exactly 0.1125 g of Human Serum Albumin (HSA) was 
added. Approximately 10 mL of veronal buffer was added and 
HSA was allowed to dissolve. The solution was transferred to 
a 25 mL volumetric flask and brought to volume with veronal 
buffer. This solution was stored at 4°C.
(e) Decontamination of Plastic and Glasswares
The same protocol as described in Chapter 2 was 
employed. In Table 2.2, details are provided about the type 
of glassware and plasticware employed.
fii^ DONOR POPULATIONS
As described in Chapter 2, this study was carried out on 
26 subjects occupationally exposed to nickel at INCO's 
electrolytic refining operations in Port Colborne (Ontario, 
Canada) and Thompson (Manitoba, Canada). A collection 
involving twenty workers was conducted at Thompson over a 
single 24-h period involved three shifts. Two sera samples 
were collected for each donor. The sera for the workers from 
the day shift (7am - 3pm) and afternoon shift (3pm - 11pm)
were collected at the start of the shift. The donors from 
the midnight shift (11pm - 7am) had their sera taken at the 
end of a shift. Two exceptions to this were the General 
Foreman (Refinery) and the General Foreman (Safety and 
Production) who although they worked between 7am and 4pm, 
were not able to have their sera taken until 11:00am and 
12:00 (noon) because of their workload. The sera for the
collections at Port Colborne were taken at the beginning of 
the day shift at 8:00 am (1st collection) and between 8:00 
and 9:00am for the second collection.
Detailed job classifications for both donor groups are 
given in Table 3.1.
During all 24-h multi-void urine collections there was 
no attempt to restrict diet (i.e., fasting) or increase 
liquid intake (i.e., water loading) above their normal level. 
Futhermore, there was no attempt to restrict alcohol intake.
(iii) METHODS
(a) Urine Collection Procedures
As described in Chapter 2, each void was analyzed for 
nickel, creatinine and specific gravity (p) and its pH was 
measured. In addition, dip-stick analysis for ketones, 
bilirubin, glucose, nitrite, blood, urobilinogen and protein 
were also performed. Selected specimens were analyzed for 
total protein (Bradford, 1976) and microglobulin (RIA 
assay).
(b) Serum Collection Procedure
Serum samples were collected as described in Chapter 2B
(iii) b. Each sample was analyzed for nickel, creatinine and 
/?2 " microglobulin (RIA assay).
Table 3.1
JOB DESCRIPTION OF WORKERS
JOB NUMBER OF WORKERS
___________________  Port Colborne Thompson
Foreman (Refinery) 1 1
Foreman 0 la
(Safety fc Protection)
■L
Process Assistant 1 0
Boxman 2 1
Scrapwash 1 3
Plating Tankman 0 6
Cobalt Recovery 0 1
Copper Recovery 0 1
Purification/Thickener 0 4
Equipment Man 0 lc
Labourer 1 0
Electrician (Refinery) 0 1
Si Present job does not require spending significant time in 
the electrolytic refinery. Previously he had worked for 
10 y as a foreman in the electrolytic refinery.
k This job involves collecting samples of electrolyte 
throughout the refinery for laboratory analysis.
c This job requires the worker to be in and out of the 
refinery.
(c) Determination of Serum and Urinary Nickel
These procedures are identical to those described in 
Chapter 2B (iii)c and e.
(d) Determination of Serum and Urinary Creatinine
These were measured by the Jaffe reaction employing a 
single- channel Technicon Auto Analyzer with a dialysis block; 
a detailed description is found in Chapter 2B (iii) f.
fe) Determination of Specific Gravity
Specific gravity was measured on a hand-held, 
temperature-compensated, refractometer (American Optical 
Corporation). The accuracy of this instrument was comparable 
to established equipment in the Clinical Chemistry Laboratory 
at the Chedoke-McMaster Medical Centre.
(f) Determination of Osmolality
This parameter was measured by the Clinical Chemistry 
Laboratory of the Chedoke-McMaster Hospital by freezing-point 
depression of centrifuged urine samples using an Advanced 
Instruments Osmometer Model No. 68-L.
(e:) Determination of Urinary Parameters bv Dip- Sticks
This is a semiquantitative method for the simultaneous 
determination of up to six or seven chemical properties of 
urine. This is done by dipping into the specimen of urine a 
strip of hydrophobic plastic that has test areas impregnated
with various chemical indicators. The reagent test areas are 
completely immersed in fresh, well mixed, uncentrifuged urine 
and then removed immediately to avoid leaching out of any 
chemical. Excess urine is removed by running the edge of the 
strip against the rim of the urine container. The strip is 
held in a horizontal position to prevent mixing of chemicals, 
and read at specific time intervals by comparing the 
developed colours of a test area to standard colour charts.
The detailed instructions for the use of these test
strips is given by the manufacturer in an information sheet 
that is included with every package.
(10 Determination of Total Protein
The total protein content of urine was measured by the
Bio-Rad protein assay. Bradford (1976) first demonstrated
the usefulness of this method. It is based on the
observation that the absorbance maximum for an acidic 
solution of Coomassie Brilliant Blue G- 250 shifts from 465 nm 
to 595 nm when binding to protein. Nesbett et al. (1978) 
found that for urine-protein determinations it is necessary 
to make sure the urine pH is below 8.0. Their results were 
comparable if not superior to sulfosalicylic (turbidimetric) 
measurements. This is consistent with the results found in 
the present study where the Bio-Rad assay performed in a 
comparable manner to the sulfosalicylic acid standard method 
adopted by the American Society of Clinical Pathologists 
(code ST-63 1973). Bio-Rad protein determination has been
shown to have a linear standard curve and is relatively free
from most of the interferences that limit the application of
2+the earlier Lowry protein assay. It has been shown that Ni
does not interfere with the Bio-Rad method (Maxwell, 1984)
The total protein working standards were made up fresh
daily by pipeting accurately aliquots (with a fixed volume
100- pL Eppendorf pipettor) of an HSA standard solution (4.5 
-1mg mL ) into a 5 mL volumetric to give final concentrations
_ i
between 4.5 and 45 mg dL . The working standards were 
brought to volume with veronal buffer (pH = 7.4). The
purchased dye reagent was diluted (5x) with DDW and filtered 
prior to use. This reagent was made up fresh each day. In 
the assay, 100 pL (from a fixed volume 100- pL Eppendorf 
pipettor) of standards, urines and blanks (veronal buffer) 
were placed in dry test tubes. Then 5.0 mL (from a Brinkman 
Dispensette) of diluted dye reagent are added. The solution 
was mixed by gentle inversion to avoid excess foaming. After 
a period of ~ 30 min, the absorbance was measured at 595 nm. 
The unknowns were read from a standard curve.
The total protein was measured for all the urine samples 
that showed trace amounts by the dip- stick method and on all 
samples selected for microglobulin determination.
fi^  Determination of
The ultrafiltrable fraction of nickel in serum (ofy^ ) was 
determined by ultracentrifugation and nickel analysis of the 
supernatant by electrothermal atomic absorption spectrometry
(EAAS).
The serum was thawed at room temperature and 5.0 mL (lmL 
Gilson pipettor) were added to a threaded- top polycarbonate 
ultracentrifuge bottle. The tubes were put in a fixed angle 
titanium rotor (Type 70.1 Ti) and ultracentrifuged at 230 000 
g for 17 h at 4°C on a Beckman Ultracentrifuge (model L8-80). 
The tubes were then removed from the rotor in a cold room and 
the volume of supernatant was measured. The supernatant was 
collected without disturbing the pellet and the 
low-molecular-mass lipids at the top of the tube. The 
protein content of the supernatant was determined by the 
Bio-Rad procedure.
The nickel content of the supernatant was measured by 
EAAS. The value was calculated by comparing the amount 
of nickel in the ultrafiltrate (i.e., the supernatant) to 
that found in the serum before centrifugation.
(i) Determination of urinary pH
The pH was measured by a Radiometer model M84 pH meter, 
or similar instrument, that had been standardized against two 
buffers.
(k) Determination of 6^- microglobulin
Human microglobulin p) is a low molecular mass
protein (relative molecular mass of 11800). It is produced 
by the nucleated cells of the body and eliminated via the 
kidneys. After filtration through the glomeruli, it is
reabsorbed by the proximal tubular cells, where it is 
rapidly catabolized within the lysosomes (Bernier and Conrad, 
i969; Conway and Poulik, 1977). Normally, only trace amounts 
of /?2 ~mieroglobulin are excreted in the urine. However, 
exposure to metals such as Hg and Cd, or organic chemicals 
(e.g., aminoglycosides) that damages the proximal tubule, can 
lead to larger amounts in the urine due to tubulointerstitial 
disorders resulting in decreased reabsorption of this 
protein.
Two different RIA kits from Pharmacia were used because
the Phadebas micro (RIA-1) kit used initially was phased
out by Pharmacia during the course of this work and was
replaced by the RIA (RIA-2) test kit. Both employ a
competitive radioimmunoassay. The Z^" mieroglobulin in the
125sample competes with a fixed amount of added I-labelled
125Z?2 ~ mieroglobulin ( I- p^- p) for the binding sites of
anti- Z?2 "mieroglobulin antibodies. After the appropriate
incubation time, the unreacted @2 P  is separated from that
bound to the anti-Z^A antibody by two methods. In the RIA-1
kit, the anti- P ^  p  antibodies are covalently bound to
Sephadex particles which are removed from the "free” (3^ ~ P by
centrifugation followed by decantation and subsequent washes.
The RIA-2 kit employs the addition of a second antibody which
precipitates the primary antibody complex. Separation
is achieved by centrifugation, which is followed by
decantation and washing to remove the "free* t1 from the
125bound @ 2~ P* The bound I-labeled ^  measured by a
125gamma counter. The measured radioactivity due to I is 
inversely related to the concentration of unlabelled P^ A 
the unknown or standard. The percent of bound activity
J a c t i v e  b„u»d -  ■’’S . V S f f g f i S S r  *  100
is plotted against the standard /^-mieroglobulin
concentrations or amount on semi-log paper. The urinary P^ 
concentrations were obtained from the standard curve 
employing an appropriate dilution factor as required. Table 
3.2 compares the reagents and methods employed in both 
methods.
Immediately after collection, urine specimens were 
adjusted with 1.0 M NaOH to a pH of between 6 and 8 and were 
promptly frozen to prevent degradation of the P<£ ix (Lauwarys 
et al.,1984). Transport to the laboratory was in ice-packed 
freezer containers. The transport from Thompson also 
included placement of containers in air- plane cargo areas at 
- 10°C. On arrival at the laboratory, the frozen urine 
samples were immediately placed in a freezer (<-10°C). For 
both Port Colborne collections, the P<g-jx was measured using 
the RIA-1. However, when the Thompson collection was made 
Pharmacia started to phase out this test kit and replaced it 
with the RIA-2 kit. The main difference in the standards 
provided in these kits is that in the RIA- 2 method they are 
more concentrated than in the RIA-1 procedure. The lowest 
standard provided with the RIA-1 method was 10 fxg L" * while
- 184-
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for the RIA- 2 it was 400 fig L . Since the highest value of 
/?2 - fJ> measured in the Thompson collection was 178 fig L’*, 
modifications of the recommended procedure were necessary to 
permit the analysis of the samples with such "low" values. 
Details are provided below.
Low working standards for the RIA- 2 assay were made up 
by diluting the high standards with DDV to make 25, 50,100,
_ -i
300. and 400 fig L working standards (mixing was by gentle
inversion). Next 200 f£L of standard, blank (DDW) and unknown
were pipetted into the bottom of polystyrene centrifuge tubes
125(12mm x 75 mm; round bottom) . The I- (3^  P  was pipetted
(500 fjL) into each standard, unknown and blank followed by 50
fjL of antibody. Test tubes were vortexed if necessary until
they were a uniform green colour. The remainder of the steps
were the same as listed in Table 3.2. After the prescribed
centrifugation and decantation, the radioactivity of all test
tubes was measured. To avoid non-specific contributions to
the measured counts, the test tubes were then washed with a
0.05% (w/v) Tween and 0.15 M NaCl buffer, centrifuged,
125decanted and the I measured again. The P2 fi values for 
the unknowns were read off a semi-log plot of % bound versus
%  p  (ns) •
Table 3.2
P 2 - MICROGLOBULIN RADIOIMMUNOASSAY REAGENTS 
AND ASSAY PROTOCOLS
REAGENTS
RIA-1 (60- micro")_______
Buffer Solution
Added 1 vial of Tween 
solution to 300 mL of DDV; 
then added 1 vial (8.3 g) 
of buffer powder.
Sephadex- anti- &>-u complex 
Added 7.0 mL DDV to the 
purchased vial and the 
suspension was allowed to 
stand for ~2 min, then 
mixed (magnetic stirrer).
60- u Standards
1000 fjL of DDV was added 
to each vial and after 
standing for ~1 min was 
mixed to give the following 
standards: 10; 25; 75; 200 
and 500 fig/L.
60- -globulin r125n
5.5 mL of DDV was added 
to the vial and after 
standing for ~1 min was 
mixed.
RIA-2
Standards 
500 fJL DDV was added to each 
standard: 0.4; 0.8; 1.6; 4.0; 
8.0 and 16.0 mg/L /%- fi (human), 
lyophilized.
Antibody 
Antiserum raised in sheep, 
lyophilized (colour code 
yellow). Added 5.5 mL DDV to 
vial.
&>- a- globulin -(125I)
~1.7 /iCi at date of shipping, 
lyophilized (colour code blue). 
Added 5.5 mL DDV to make the 
stock solution. Vorking 
solution was obtained by 
diluting 1/10 with DDV.
Decanting Solution 
Sepharose- anti- sheep IgG 
raised in horse. One 200-mL 
vial was included in each kit 
and did not need further 
dilution.
Table 3.2 Continued
METHOD
RIA-1 (3>- micro)_______
1 (a) Blanks. Pipetted
50 jili of buffer solution 
into dry test tubes.
(b) Standards. Pipetted 
50 /jL  of fo-li standards 
into the test tubes.
(c) Samples. Pipetted
50 /aL of diluted unknowns 
into test tubes.
NOTE: Serum samples
were diluted 1/51; 
urine samples were 
diluted 1/5 with 
buffer solution.
2 Pipetted 50 /aL of
1251 - fe-[a solution into 
all the test tubes in 
step 1.
3 Pipetted 50 //L of 
Sephadex anit- /%- {a 
complex suspension into 
all test tubes.
' NOTE: The Sephdex 
anti - fclA complex 
suspensionn was 
stirred continously 
continuously on a 
magnetic stirrer 
during pipetting.
4 Each test tube was mixed 
by vortexing until the 
solution turned a 
homogeneous green colour. 
The test tubes were then 
covered with Parafilm 
and incubated on a 
horizontal shaker for
90 min at room 
temperature.
RIA-2
1 Pipetted 50 fSL of
standards into test tubes.
2 Pipetted 50 fJL of unknown 
serum or urine) samples 
DO DILUTION).
3 Pipetted 50/zL of 
125I -fc-tA.
4 Pipetted 50 /^ L of 
antibody.
5 Each test tube was mixed by 
vortexing until solution 
turned a homogenous green 
colour.
6 2.0 mL of decanting
suspension was added to each 
test tube (5 mL Gilson).
NOTE: The suspension was 
periodcally mixed to 
ensure homogeneity.
Table 3.2 Continued
METHOD
5 Separation
(a) Added 2.0 mL buffer 
to each test tube.
(b) Centrifuged the test 
tubes on a swingout bucket 
for 10 min at 2000xg.
(c) Decanted the 
supernatant by gently 
turning the tubes upside 
down with a smooth 
uninterrupted movement; 
the inverted tubes were 
placed on absorbent paper 
for 5s.
6 The bound reactivity in 
the tubes were measured 
on a LKB Universal 1282 
gamma counter with one 
minute counting. The 
background was measured 
by using empty test 
tubes.
The 7c activity bound 
obtained from the /%-// 
standards were plotted 
against the /%-// 
concentration (/zg/L) on 
semi- log paper to 
construct a standard 
curve. The unknowns were 
read off the standard 
curve and multiplied by 
the appropriate dilution 
factor.
The test tubes were then 
covered with Parafilm and 
incubated for 45 min at 
room temperature on a 
horzontal shaker.
8 Centrifuged all the test 
tubes on a swingout bucket 
for 10 min at 2000xg.
9 The test tubes were 
decanted as described in 
step 5 (c) of the RIA-1 
method.
10 The bound reactivity in 
the tubes were measured 
on a LKB Universal 1282 
gamma counter with one 
minute counting. The 
background was measured 
by using empty test 
tubes.
The 7c activity bound 
obtained from the 
standards were plotted 
against the
concentration (/zg/L) on 
semi- log paper to construct 
a standard curve. The 
unknowns were read off 
the standard curve.
RIA-1 (3>- micro) RIA- 2
7
E RESULTS
(i) URINARY 62- MICROGLOBULIN
The RIA-1 (/?2 _ micro) kit required an extra-washing step 
of the sample- equilibrated Sephadex to attain acceptable 
accuracy and reproducibility. The RIA-2 method, modified for 
low standards, was found to have comparable accuracy, 
reproducibility and limit of detection as the RIA-1 kit. 
Also, there did not seem to be a large difference between the 
values of {i obtained by the RIA- 2 procedure when the 
pellets were not washed and when they were washed once with a 
0.05% (w/v) Tween and 0.15 M NaCl buffer.
fii^ BIOCHEMICAL INDICES
The data in Tables 3.3 and 3.4 summarize the results of 
the biochemical indices of nephrotoxicity measured in the 
Port Colborne group. They suggest that the concentrations of 
indicator substances were within the normal range. A similar 
pattern was observed in the Thompson workers, although a few 
anomalies appear evident (Tables 3.5 and 3.6). Two workers
_ i
had abnormally low creatinine clearances, 29 and 41 mL min ,
oadjusted for body surface area of 1.73 m . Three workers 
were found to have elevated urinary /^-mieroglobulin in 
individual voids. However, when averaged over three or more
_ i
voids, the average values were below 200 fjbg g creatinine 
and within the normal 24-h excretion range. Tables 3.7 and 
3.8 summarize these results for the combined donor groups. 
Statistical evaluation of the results in the above tables was
- 189-
Table 3.3
LABORATORY TEST RESULTS 
(Port Colborne Study Group)
URINE
Substance 
(k, n)
(No. of donors,
No. of specimens)
Observed
Range
(x ± s)
Normal
Range
(x ± s)
Units
Creatinine 
(6, 11)
19 - 27 
(24 + 2)
21 - 26° i -1^-1mg kg d
Total Protein 53 - 143 <150d
_ i
mg d
(6, 26) (97 ± 37) (77 + 26)1
Total Protein^ 16 - 253a <95e mS Screat
(6, 26) (41 + 44)
/?2 ‘ mieroglobulin*' <50 - 85 <250f T “ 1/zg L
(5, 9) (62 + 14)
/?2 * mieroglobulin*' <30 - 70 <200® MS S  creat
(5, 9) (44 + 13) (60 ± 40)1
Specific Gravity*' 1.011 - 1.032 1.002-
(6, 97) (1.018 ± 0.0008) 1.030h
Osmolality*1 110 - 881 50 - i i -1mosmol kg
(3, 31) (530 ± 230) 1200d
p hJ
(6, 97)
5.0 - 7.7 4.8 - 7.8h ---
Table 3.3 Continued
SERUM
Substance 
(k, n)
Observed
Range
Normal
Range
Units
(No. of donors, 
No. of specimens)
(x ± s) (x ± s)
Creatinine^ 0.73 - 1.15 0.6 - 1.20^ mg dL~ ^
(12, 24) (0.93 ± 0.15) (0.99 ± 0.12) 1
o *“ 1
One void for one donor was above 95 mg gcrea^ when this void 
was combined with the 4 other voids analyzed for this donor
_ i
the average was 57.5 mg gcreat-
b 1The creatinine clearance was 148 + 32 mL min" (range
100 - 211 mL min" or 132 + 28 mL min" ^  (range 84 - 190)
oadjusted to a standard surface area of 1.73 m . 
cDi Giorgio, 1974.
j
Clinical Chemistry Laboratory, Adult Reference Ranges, 
Chedoke-McMaster Medical Centre.
eHerber, 1984.
f
Pharmacia // instruction book.
^Lauwerys, 1983. 
hTietz, 1976.
1Sunderman and Horak, 1981.
(n = 18 or 28)
^Spot urine samples.
NOTE: None of the observed body- fluid concentrations
differed significantly from the normal values (p>0.05) 
tested relative to the mid-point of the normal range and/or 
mean + SD when given, see text.
Table 3.4
DIP STICK RESULTS FOR URINE SAMPLES 
Port Colborne Study Group
(k = donorsa, n = total analysis)
Test Negative
k(n)
■L
Positive
k(n)
Ketones 6(85) 4(8)
Bilirubin 6(83) 6(10)
Glucose 6(93) 0(0)
Nitrite 6(93) 0(0)
Blood 6(93) 0(0)
Urobilinogen 6(84) 5(9)
Protein 6(53) 6(40)
aAges: 31, 35, 48, 56, 57, 59 years.
Only trace levels were indicated in all cases.
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Table 3.5
LABORATORY TEST RESULTS 
(Thompson Study Group)
URINE
Substance 
(k, n)
Observed
Range
Normala
Range
Units
(No. of donors. 
No. of specimens)
(£ ± s) (x ± s)
Creatinine^ 
(18, 18)
14 - 25g 
(20 + 4)
21 - 26 mg kg" 1 d" 1
Total Protein 28 - 129 <150 1mg d
(20, 20) (100 + 38)g (77 ± 26)
Total Protein05e 12 - 116 <95 mg screat,
(20, 58) (46 ± 19)
p
Po- mieroglobulin ND - 178 <250 m  L'1
(20, 47) (80 + 37)
J
/?2 " mieroglobulin ’e ND - 442 <200 f1g g creat
(20, 47) (91 ± 87) (60 ± 40)
Specific Gravity 
(20, 142)
1.003 - 1.030 
(1.018 ± 0.0007)
1.002-
1.030
-----
pH®
(20, 142)
4.9 - 7.8 4.8 7.8 ■ " —
aFor sources see Table 3.3.
^Excluding two donors with low creatinine clearances (See 
text for details)
"One void was above 95 mg g^reat (^-6) when this void was 
combined with other from that donor the average was 59.4
mg &creat *
Table 3.5 Continued
SERUM
Substance 
(k, n)
(No. of donors, 
No. of specimens)
Observed
Range
(x ± s)
Normala
Range
(x + s)
Units
f
Creatinine 0.79 - 1.36 0.6 - 1.20
_ i
mg dL
(20, 40) (1.10 ± 0.15)® (0.99 + 0.12)
/?2 " mieroglobulin 0.85 - 2.05s 0.8 - 2.5h
_ ^
mg L
(20,20) (1.44 + 0.33) (1.6 ± 0.4)1
J
Three donors had individual voids with mieroglobulin
levels above 200 /zg g" ^  (i.e.^ 258, 283, 442 and 265 /zg g" *) . 
Vhen the results for all voids analyzed were combined, the
_ i
average was less than 200 /zg g in each case. 
eSpot urine samples.
f i
The creatinine clearance was 101 + 25 mL min (all values)
-1 - 1 and 107 + 16 mL min (range 84 - 145 mL min ) when
excluding the two low values discussed in the text. The
p
creatinine clearances adjusted to 1.73 m were 87 + 22
-1 -1 mL min (all values) and 93 + 13 (range 70 - 117 mL min )
when excluding the two low values discussed in the text.
^Statistically significant, p<0.05; relative to normal range 
or mean + SD.
^Pharmacia RIA instruction book.
^■Sunderman and Horak, 1981.
Table 3.6
DIP STICK RESULTS FOR URINE SAMPLES 
Thompson Study Group
Q
(k = donors , n = total analysis)
Test Negative
k(n)
Positive
k(n)
Ketones 20(132) 1(3)
Bilirubin 20(132) 3(3))
Glucose 19(120) 7(15)
Nitrite 20(127) 4(8)
Blood 20(133) 1(2)
Urobilinogen 20(124) 6(11)
Protein 19(100) 14(35)
a The average age of the workers was 45 + 8 y with 
the range 32 - 57 y.
b Only trace levels were indicated in all cases.
done by a one-group comparison of the mid point of the normal
range to the mean + SD of the observed serum or urinary
parameter using small sampling theory and the student t 
statistic (t = [{X-/z}/s],fn~ ) ? where X is the mean of a sample 
of size n and fi is the mean of a normal population (mid point 
of the normal range). Each serum or urinary parameter was 
tested using the null hypothesis Hq : /z ..= X and the
alternative hypothesis H : /z f X. In the few cases wherea
reference values were available as mean + SD, the
significance test consisted of small-sample t-test for 
independent samples (McClave and Dietrich, 1985).
fiii") NICKEL CLEARANCE AND a^1
Nickel clearances (the volume of serum from which
ultrafilterable nickel is removed in one minute) were
calculated using the formula CNi = % i V/a^i^Ni ’ =
nickel concentration in the 24-h collection, V = the flow
_ ^
rate in mL min based on the 24-h volume; the
ultrafiltrable fraction of nickel in serum; and = average 
nickel concentration of two serum specimens, one collected at 
the beginning and the other at the end of the 24- h collection 
period. The clearance of nickel when divided by the 
creatinine clearance (= U e -^ V/S t) yields the fractional 
clearance of nickel (see Figures 3.2 and 3.3). The 
creatinine clearance may be taken as an estimate of the 
glomerular filtration rate (GFR). Figures 3.2 and 3.3 
illustrate that the fractional clearance of nickel has a
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flow-rate dependence. It can be shown (see Theoretical 
Aspects and Discussion, Section B), that the exponent of the 
curves in Figures 3.2 and 3.3 represent the term Ab =
^creat ~ ^Ni (or on averaSe 1 ~ ^Ni)* This allows a separate 
evaluation of Ab from that described in Chapter 2. All the 
nickel clearances were less than the creatinine clearances 
and the fractional clearances of nickel were less than 
100 percent (see Figures 3.2 and 3.3; Table 3.7). Table 3.8 
provides a comparison of different assessments of Ab = 
^creat”^Ni * ^rac‘ti°nal clearance values vary from 21 to
46 percent of the GFR.
The ultracentrifugation experiments with serum 
established that 24 + 6 percent of the nickel was not bound 
to high-molecular-mass molecules, which constitutes the 
fraction of serum nickel that is available for glomerular 
filtration (i.e., = 0.24 + 0.06; n = 6).
In Figure 3.4, the 24-h average urinary nickel excretion 
rate (Ej^ = Uj^V) is compared with the serum nickel levels. 
The observed relationship conforms to the equation 
£>Ni = 0.10 + 0.40, r =0.97; here is the nickel
_ i
excreted in ng min , calculated from the 24- h nickel 
excretion (U^^V).
(iv) URINARY OSMOLALITY
For the first collection at Port Colborne the 
relationship between urinary values of specific gravity and 
osmolality was found to comply with the relationship
T a b l e  3 . 7  
C L E A R A N C E  S U M M A R Y
D o n o r  G r o u p N i c k e l C l e a r a n c e C r e a t i n i n e C l e a r a n c e
m L  m i n " 1 m L  m i n " 1 m L  m i n " 1 m L  m i n " 1
M E A N + S D
( R A N G E )
M E A N + S D a
( R A N G E )
M E A N + S D
( R A N G E )
M E A N + S D a
( R A N G E )
P o r t  C o l b o r n e 2 5 + 7 2 1 + 5 1 4 8 + 3 2 1 3 2 + 2 8
(n=7; n i c k e l ) * 1 
( n = 1 2 ;  c r e a t i n i n e )
(17- 3 5 ) (15- 2 9 ) ( 1 0 0 - 2 1 1 ) ( 8 4 - 1 9 0 )
T h o m p s o n  
( n = 2 0 ;  n i c k e l )
( n = 1 8 ;  c r e a t i n i n e ) 0
4 1 + 1 2  
(25- 8 2 )
3 6 + 9  
(22- 6 6 )
1 0 2 + 1 9  
( 8 4 - 1 4 5 )
9 3 + 1 3  
( 7 0 - 1 1 7 )
B o t h  C o l l e c t i o n s 3 7 + 1 3 3 2 + 1 1 1 2 4 + 3 1 1 0 9 ± 2 8
( n = 2 7 ;  n i c k e l ) * 1 
( n = 3 0 ;  c r e a t i n i n e ) 0
( 1 7 - 8 2 ) ( 1 5 - 6 6 ) ( 8 4 - 2 1 1 ) ( 7 0 - 1 9 0 )
a  T h e  c l e a r a n c e s  a d j u s t e d  t o  a  b o d y  s u r f a c e  a r e a  o f  1 . 7 3  m 2 w e r e  c a l c u l a t e d  
b y  t h e  f o l l o w i n g  f o r m u l a  e m p l o y e d  b y  T i e t z  ( 1 9 7 6 ) .
c Ui‘Vi .. 1 . 7 3
i -  5 7  x
W h e r e :  A  =  b o d y  s u r f a c e  a r e a  ( m 2 ) c a l c u l a t e d  f r o m :
l o g ( A )  =  ( 0 . 4 2 5 x l o g ( W ) ) +  ( 0 . 7 2 5 x l o g ( H ) ) - 2 . 1 4 4
W  =  w e i g h t  ( k g ) ; H  =  h e i g h t  ( c m )
C ^  =  c l e a r a n c e  o f  a n a l y t e  (i) i n  m L  m i n " 1 ( t h e  h y p o t h e t i c a l  v o l u m e
o f  s e r u m  t h a t  h a s  t h e o r e t i c a l l y  b e e n  c l e a r e d  o f  a n a l y t e  ( i ) ; 
i n  t h e  c a s e  o f  n i c k e l  i t  i s  t h e  v o l u m e  f r o m  w h i c h  
u l t r a f i l t r a b l e  n i c k e l  i s  r e m o v e d ) .
U .  =  u r i n e  c o n c e n t r a t i o n  o f  a n a l y t e  (i) w i t h  t h e  s a m e  u n i t s  a s  i n  
s e r u m .
=  s e r u m  c o n c e n t r a t i o n  o f  a n a l y t e  (i) w i t h  t h e  s a m e  u n i t s  a s  i n  
u r i n e .
=  U r i n e  f l o w  r a t e  i n  m L  m i n -1 . 
k  T h e r e  w e r e  5  c o l l e c t i o n s  w i t h o u t  s e r u m  n i c k e l .
c E x c l u d i n g  t w o  d o n o r s  w i t h  l o w  c r e a t i n i n e  c l e a r a n c e s  
( 2 9  a n d  4 1  m L  m i n " 1 p e r  1 . 7 3  m 2 ).
Table 3.8 
PREDICTION OF CREATININE CLEARANCE 
THOMPSON STUDY GROUP
Donor Predicted8, Predicted Observed Clearance
Clearance Clearance
(mL min-1 ) (mL min"1) (mL min-1 ) (mL min"1
A 112 92 123 101
B 95 91 113 109
C 100 90 90 82
D 106 100 106 100
E 105 100 105 100
F 91 76 84 70
G 123 113 95 87
H 79 69 112 98
I 73 65 91 80
J 120 97 145 117
K 74 60 98 80
L 105 91 111 96
M 91 80 119 105
N 78 70 32 29
0 108 90 49 41
P 145 117 96 77
R 116 95 134 110
S 107 86 121 97
T 110 98 86 76
V 105 91 105 91
MEAN±SD 102 ± 18 88 ± 15 101 ± 26 87 ± 22
(all donors)
MEAN+SD 103 + 18 89 ± 15 102 ± 19 93 ± 13
(without donors N k 0)
Table 3.8 Continued
PREDICTION OF CREATININE CLEARANCE 
PORT COLBORNE STUDY GROUP
Donor Predicted8, Predicted Observed Clearance
Clearance Clearance
(mL min“1 ) (mL min-1 ) (mL min-1 ) (mL min-1)^
A 87 72 100 84
B 99 90 138 124
C 90 80 135 119
D 79 73 109 102
E 125 111 132 117
F 123 113 153 140
a ; 136 114 185 155
b ' 137 123 211 190
c' 105 98 132 123
d ' 94 84 143 126
e ' 149 132 176 156
f ' 155 143 167 154
MEAN+SD 115 ± 26 103 ± 23 148 ± 32 132 + 28
a CREATININE CLEARANCE (mL min"1) = in y)x(mass in kg)
(serum creatinine; mg dL"1 )x72
This formula is based on serum creatinine determination by 
Auto-Analyzer/dialysis protocol (Cockroft and Gault, 1976).
CREATININE
CLEARANCE
predicted' 
clearance 
column 1
1.73 (mL min" *per 1.73 m^)
A (m2 ) 
o
A = body surface area (m ) calculated from:
log(A) = (0.4251og(W)) + (0.7251og(H)) - 2.144
¥ = weight (kg); H = height (cm); from Teitz (1976).
The unprimed and the primed donor notation correspond to the first and 
second 24-h collection, respectively, of the same donor.
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(v) EFFECT OF EXPOSURE ON
When the Port Colborne urinary nickel levels were 
normalized with specific gravity, the resulting values
appeared to increase during the shift with a subsequent 
decrease during the post-shift period (See Figs. 3.6 and 
3.7). The values of observed after the layoff were lower 
by approximately 36 - 70 percent, compared to pre-layoff 
values. Interestingly, Ug^ values (for individual voids) in 
the second 24-h collection at Port Colborne were found to be 
more uniform throughout the day as illustrated in Figures 3.6 
and 3.7. In the Thompson collection, there was not always an 
indication of an increase in Ug^ values during the shift, nor 
was a subsequent post- shift decrease always evident (see 
Figs. 3.8 to 3.10).
F DISCUSSION
(i) BIOCHEMICAL INDICES OF KIDNEY FUNCTION
Two markers of renal status usually associated with Cd 
nephrotoxicity, total protein and P, were evaluated in the 
current investigation of electrolytic refinery workers. 
Normaly only trace amounts of (3<£ p  and total protein are 
present in the urine. Excretion of p  is noticeably
o
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Figure 3.6. Fluctuations in standardized urine nickel
concentrations (U^) for a nickel electrolytic refinery
worker (donor %>£;) during two 24-h multi-void
collections (Port Colborne cohort). The diagonal lines 
indicate the day shift, which started at 7:00 am and 
ended at 3:00 pm.
T o p  Curve: ( - 0 - 0 -  ) estimated from U N i , V  and
(Equation 2.6) and adjusted to p = 1.021 (-A-A-)
prior to a one month layoff.
Bottom Curve: (-•-•-) estimated from UNi, V and bNi
(Equation 2.6) and adjusted to p - 1.021 (-A-A-) at 
the end of a one month layoff (prior to resuming work).
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Figure 3.7. Fluctuations in standardized urine nickel
concentrations (U^) for a nickel electrolytic refinery
worker (donor during two 24-h multi-void
collections (Fort Colborne cohort). The diagonal lines 
indicate the day shift, which started at 7:00 am and 
ended at 3:00 pm.
T o p  Curve: ( - 0 - 0 - ) estimated from , V and
(Equation 2.6) and adjusted to p = 1.021 (-A-A-)
prior to a one month layoff.
Bottom Curve: (-•-•-) estimated from V and b^^
(Equation 2.6) and adjusted to p - 1.021 (-A-A-) at 
the end of a one month layoff (prior to resuming work).
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Figure 3.9. Fluctuations in standardized urine nickel 
concentrations for a nickel electrolytic refinery worker
(donor E^) during a 24-h multi-void collection.
(-o-o-) estimated from Uj^ adjusted to p - 1.018. The
diagonal lines indicate the midnight shift at Thompson, 
which started at 11:00 pm and ended at 7:00 am.
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Figure 3.10.  ^ Fluctuations in standardized urine nickel
concentrations for a nickel electrolytic refinery worker
(donor NT) during a 24-h multi-void collection.
(-0-0-) estimated from UNi adjusted to p = 1.018. The
diagonal lines indicate the midnight shift at Thompson, 
which started at 11:00 pm and ended at 7:00 am.
increased in nephrotubular disorders. This change can be due 
to exposure to heavy metals such as Cd (Lauwerys, 1983), Au 
based anti-rheumatic compounds (Merle et al. , 1980), or to 
urinary tract infections (Schardijn et al., 1979). In renal 
diseases, p level in the serum reflects alterations in GFR 
more accurately than serum creatinine (Vibell et al. , 1973 
and Shea et al., 1981). Usually, the amount of protein
excreted in the urine from normal donors rarely exceeds 150
_ i
mg d . Increased excretion of urinary protein is an early 
sign of renal damage. Proteins cross the glomerular filter 
by a complex process that depends on the endothelial pore 
size, electrical charge and the binding characteristics of 
the protein molecule as well as on the absolute value of the 
glomerular filtration rate (Lauwerys, 1984). Proteins with 
molecular mass below 40000 to 60000 pass easily through the 
glomerular filter and are reabsorbed by the proximal tubular 
cells of the nephron. When there is glomerular damage, the 
glomerular permeability is usually increased and therefore 
larger quantities of high molecular mass proteins enter the 
glomerular filtrate and appear in the urine (Lauwerys, 1984). 
Low-molecular mass proteinuria is usually not increased 
because their reabsorption has not changed. If there is 
tubular disfunction, the amount of protein filtered through 
the glomeruli is not increased. However, in this instance 
the high- and low-molecular mass proteins normally filtered 
are not reabsorbed to the same degree. Hence larger 
quantities of the low-molecular mass proteins appear in the
urine (Lauwerys, 1984). In the present study, the urinary 
levels of peg- n  are used as a marker of renal tubular damage, 
while total protein is used as an indicator of glomerular 
dysfunction (high-molecular mass proteinuria). Chapter 4 
gives a more complete description of the anatomy and 
physiology of the kidney and its funtional unit the nephron. 
In this study there were two donors (one from each
collection) who had voids with a total protein level above
- 1 -1 95 mg gcrea^ and only one void was above 200 mg gcrea^* When
these voids with high levels of total protein were combined
with other voids from the same donor the "average” was below
-1 -1 95 mg gcreat? which is much below the level of 250 mg gcreat
that is considered to be an indication of abnormal kidney
function associated with Cd exposure (Lauwerys, 1983; Herber,
1984). The urinary concentration of ^  in four voids
_ -j
derived from three donors exceeded 200 /zg gcrea-j:* However, 
when these results for each donor were combined with those 
for the remaining voids, the 24-h "average" was below 200
_ i
//g gcrea-fc i-n each case. Values exceeding this level are 
usually considered an indication of Cd nephrotoxicity
(Lauwerys, 1983). Since high levels of the tubulo-disorder
marker &  an(^  elevated total protein levels were not 
apparent in this study of electrolytic refinery workers,
glomerular or tubulonephrotoxicity appears not to occur.
The serum fi levels for the Thompson collection were 
within the normal range (not significant p > 0.05 when means 
are compared). There were 7 donors in the Thompson
collection with one of the two sera creatinine levels above
-1 -11.2 mg dL and none had levels below 0.60 mg dL . This is
reflected in the mean which was significantly different from
the normal mean (p<0.05). This indicates slighty elevated
levels of serum creatinine in the Thompson collection, while
in the Port Colborne collection they are within the normal
range (not significant p>0.05; with no donors outside the
normal range). For the Thompson group, the highest serum
- 1creatinine concentration was 1.36 mg dL . Levels <1.4 mg
_ i
dL are considered minor elevations (Lilis et al. , 1980) or
even the upper range of normal (Thun and Clarkson, 1986) In
the Port Colborne collection, 3/11 of the 24-h urinary
- 1 - 1creatinine excretions (mg kg d ) were outside the accepted 
normal range. Because there was 1 above and 2 below the 
range, these outliers did not cause the creatinine excretion 
to be significantly different from the normal values 
(p>0.05). The Thompson collection was statistically 
different (p<0.05) with 9/20 below and none above the 
accepted range. Consequently, the Thompson subgroup has 
relatively low 24-h urinary creatinine excretion and slighty 
increased serum creatinine levels.
The pH values of all the urine voids were within the 
normal range of 4.8 to 7.8 cited by Faulkner and King (1976). 
This indicates that the kidneys in both study groups maintain 
normal hydrogen ion balance under the conditions of the 
studies.
The osmolality of random urine samples is usually within
_ -1
a normal range of 50 to 1200 mosmol kg (^O) (private 
communication, Clinical Chemistry Laboratory,
Chedoke-McMaster Medical Centre). Since specific gravity can 
be used as a measure of urine osmolality even in the presence 
of proteinuria (Gault, 1982), the regression equation in 
Figure 3.4 can be used to estimate the urine osmolality in 
this study. The appropriate specific gravity range 
calculated from the normal osmolality range is 1.001 to 
1.034. As evident in Tables 3.3 and 3.5 the specific gravity 
and hence the osmolality of the urines collected in this 
study are as expected and thus renal concentrating ability 
was normal in the work and home environments.
Each urine void was screened for indicators of general 
health effects and abnormal kidney function in a 
semi-quantitative manner by dip sticks. This was used as a 
guideline for further laboratory test of total protein. 
Specimens for which dip- stick tests showed trace levels of 
urinary protein were analyzed by the Bio-Rad protein assay. 
Both study groups exhibited a low incidence of positive trace 
levels for the parameters measured. Below is a brief summary 
of each test and its significance for kidney function or 
general health. The appropriate biochemical/physiological 
information is found in a number of sources such as Green 
(1976), Leaf and Cotran (1980), Matta and Wilbraham (1981) 
and Vander et al. (1985).
Ketones. Ketone bodies (acetoacetic acid, ft- hydroxybutyric 
acid and acetone) are produced during the oxidation of fatty
acids. Accumulation (ketosis) results from the incomplete 
metabolism of fatty acids, generally because of carbohydrate 
deficiency or low carbohydrate metabolism as in untreated 
diabetes mellitus. Normal urine specimens ordinarily yield 
negative results with this method. In both groups of this 
study, there were a total of 11 voids (5%) from 5 donors 
(Table 3.6) that had trace levels of ketones. This 
illustrates that there is a low incidence of ketonuria in 
both study groups and that it is to be expected that the 
donor population is essentially free of renal complications 
such as papillary necrosis or nephrotic syndrome associated 
with diabetes mellitus (Leaf and Cotran, 1980).
Bilirubin. This is the orange- coloured or yellowish pigment 
in the bile. It is produced from the haem moiety (without 
iron) of the haemoglobin molecule during the catabolism of
erythrocytes that occurs mainly in the reticuloendothelial
cells in the bone marrow and the spleen. Any blockage or
failure of the bilirubin excretory pathway (e.g. blockage of
bile-ducts by a gall stone) will result in its accumulation 
in the blood causing the condition know as jaundice and 
excretion in the urine rather than in the faeces. For both 
collections, nine donors (13 voids; 6%) had detectable trace 
levels of bilirubin in their urine. No donors had bilirubin 
in all of their voids, indicating that this occurrence was 
transient and of minimal importance.
Glucose. This sugar is usually entirely reabsorbed in the 
kidney and hence not present in the urine. If present, it is
usually an indication of impaired glucose metabolism 
associated with diabetes mellitus or an indication of poor 
reabsorption of glucose in the kidney. In the Port Colborne 
sub-group, there was no indication of glucose in the urine; 
while there were 7 donors at Thompson who had 15 voids (11%) 
with a trace of glucose. It was not found in all the voids 
of any one donor, indicating that the incidence of low levels 
of glucosuria was transient in this population even though 
there was no attempt to restrict food intake.
Nitrite. Normally no nitrite is detectable in the urine. A 
positive test indicates significant bacteriuria that may 
indicate pyelonephritis, cystitis and urethritis. In this 
study there was no indication of nitrite in the Port Colborne
subgroup, while there was for 4 donors (8 voids; 6%) at
Thompson. No individual had nitrite present in all voids. 
Therefore, the incidence of bacteriuria is low in this 
population.
Blood. Haematuria is associated with many kidney disorders 
such as acute nephritis, calculi, renal carcinoma or chronic 
kidney infection. In this study there was no evidence of the 
presence of blood in the Port Colborne group, while only 1 
donor (2 voids out of 4) had a trace at Thompson. This
illustrates the low occurrence of haematuria in this study. 
Urobilinogen. Bilirubin is oxidized in the large intestine 
by bacterial action to colourless urobilinogen, some of which 
is reabsorbed and excreted in the urine. A small amount in 
urine is normal and increased levels are associated with
hepatic disease while decreased levels indicate biliary 
obstruction. The dip stick method will only detect high and 
normal levels. Low levels of urobilinogen or its complete 
absence in the specimens being tested cannot be determined. 
There was no indication of increased urinary urobilinogen in 
both groups.
Protein. Proteinuria may be caused by increased permeability 
of the glomerular filter associated with a number of kidney 
deseases such as acute glomerulonephritis, or by 
pyelonephritis, a tubulointerstitial disease. In this study 
none of the voids indicated more than trace levels of urinary 
protein.
In summary, the trace levels and transient nature of the 
results from the dip- stick screening of urine specimens 
indicate that there was no evidence of complicating factors 
in kidney function such as bacterial infection nor any renal 
indication of other major health perturbations in the 
populations examined. The only abnormality observed in the 
study was that of slightly increased serum creatinine and 
decreased urinary creatinine excretion in the Thompson group.
(i i) CREATININE CLEARANCE
The elevated serum creatinine levels are within the
upper limit cited by other authors, but as pointed out by
Gault (1982) and Thun and Clarkson (1986) , 50 to 67% of normal GFR
may be lost in some patients before the serum creatinine
-  1concentation exceeds the upper normal limit of 1.4 mg dL
Creatinine clearance is known to decrease with age (e.g., 
Gault, 1982). The age dependence of creatinine clearance for 
both donor groups was calculated from a formula given by 
Gault (1982) which employs age, body mass and serum 
creatinine levels to predict creatinine clearances (Table 
3.8). There are two Thompson donors (N and 0) with observed 
clearances much below their predicted values. The mean of 
the predicted values in columns 1 and 2 of Table 3.8 for the 
Thompson cohort are in good agreement with the mean of the 
observed values (columns 3 and 4) both including and 
excluding the two donors (N and 0) with low creatinine 
clearances However, the standard deviation in the observed 
group is larger when these low values are included while 
there was no change in the predicted standard deviation. 
This illustrates that the low clearances observed for donors 
N and 0 is not dependent on age. The Port Colborne cohort 
has larger, but not significant (p>0.05), observed creatinine 
clearances than the predicted values. This is attributed to 
the higher 24-h flow rate found in the Port Colborne (1.3 + 
0.6 ml min ) group in comparison to the Thompson (1.1 + 0.4 
mL min ) (see Table 2.8). Since the creatinine clearances 
for the Thompson group were normal (donors N and 0 excluded), 
the slightly elevated creatinine serum levels and depressed 
urinary creatinine excretion found (Table 3.5) may well be 
due to an inappropriate selection of normal values for this 
metabolite. The principal value in the determination of 
urinary excretion of creatinine is not the evaluation of
renal function (unless part of a creatinine clearance test),
Because creatinine excretion is relatively constant for an
individual, it can be used as a check on the completeness of
a 24-h collection (Faulkner and King, 1976). Therefore the
low creatinine excretion and clearance values observed for
donors N and 0 could be due to the 24-h collection being
incomplete and is not necessarily due to renal dysfunction.
As pointed out by Faulkner and King (1976), a number of
factors can cause errors in the measurement of creatinine
clearances. Among the most common are faulty timing,
vigorous exercise during the collection period and improper
- 1hydration of the patient (a urine flow of 2 mL min is 
ideal). This flow-rate tends to eliminate retention of urine 
in the bladder as a source of negative error. During the 
present study, there was no effort made to water- load any 
donors to ensure a high urine flow rate. It is interesting 
to compare the biochemical indices of kidney function for the 
donors with low creatinine clearances (N and 0) and other
-j
donors with V<0.6 mL min (Table 3.9). From the data in 
this table it is clear that there is not one parameter that 
is common to all of the donors in this subgroup. This 
suggests that there may not be a single underlying cause. 
Because of the possible errors associated with the 24- h urine 
collections of donors N and 0, it seems advisable that 
measurement of their GFR should be re-evaluated.
It is interesting to note that both acute renal failure 
and primary glomerulonephritis (acute nephritis) are
Table 3.9
BIOCHEMICAL INDICIES OF KIDNEY FUNCTIt
(DONORS WITH 24-h FLOWRATE LESS THAN 0.6 mL i 
UNUSUALLY LOW CREATININE CLEARANCES)
Donor** Age
(v)
Veight
(lb)
Job
4----------
Creatinine
21 - 26*
Total
Protein
UK1PE TEST
Total
Protein
IESULTS
Specific
Cravity
»
24- k Flovr.t.
Creatiaiae* 
0.8 - 1.2h
fir* „
0.8 - 2.5*
SEIUM
Nickel*
rEST IESULTS —  
Creatiaiae**b 
Clearance Uc
(agkg*1 d*1) <150* ag d‘1 <95* eg SCreat /jg L*1 *  *cre»t 1.002 • 1.030 aL aia* 1 (■« dL' ‘) ■8 L’X « L ' * 71 - 135* aL ain’Vl-73 a2
*T 54 170
Section Leader 
Tank lease
7.1 28 2E <50 <32 1.003 -1.023 0.43 1.02/1.38* 1.54 6.53/5.90 29
°T 43 200 Plating Tamkaaa 8.7
42 54 83 105 1.009 - 1.025 0.84 1.13/1.13* 1.20 2.75/3.70 41
tt
34 178 lefinery
Laboarer
15 65 59 56 41 1.027 - 1.030 0.48 1.02/1.13* 0.85 6.95/5.83 76
he* 31 155 Bosaaker 24 — - - - 1.028 - 1.031 0.53 0.73 — -- 154
*TC 31 155 Boxaaker 27
4.8 48 — - 1.024 - 1.028 0.70 0.93 — - 140
*The m u  ♦ SD for both collections exclndiag donor* Nj and 
Of i» 109 i 28 al aii'1 per 1-73 a2.
*The range for both collections excluding donors f<T and Oj is
70 to 190 nL ain" 1 per 1.73 a2.
rHcg 5 It usher of voids with no parameter detected.
Pos s nnalter of voids with only a trace level present.
*hc and FpQ are two 24-h collections froa the same donor 
who took 7.5 ag Traaxoae per day. This tranqsilizer is 
known to aake orinatioa difficult and the resalts are 
iacladed in this table for coaparisea only.
^creat^creat on 24-h collections. For this stady
aeaa ♦ SD was 120 ± 50,range (48 - 315) for 32 donors.
^Subscript. T i Thompson; PC = Port (‘o I borne.
associated with a reduction in the GFIt and an increase in 
serum creatinine (Thomson et al., 1982; Clark,1982; Thun and 
Clarkson, 1986). The significance of these abnormalities 
will be discussed in more detail in Chapter 4.
Certainly in comparison with comparable exposures to a 
known nephrotoxic metal such as Cd (Elinder et al. ,1985a,b)> 
any changes in renal function caused by nickel exposure in 
electrorefining appear to be minimal. Chapter 4 and 5 will 
discuss the observed nephrotoxic effects of nickel on rats 
which support the observed low incidence of renal dysfunction 
in electrolytic refinery workers.
fiii) DETERMINATION OF
As described in Section C(ii) of Chapter 1 there does
not appear to be any agreement on the exact size of the
ultrafiltrable or high molecular mass fractions of nickel(II)
in human serum. The work by Lucassen and Sarkar (1979) found
2+only 4.2% of the total Ni bound to L-histidine which 
comprises the ultrafiltrable fraction. Their experiment was
/> Q
done by adding NiC^ to 2.0 mL of serum and diluting to a 
constant volume of 2.5 mL before ultracentrifugation. 
Therfore, this estimate does not necessarily represent the 
endogenous nickel distribution. In the present work, six 
determinations were made of the actual endogenous low- and 
high-molecular-mass fractions of nickel(II) in human serum. 
The low molecular mass fraction of 24% (a^ = 0.24 + 0.06) is 
substantially higher than the 4.2% observed by Lucassen and
Sarkar (1979). However it is greater than the 15% observed 
by Asato et al. (1975) for rabbit serum and less than the 40%
ultrafiltrable fraction attributed to human serum by
Sunderman et al. (1972) and Nomoto (1980). It has
been shown that there are large species variations in the
proportions of ultrafiltrable and protein-bound serum nickel 
(Hendel and Sunderman, 1972). New Zealand rabbit sera are 
known to have a larger concentration of nickel than human 
sera, which may explain the different distribution between 
high- and low-molecular-mass components. The species 
distribution work done by Sunderman et al. (1972) on human 
sera also involved direct measurement of nickel. However, 
the nickel concentrations found for the sera from healthy
_ -j
unexposed subjects (2.3 //g L ) was much higher than
_ -i
currently being reported (0.46+0.26 //g L ; Sunderman et al. . 
1984) , and thus the value for may not be correct because 
of the dubious nickel(II) measurements.
For all calculations of nickel clearance in the next 
section, 0.24 was employed.
(iv) CLEARANCE OF NICKEL
The creatinine and nickel clearances based on the
combined voids for 24-h collections were calculated from
Equations 1 and 2 of Section B and adjusted to a body surface
o
area of 1.73 m . They are summarized in Table 3.10. 
Observed nickel clearances were less than the corresponding 
creatinine clearances, including the two donors with
abnormally low creatinine clearances (Tables 3.9). Because 
creatinine clearance is a measure of glomerular filtration 
rate (GFR) (Duarte et al., 1980; Epstein, 1977) any substance 
that has a clearance below GFR is being reabsorbed in the 
kidney (Green, 1976). The low nickel clearance may thus be 
interpreted as evidence for its reabsorption in the kidney. 
The animal data reported in Chapter 4 are consistent with 
this conclusion. This is also supported by the fractional 
clearances of nickel (^Ni/^creat^ being less than 100 
percent. The reabsorption process is a function of the urine 
flow rate as illustrated by the variation in fractional 
clearance of nickel with flow rate (see Figures 3.2 and 3.3). 
The nickel clearance varies from individual to individual as 
indicated by the different sets of curves depicted in Figure
-j
3.2 (c.f., values of F C ^  at V = 1 mL min’ ).
In the Theoretical Considerations of Renal Clearance 
(Section B), it was illustrated that the general equation for 
the fractional clearance (FC) of nickel may be written as 
shown in Equation 3.16.
FC =   vbcreat bNi (3.16)
creat C°reat
This equation is very similar to Equation 2.4 with b^ = b ^  
and b2 = bcreat. Therefore, a plot of CNi/Ccreat j^rsus V 
(see Figs. 3.1 and 3.2) should yield estimates of
Ab = bcreat" bNi ^  CNi/Ccreaf Ib is clear from FiSures 3 -2
and 3.3, that the fractional clearances of nickel tend to 
increase rapidly at low flow rates and level off somewhat at 
high flow rates. The shape of these FC curves can be 
rationalized by examining the family of theoretical curves
A K
plotted in Figure 2.38, where V (the uncompensated volume 
residual in Equation 3.16) has been plotted against V for 
various values of Ab and V. Thus the nickel FC curves belong 
to the sub-group of curves with Ab>0. Table 3.10 compares 
estimates of Ab for log versus log V plots, Uj^/U ^ 
versus V plots, and ^Ni/^creat versus V plots. No 
statistical difference occurs between these alternative 
estimates.
Figure 3.4 displays the relationship between urinary 
excretion rate (Ej^ = ^Ni^O and serum nickel levels. As 
shown in Section B (Eqn. 3.20), the slope of this equation is 
a measure of the effective clearance of nickel (i.e. slope = 
1/aCj^; unadjusted to surface area). Consequently, the 
volume of serum from which available nickel is removed per
—  -i
unit time, C ^  = 1/a^xslope = 1/(0.24x0.10) = 42 mL min , 
and thus about 65 7c of the nickel in the glomerular filtrate 
[i.e. 100( 1 - 42/GFR)] is reabsorbed taking the GFR = 120
_ i
mL min . This alternative method of estimating nickel 
clearance yields a value close to that found in the Thompson
_ -i
collection (41 + 12 mL min ) and reasonably close to the
_ -i
overall average (37 + 13 mL min ) ; but is higher than that
_ -j
observed for the Port Colborne collections (25 + 7 mL min ;
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Table 3.10
ASSESSMENT OF THE URINE FLOW- RATE POWER COEFFICIENT bi FOR CREATININE, 
NICKEL AND THE CORRESPONDING Ab VALUES
Donor L ft _Ni ’ r bcreat ’ r lb=bcreaf bNib Ab=bcreat- bNiC’g> r 4b=bcreat- btiid’E' 1
A 1.14, 0.85 1.41, 0.81 0.27 0.27, 0.42 0.21, 0.45
B 1.09, 0.95 1.17, 0.95 0.08 0.08, 0.81 0.10, 0.90
C 0.68, 0.72 1.13, 0.96 0.45 0.46, 0.73 0.56, 0.78
D 0.77, 0.92 1.08, 0.94 0.31 0.26, 0.67 0.26, 0.66
Ee 0.44, 0.80 ‘ 1.08, 0.98 0.64 0.64, 0.88 T -|i ■
F 0.54, 0.96 1.05, 0.97 0.51 0.52, 0.93 0.23, 0.40
G 0.67, 0.93 1.08, 0.99 0.41 0.35, 0.85 0.35, 0.86
He 0.58, 0.86 1.01, 0.95 0.43 0.50, 0.87 - -
I 1.01, 0.94 0.96, 0.96 -0.05 -0.05, 0.20 0.03, 0.17
J 0.59, 0.86 0.85, 0.92 0.26 0.26, 0.45 0.57, 0.67
K 0.49, 0.99 0.61, 0.99 0.12 0.11, 0.90 0.25, 0.98
MEAN±SDf 0.70 ± 0.20 1.04 + 0.22 0.26 ± 0.18 0.25 + 0.18 0.28 ± 0.18
a Evaluated from plots of log(U^) versus log(V).
b Ab was calculated by subtraction of bi values in columns 2 and 3.
C N tAb was evaluated from plots of — — —  versus V.
Ucreat
d C?c *
Ab was evaluated from plots of — — --  versus V.r
creat
e Serum nickel was not evaluated for donors E and H. 
 ^MEAN + SD does not include donors E and H.
® There was no statistical difference between these measures of 
Ab = bcreat‘ bNi? P > 0‘05-
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Table 3.9).
The shape of the fractional clearance plots for nickel 
has a close resemblance to that for the fractional clearance
of urea (Smith, 1964). Vhen V is larger than 2 mL min’ *
- 1 - 1 - 75 mL min , but when V is less than 2 mL min C urea urea
decreases (Green, 1976; Pickford and Lambie, 1976). Tubular 
reabsorption of urea is by passive diffusion down a 
concentration gradient created by the reabsorption of water 
associated with the active reabsorption of NaCl (Pickford and 
Lambie, 1976). Therefore, by analogy to urea it is 
reasonable to postulate that the reabsorption of nickel in 
the kidney has a large passive component.
Cv'l EFFECT OF EXPtlSURE ON U°
From the discussion it is clear that nickel is 
reabsorbed in the kidney and thus a substance like urea or 
total solutes will have a very similar excretion pattern. In 
the previous Chapter, total solutes (p-1) was selected to be 
more appropriate for adjustment of urinary nickel than 
creatinine. It is known that soluble nickel to which 
electrolytic-refinery workers are exposed is rapidly absorbed 
into the body and is excreted with a half-life near 24 li. 
Therefore, it is reasonable to expect to see fluctuations in 
nickel levels that represent a worker’s exposure during the 
work shift resulting in an increase in adjusted to
p = 1.018; see Chapter 2). After the shift, when the worker 
is no longer exposed to nickel, a decrease in is
expected. The model depicted in Figure 3.1 illustrates this.
Figures 3.6 to 3.10 illustrate the occurance of changes
in throughout the 24-h collection period. For donors in
both study groups (Figs. 3.6 to 3.8), the values
generally appear to increase during the shift with a
subsequent decrease during the post-shift period. These
results follow the same pattern reported by Tola et al.
(1979) and Tossavainen et al. (1980) who found an increase in
the levels of urinary nickel adjusted by specific gravity
when workers were exposed to soluble nickel in electroplating
processes and a decrease when they were off work (see Fig.
3.1). As explained in the introduction to this chapter, a
linear one- compartment kinetic model gave estimates of the
24-half-life of Ni of between 17 and 39 h in urine, and from 
20 to 34 h in plasma (Tossavainen et al. , 1980). It is not 
surprising therefore that the maximum value is reached
post-shift. Since air concentrations were not available in 
the present study, modelling of the data in a quantitative 
manner was not possible.
The post-layoff curves in Figures 3.6 and 3.7, obtained 
just before the workers returned to their jobs after a one 
month layoff, are approximately 36 to 70% lower than the 
pre-layoff values. Nevertheless, these, urinary levels are in
_ i
the range of 6 to 27 //g L which is above the range 0.5 to
_ i
6.0 /ig L expected for nonexposed healthy adults (Sunderman 
et al., 1986b). This indicates that there is a slow release 
of nickel from pools stored in the body which causes nickel
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to have an effective half life considerably larger than 24-h. 
This has been observed in other studies for retired nickel 
workers exposed to particulate forms of nickel (Nieboer et 
al. , 1984a) and is discussed further in Chapter 5. The
suggestion of variation in during the second Port
Colborne collection as illustrated in Figure 3.7 is 
unexpected. Examination of the data corresponding to all 6 
donors indicates either invariance of (as in Fig. 3.6)
during the 24-h period or some suggestion of a systematic 
change (as in Fig. 3.7). Since these workers were not at 
work and had been off for one month, some diurnal variation 
is suggested.
An interesting application of the specific gravity 
adjustment of urinary nickel concentrations described in 
Chapter 2 is that A U ^  max (maximum of adjusted to
1.018] - minimum of adjusted to 1.018]) observed
during the 24-h collection period may be taken as an estimate 
of current exposure according to the model described in the 
legend to Figure 3.1. Table 3.11 summarizes by job 
description the AUS- levels found in the Thompson Cohort.
li 1 ^ IucLX
A number of comments seem appropriate about the distribution
of these values. The foreman, electrician, equipment man and
scrapwash supervisor (see footnote b, Table 3.11) all spent
more than half of the work shift away from the electrolytic
tankhouse. This is in agreement with the relatively low
AUS- values observed. The remaining jobs or work areas
in l , max
represent workers more closely associated with the
electrolytic refining process. All have elevated AUJJ^  max 
values of comparable magnitude with few exceptions. In the 
purification/thickener area there was one donor who had 
approximately 2.4x the nickel levels of the mean, while in 
the plating subgroup there were two donors, who had AUS- ^
IN 1 ^ ItlcLX
levels ~ 1.4x than the mean. Because there was only one
worker from the cobalt recovery area it is not appropriate to
speculate if the relatively high A U ^  max is representative
of this area. Personal air sampling data are required to
rationalize more fully the range of AUJJ. observed.
in i, max
Generally, there is a good correlation between the rise in 
urinary nickel concentration during the 24-h collection 
period which included a workshift as a result of exposure at 
work and job description.
Table 3.11
ESTIMATE OF CURRENT EXPOSURE (AUW - )
IN THE THOMPSON COHORT IN RELATION TO JOB CLASSIFICATION
JOB DESCRIPTION AU?r • (ufr L’ Ni,max
Individual Donors
l^a 
mean + SD
Foreman 6.12
(Safety and Protection)
Equipment man 7.92
Foreman 8.64 -
(Refinery)
Electrican 11.5
Copper recovery 19.1
Boxman 36.0
Cobalt recovery 59.6
Scrapwash 32.0, 29.5, 5.76b 22.4 ± 14.5
Purifcation/Thickener 12.4, 62.lc,23.6, 25.8 ± 25.4
5.04d
Plating Tankman 47.0, 39.6, 29.0 37.7 ± 11.1
31.1, 53.8e , 25.6
^ UNi,max = UNi,max “ UNi,min <at the beginning or end of the 
24-h period; adjusted to p=1.018).
This donor was the scrapwash supervisor.
~ 2.4 x higher than mean.
A  1 ' *
Average U ^  for this donor was 81.5 //g L~ , but there was 
small change during the 24-h collection.
e~ 1.4 x higher than mean.
CHAPTER 4 UPTAKE AND DISTRIBUTION OF NICKEL
IN THE RAT KIDNEY
A INTRODUCTION
(i) Renal Toxicity of Metals
The nickel clearance study of Chapter 3 concludes that 
nickel is reabsorbed in the human kidney in .a manner very 
similar to urea. Since urea is largely reabsorbed by passive 
diffusion down a concentration gradient generated by the 
reabsorption of water (Pickford and Lambie, 1976), it was 
postulated that renal reabsorption of nickel has a large 
passive component. In this chapter, a rat model will be used 
to investigate the relative contributions of the passive and 
active components of the nickel reabsorption process in the 
nephron.
The biochemical indices evaluated for electrolytic
nickel-refinery workers in Chapter 3 illustrate that compared 
to known nephrotoxic metals such as cadmium, the changes
observed in renal function due to nickel exposure are
minimal. Thus it is likely that the accumulations of nickel
found in post-mortem kidney specimens in adults without known 
occupational or iatrogenic exposures to nickel compounds are 
medically insignificant. The highest concentrations of 
nickel are usually found in the lung, followed by kidney and 
liver (Nomoto, 1974; Sunderman, 1984d; Zober: et al., 1984;
Kollmeier et al. , 1985; EPA, 1986; Rezuke et al. , 1987).
Animal studies show the same general trend in that, for
nickel(II) salts administered parenterally to a variety of 
animals, the largest accumulation was found in the lung, 
kidney, liver and endocrine gland, with relatively little 
nickel found in neural tissue (Mushak, 1980). Such studies 
also show that after several half- lives (h to d) there is 
little permanent evidence for long-term tissue -accumulation. 
Thus both animal and human data illustrate a potential of 
short-term accumulation of nickel in the kidney and elevation 
with age in the lung, the organ exposed to particulate nickel 
compounds (EPA, 1986). The work described in this chapter 
will use an animal model to explore the manner in which the 
kidney handles nickel and exhibits its toxicity when present 
in excess.
As summarized by Nieboer and Sanford (1985),
metal- ion- induced kidney damage is not a general cytotoxic
effect, but is specific for individual metals. For example,
2+~50 7c of the uranyl ion (UO2  ) is bound to bicarbonate which
is filtered through the glomerulus and becomes attached to
the membrane of the proximal tubule cells when it dissociates
2+from HCOg concomitant with a drop in pH. The UO2  ion
inhibits tubular reabsorption of many substances and
epithelial cell death follows. Cadmium is largely excreted
in the urine complexed with the low-molecular-mass protein
metallothionein (CdMT). In a healthy kidney, the CdMT
complex is reabsorbed in the proximal tubule„.and is degraded
2+intracellularly within the lysosomes. Released Cd is 
thought to be scavenged by de novo synthesized
metallothionein in the kidney (Lauwerys, 1983). The current
hypothesis is that saturation of the induction of renal
2+ 2+ metallothionein results in free Cd which is toxic. Cd
ion can impair a cell by inhibiting the function of lysosomes
and the nucleus, and induces tubular loss of protein and
suppresses peritubular amino acid transport (Foulkes, 1983;
2+Fowler, 1983). Pb is taken up in the proximal tubule cells 
where it inhibits the mitochondria. It also accumulates as 
inclusion bodies in cell nuclei. However, it is thought that 
chronic industrial exposure to lead can affect the glomerulus 
resulting in reduction of the effective filtration capacity 
(Lilis et al., 1980). A complication of the treatment of 
rheumatoid arthritis with gold salts is the development of a 
membranous glomerulonephropathy in humans (Duke et al.. 
1982). This is usually characterized by the presence of 
electron-dense deposits on the epithelial side of the 
glomerular capillary basement membrane. Duke et al. (1982) 
conclude that high doses of gold salts in rats appear to 
result in direct toxic damage to the renal tubular 
epithelium, a condition not found in humans. Low doses in 
man are known to cause an immune- complex type of 
glomerulonephritis. From the above description it is clear 
that not only is metal- ion- induced kidney damage not a 
general cytotoxic phenomenon, but it tends to be site 
specific, often depending on dose.
Metals may also have a regulatory role in kidney
2 +  -|- -f.
function, including Ca , Na and K. In addition, Phillips
et al. (1983) postulate that vanadium, a possible essential 
element in animals, may play a regulatory role (as the 
vanadate anion) in salt and water excretion by modification 
of the Na+ pump in the kidney. However, these authors also 
recognise that at high concentrations vanadate has toxic 
renal effects.
From this brief review of the action of metals on the
kidney, it is clear that there is no simple common response.
Their roles may be essential, essential and toxic, or simply
toxic. In this chapter an attempt is made to clarify the
04 -
uptake, toxic effects and excretion of Ni in the male-rat 
kidney.
fii") Experimental Approaches to Nephrotoxicity
The remainder of this introduction will give a brief
review of the more common types of animal studies used in the
evaluation of transport mechanisms (e.g., p-aminohippuric
acid, PAH, uptake) and the action of nephrotoxins (e.g., 
2+Pb ). In vivo studies usually involve the evaluation of 
kidney function or toxicity by various methods such as 
histology, excretion of proteins, amino acids or 
N- acetyl- f3- D- glucosaminidase (NAG) following the injection of 
a toxic xenobiotic. This approach usually consists of 
multiple evaluations over an extended time period (e.g., 
24-h) rather than a single measurement. However, these types 
of studies would not lead to more information on the 
passive/active components of nickel uptake in the nephron
than the human work already described in Chapters 2  and 3.
Nevertheless, they may supply information on why the kidney
24-does not appear to be a major target organ for Ni
In vitro studies usually involve one of the following 
methods: examination of renal slices, ex vivo perfusion of 
isolated kidneys, and studies with isolated - glomeruli or 
proximal-tubule fragments. Techniques involving isolated 
tissues offer the general advantage of being able to study 
purely nephrogenic changes that are difficult to assess in 
the whole animal due to a number of extra-renal effects (Bach 
and Lock, 1982). These difficulties, which include 
undesirable changes in renal haemodynamics, generalized 
changes in the cardiovascular function, and problems of 
maintenance of whole animal body temperature, are minimized 
in isolated-tissue studies (Berndt, 1987). Renal slices of 
kidney tissue can be prepared free hand, with the aid of a 
Stadie- Riggs microtome (Berndt,1981), or with a mechanised 
device in which tissue is kept in an oxygenated medium for 
the duration of the cutting process (Krumdieck et al., 1980). 
These slices (a 0.2 to 0.5 mm thick) are incubated in a 
balanced salt solution that usually has added nutrients such 
as glucose as well as the chemical being investigated. The 
uptake of a chemical is measured by the so called slice to 
medium (s/m) ratio: i.e., the ratio of the__concentration of 
the substance being investigated in the renal slice per unit 
tissue weight to that of the substance per unit volume of 
bathing solution (Berndt, 1987). Renal slices have also been
used in transport and metabolism studies (e.g., PAH 
transport; Foulkes and Miller, 1959). However, this 
technique does involve an altered organ in which the 
functional and a portion of its structural integrity have 
been partially damaged because of mechanical injury (Bach and 
Lock, 1982).
The isolated perfused-kidney technique involves removal 
of the kidney after a catheter has been inserted through the 
superior mesenteric artery, across the aorta and into the 
right renal artery of the rat (Berndt,1987). This permits 
continuous perfusion of the kidney to be maintained during 
the isolation process. The kidney is then placed into an 
apparatus that includes a pump for movement of the perfusate 
(containing the chemical of interest), an oxygenator and a 
mechanism for control of temperature (Bach and Lock, 1982). 
Although the isolated perfused-kidney maintains the 
structural integrity of the kidney, the system is perfused 
with an artificial medium that does not always maintain all 
functional properties such as the ability to concentrate 
urine normally (Bach and Lock, 1982). The perfused kidney 
assesses the whole organ and cannot directly differentiate 
the exact site of change or transport along a nephron, 
identify the population of nephrons affected, nor reveal any 
subtle changes in renal "haemodynamics" _or cardiovascular 
function that are related to a toxic action_(Bach and Lock, 
1982; Berndt, 1987).
Studies involving isolated proximal tubules and
' glomeruli have the same general advantages and disadvantages 
described above for renal slices.
In the current work, in vitro isolated renal slices and 
proximal-tubule studies are combined with in vivo time-course 
studies involving histology, autoradiography and subcellular 
fractionation to investigate the renal uptake and toxicity of 
nickel.
B MATERIALS AND METHODS 
(i) MATERIALS
(a) Chemical Reagents
Pertinent information about the routine chemical
reagents and animal diets used is summarized in Table 4.1 and 
of the radiolabelled reagents in Table 4.2.
(b) Nickel- injection Solutions
2+  -  1The 1.5, 3 and 6  mg Ni kg injection solutions were
made up from N i C ^ ’dl^O; 5 ml of DDW was added to
appropriate amounts of this nickel salt so that a 0.7 mL
injection of the solution contained the appropriate amount of 
2+Ni per kg of body weight.
(c) Laboratory Solutions (Renal Slices)
HEPES Incubation Medium fpH = 7.4 and 5.5). The following 
reagents were added to a 500-mL beaker and brought close to 
volume with DDW. The pH was then adjusted to 7.4 or 5.5 with
Table 4.1 
CHEMICAL REAGENTS
Chemical Reagent Source Grade Use or. Comment.
Acetic acid BDH
(Glacial)
Ammonium molybdate BDH 
L- Ascorbic acid BDH
CaCl2 -2H20 BDH
DNP BDH
2,4- Dinotrophenol
EDTA
Ethanol
Glucose
HC1
HEPES
L- Histidine 
KC1
k h 2p o4
BDH
James
Burrough
BDH
BDH
Sigma
Sigma
Fisons
Sigma
Aristar
AnalaR
AnalaR
AnalaR
AnalaR
AnalaR
absolute
AnalaR
Aristar
Analytical
Reagent
>99%
Na/K ATP- ase
Na/K ATP-ase
Na/K ATP-ase
Renal slice 
incubation medium
uncoupler of oxidative 
phosphorylation renal 
slice study
Na/K ATPase 
(Ethylenediaminetetra- 
acetic acid disodium 
salt)
99.86 % (v/v) 
minimum
Renal slice 
incubation medium
Na/K ATP- ase ampoule of 
pure HC1 (1 ampoule 
prepares 1 L of 1 MIIC1)
Renal slice 
incubation medium
L- histidine
monohydrochloride
(monohydrate)
Renal slice 
incubation medium and 
Na/K ATPase
Monopotassium dihydrogen 
phosphate
Table 4.1 Continued
Chemical Reagent Source Grade Use or Comment
MgCl2 -6H20
Na2ATP
NaCl
NaOH
NiCl2 *6H20
p-Nitrophenol
p-Nitrophenol 
phosphate
Ouabain
PAH
Percoll
PMSF
BDH
Sigma
AnalaR
Fisons
Sigma
BDH
BDH
Sigma
Sigma
Sigma
Pharmacia
Sigma
Analytical
Reagent
Anhydrous
pellets
AnalaR
>99%
Phosphate
substrate
Renal slice
incubation medium and 
Na/K ATPase and Alkaline 
phosphatase
Na/K ATP- ase 
/
Adenosine 5 - Tri­
phosphate (ATP)
Disodium salt
Renal slice 
incubation medium and 
Na/K ATPase
Isolation of Glomeruli 
and Tubules/Alkaline 
phosphatase
Renal slice
incubation medium 
and histological 
study
Alkaline phosphatase 
standard
Alkaline phosphatase
Na/K ATP-ase
p-aminohippuric 
acid (sodium salt 
crystalline) for 
renal slice study
Gradient used for the 
isolation of basolateral 
and brush- border 
membranes
Na/K ATP-ase 
protease inhibitor 
(Phenylmethylsulfonyl 
Iluoride)
Table 4.1 Continued
Chemical Reagent Source Grade Use or Comment
Probenecid Sigma anhydrous
p- [dipropylsulfamoyl] 
benzoic acid
Sodium acetate 
trihydrate
Fisons Analytical
Reagent
Renal slice 
incubation medium
Sodium arsenate BDH AnalaR Na/K ATP-ase
Sucrose Sigma Isolation of Pg pellet
Tris- Buffer BDH Aristar Na/K ATP- ase and 
Alkaline phosphatase 
(2- Amino- 2- 
(hydroxymethyl) 
propane-1,3- diol)
Trisodium citrate BDH AnalaR
DIET
Na/K ATP-ase
Type of Diet Source Grade Source
Powder Labsure LAD1 Christopher Hill Group 
Ltd. Poole Dorset
Pellets Spratt Lab Diet
Nn 1
Spratts, Barking, U.K.
Table 4.2
RADIOLABELLED REAGENTS AND SCINTILLATION LIQUIDS EMPLOYED
Reagent Source Grade Use or Comment
Scintillation
Cocktail
( H)L- Histidine
United PICO-FLUOR
Technologies 30 
Packard
Amersham
Scintillation 
solution for 
aqueous and non- 
aqueous samples
40- 60 Ci/mmol 
sterilized aqueous 
solution containing 
27c ethanol.
63NiCl, Amersham 1 mCi mL” ^
80 fig Ni^+ mL" *
II- PAH Amersham 1 mCi Q
p- amino[ H] hippuric 
acid
II- Proline Amersham 10- 20 Ci/mmol 
sterilized aqueous 
solution.
II- Thymidine Amersham 20- 30 Ci/mmol 
sterilized aqueous 
solution containing 
107o ethanol.
1 M NaOH or HC1 as required and brought to volume in a 500-mL 
volumetric flask.
HEPES 11.92 g (100 mM HEPES)
CaCl2  (as CaCl2 -2H2 0) 0.13 g (1 . 8  mM Ca2+)
MgCl2 -6H20 0.024 g (0.17 mM Mg2+)
Glucose 0.50 g (5.6 mM)
Sodium acetate trihydrate 0.68 g (10 mM acetate)
Na+ (as NaCl) 3 . 2 2  g (110 mM Na+)
K+ (as KCl) 1.49 g (40 mM K+)
The prepared medium was stored in a refrigerator in a 
beaker covered with Parafilm until use.
(d) Preparation of Labelled Solutions
63 2+ 1Ni (100 /ig Ni L~ ) . The stock nickel solution was made
by adding 0.4487g of N i C ^ ’OI^O to a 50-mL volumetric flask,
dissolved in and brought to volume with HEPES buffer (pH =
7.4). This solution (0.03775 M Ni^+) was further diluted one
hundred- fold with HEPES buffer (100 /zL to 10 mL) to yield the
secondary stock. The labelled working solution was made up
by delivering 100 /zL of the secondary stock solution to a
25-mL volumetric flask and then adding enough buffer so that
it was ~3/4 full. Subsequently, 250 /zL of diluted ^Ni^+
stock (50 /zL ^ N i C ^  stock,Table 4.2, diluted with 3.5 ml
HEPES buffer) was added and the mixture was_brought to volume
with HEPES. Stock solutions were stored in_ a refrigerator
(4°C) when not in use. The working nickel solution was made
up fresh every day.
Histidine. The stock histidine solution was made up by
dissolving 0.2288 g of L-histidine (monoc.hloride, 
monohydrate) in a 50-mL volumetric flask. The working 
solution was derived from this by diluting 2 0 0  piL of the 
stock solution to 1 0  mL. The stock solution was stored in a 
refrigerator (4°C) when not in use. The working histidine 
solution was made up fresh daily.
^Ni(His)o (100 /zg Ni L . An aliquot (200 pL) of the
working histidine solution was added to a 25-mL volumetric 
flask and brought to ~3/4 volume with HEPES buffer (pH =
7.4). After mixing, 250 pL of the diluted ^ N i ^ +stock and
2+100 pL of the ‘cold’ Ni secondary stock solution were added
as described above in the final step of the preparation of 
63 2+the working Ni solution. The solution was brought to 
volume with HEPES buffer (pH = 7.4), mixed, and allowed to 
stand for 2 h at room temperature before it was used. Only 
freshly prepared solutions were employed in experiments.
^Ni(His)^ (100/zg Ni L . An aliquot (101 pL) of the
working histidine solution (pH = 7.4) was added to a 25-mL 
volumetric and brought to ~3/4 volume with HEPES buffer (pH =
5.5). After mixing, 250 pL of diluted hot ^ N i ^ +solution (pH
2+= 7.4) and 100 pL of the ‘cold’ secondary stock Ni solution 
(pH = 7.4) were added as before. The solution was brought to 
volume with HEPES buffer (pH = 5.5), mixed, and allowed to 
stand for 2 h at room temperature before it was used. Only
freshly prepared solutions were employed in experiments.
^H-PAH (0.25 mM). Both labelled (20 pL) and ‘cold'
(0.00484 g; sodium salt) PAH were added to a 1 0 0 -mL 
volumetric flask. They were dissolved in HEPES or Tyrodes 
buffer (pH = 7.4) and brought to volume. When not in use, 
this solution was stored in a refrigerator (4°G).
(e) Preparation of Unlabelled Solutions
Probenecid TO.04 . Probenecid (0.0571 g) was dissolved
in ethanol in a 5-mL volumetric flask. This gave a final 
concentration of 8x10"^ M when 20 pL of this solution was 
added to 1 mL of incubation medium.
2.4-Dinitrophenol fDNP. 20 mM). DNP (0.0184 g) was
dissolved in ethanol in a 5-mL volumetric flask. This gave a 
final concentration of 1 mM of DNP when 50 pL of this 
solution was added to 1 mL of incubation medium.
Na/K ATP- ase. Solution A was made up by dissolving 1 g of 
ammonium molybdate in a total of 10 mL of DDW. Then 6  g of 
ascorbic acid was dissolved in 70 mL of DDW to which 100 mL 
of 1 M HC1 was added. (Note the 1 M HC1 was accurately made 
from a standard ampoule of Aristar (BDH) HCl.) The ascorbic 
acid solution was then cooled to 0°C on an-ice bath. Just 
before the end of the first incubation (see below) the 
molybdate and ascorbic solutions were mixed. The final
solution is a characteristic yellow colour.
Solution B was made up by dissolving 10 g of sodium 
arsenite (in a fume hood), 10 g sodium citrate and 9.5 mL of 
glacial acetic acid in DDW. The resulting solution was then 
made up to 500 mL (volumetric flask) and thoroughly mixed.
The assay mixture was made up by dissolving the 
following substances in DDW and bringing to a total volume of 
100ml with DDW and thoroughly mixing:
NaCl 0.842 g
KC1 0.228 g
MgCl2  0.096 g
TRIS 0.872 g
EDTA 0.044 g
Na2ATP 0.264 g.
To 50 mL of the above solution, 0.0436 g of ouabain was 
added.
Alkaline Phosphatase. The buffer + activator solution was 
prepared by making up a TRIS buffer (0.25 M, pH = 8 .8 ) and 
adding enough MgCl2  (activator) to the buffer so that it was 
5 mM.
The substrate consisted of a solution of 0.05 M 
p-nitrophenylphosphate and 0.1 M NaOH (with EDTA 0.05 M).
(ll) METHODS
(a^ NiC^ Injection Study
Injection Protocol. The experimental animals were 1 2  male 
Vistar Albino rats. The rats were housed individually in 
plastic metabolic cages and were permitted free access to 
powdered diet (Labsure, LAD1) and distilled water. All rats 
were allowed to acclimatize to the metabolic cages for 1 2  h 
before injections. Subcutaneous injections (0.7 mL) were
given between 9:00 and 11:00 am. Dosages of 1.5, 3 and 6  mg
_ i
Ni kg were given to groups of 3 rats. The rats were
sacrificed by cervical dislocation 48- h after injection. 
Urine samples (24-h) were collected and the distilled water
consumed in each 24-h period was measured for all groups. 
The mass of faeces produced and powdered diet consumed were 
monitored for the two 24-h periods following injection.
Histology. The kidneys were removed from all animals and 
placed in 10% (v/v) formalin for fixation. Slices 2-4 mm
thick were prepared with a single- edge razor to include the 
papilla. They were washed in 0.1 M phosphate buffer (pH =
7.4) for four 30-min. periods. Fresh buffer was used for 
each washing. The tissue was dehydrated using gradually more 
concentrated solutions of ethanol as follows:
50 7c (v/v) ethanol 1 h
85 7c (v/v) ethanol 1 h
1 0 0  7> (v/v) ehtanol 2x1.5 h.
The washed tissue slices were then infiltrated with JB-4
methacrylate resin using a freshly catalysed monomer for 12 h 
at 4°C. Infiltrated tissue was then embedded by placing it 
in a mould in which there was a solution of monomer A and 
plasticizer B that had been mixed in a ratio of 25 mL to 1 
mL. Embedding (polymerization) was allowed to occur at room 
temperature.
The semi-thin sections (2 jm) were cut using glass 
’Ralph' knives on a Bright microtome and were then floated 
from a water bath (room temperature) onto a glass microscope 
slide. Staining with one of four histochemical stains 
followed: Toluidine Blue, Giemsa, Massons Trichome and
Periodic-acid Schiff (PAS). The first three stains are good
general stains for differentiating histological detail, 
whereas the PAS stain is used for mucoid and glycoprotein.
(b) Uptake of Nickel in Renal Slices
All radioactive working solutions were made up just 
prior to use. Before a run was initiated, 95% Og/bTo CO2  
(v/v) was bubbled through these solutions for 20 min at room 
temperature. In addition, approximately 400 mL of HEPES
buffer solution was placed on an ice bath and 95% 0 2 /5 % CO2  
(v/v) was bubbled through it for 20 min. During the
subsequent incubation, the atmosphere was not enriched in 
oxygen, although such an atmosphere was maintained above the 
incubation medium in one experiment.
The rats were sacrificed by cervical dislocation and the 
kidneys were excised. Subsequently, the capsule was removed
Table 4.3
EQUIPMENT, PLASTICWARE AND GLASSWARE EMPLOYED
Description
Centrikon 
T- 2055
Tissue Culture 
Multi-well plates
LKB Multirack
LKB Uvicord 2
LKB Vairoperpex Pump 
MSE Gradient
Source
Kontron
Flow
Laboratories,
LKB
LKB
LKB
MSE
Comments
Ultracentrifuge
24-Flat bottem wells (1.7x 
1.6 c m), approx. 3.6 mL; 
used for incubation of 
renal tissue slices
Fraction collector for a 
Sephadex G- 75 column
Measurement of elution 
profile at A-254 nm
Pump for G- 75 column
Fractionation of a 
Percoll gradient 
nickel in serum.
Prepspin 50 MSE Ultracentrifuge
and the kidneys were placed in the buffer solution that was 
immersed in an ice bath. Rasor cuts were made along the 
lines illustrated in Figure 4.1.
A
Figure 4.1. Diagram illustrating the lines along which 
surgical cuts were made on the excised kidney.
After dissection, the kidney segments BB/ DD' and
CC' DD' were placed in a Stadie-Riggs microtome with the cuts 
/
BB and CC' face down on hardened filter paper so that slices
/
could be taken off the surfaces DD . This allowed the uptake 
of nickel to be measured on a cross section of the rat 
kidney. Freshly cut renal slices were immediately placed in 
oxygenated buffer (on an ice bath).
One mL of the appropriate incubation medium was placed 
in wells of a tissue culture multi-well plate (Table 4.3). A 
plastic spatula was used to remove two slices from the cold 
buffer. They were blotted on hardened filter paper and 
placed in the appropriate well in the multi-well plate, which 
was then attached to a steel block (to transfer heat and 
maintain temperature) anchored in a water bath at 25°C. This 
incubation system was shaken under moderate speed (~40 rev. 
min ) on a horizontal oscillating shaker for the appropriate 
time. After the incubation period, the tissue was removed
with a plastic spatula, blotted on hardened filter paper and 
weighed to obtain the wet tissue weight. A 0.3 mL aliquot of 
the post- incubation medium and the pre- incubation medium were 
placed in scintillation tubes. Next, 4 mL of scintillation 
fluid (PICO-FLUOR 30) was added to each - tube and the 
radioactivity was measured on a LKB Wallac 1219 RACKBETA. 
All nickel- containing scintillation cocktails were kept in 
the dark for > 1 2  h prior to counting to avoid
chemiluminescence. No quenching was observed for the tritium 
nor the carbon-14 channels. There was also no indication of
quenching when internal standards (1 0 - 2 0  fjL spike) of tritium
3 63 2+(for H-PAH) or Ni or its complexes were added, as judged
from an absence of spectral shifts and the good count
recovery of spiked samples (including tissue specimens).
The slice to medium ratio (s/m) was calculated from
Equation 4.1.
Slice/Medium (s/m) ratio = (4.1)
CPM(pre- incubation) - CPM(post- incubation) 
CPM(pre- incubation) x Vet tissue mass (g)
o  /^Q r> ,
The uptake of PAH , Ni and its histidine complexes 
inhibited by probenecid had 20 fjL of a 0.04 M solution of 
this compound added to the appropriate incubation medium. 
Inhibition was measured by changes in the s/m ratio..
The efflux of PAH^, ^Ni(His ) 2  anc^  ^ N i ^ + from slices 
preincubated with the labelled compound for 2  h (as above) 
was measured for a range of time periods in multiwell culture
plates at 25°C with 1 mL buffer (lOOmM HEPES, pH 7.4). The 
tissue was removed from the uptake medium, blotted on 
hardened filter paper and placed in a new multi-well with 
fresh buffer as the efflux medium. This procedure of 
removing, blotting and placing in fresh buffer was repeated 
after each incubation period (either 15 min, 30 min or 1 h) 
until a total efflux time of 3 h had elapsed.
(c) Isolation of Glomeruli and Tubules
The following procedure was adapted from that developed
in Dr. P. Bach’s laboratory at the Robens Institute,
University of Surrey.
Tubules and glomeruli are isolated by forcing kidney
cortical tissue through a series of stainless steel sieves 
ranging from 250 /zm (to disrupt the tissue) through 150 /zm 
(tubules), 124 /zm (some tubules and some large glomeruli) and 
to 75 /zm (glomeruli).
Whole kidneys were removed from ~150- g male Wistar 
Albino rats and the capsule, papilla and medulla were
subsequently removed. The cortices were cut into small 
pieces and these were broken up gently pressing them through 
a 250 /zm sieve that was on top of a series of progressively 
smaller sieves (150, 125 and 75 /zm). The tissue fragments 
were washed through the sieves using Tyrod&s solution. The 
tubular fragments and glomeruli were collected from the 
appropriate sieves and centrifuged for 3 min (300 rpm). The 
pellets formed were then washed twice with Tyrodes solution
and resuspended in a known volume of HEPES buffer (50 mL for
tubules from 10x150 g male Vistar Albino rats which yields a
_ 1
protein concentration between 2 and 3 mg mL ). For
subsequent incubations, 1.0 mL aliquots of tubule suspension
were used. The final incubation was done . at 37°C in a 
tissue-culture incubator.
Incorporation studies were performed on tissue isolated 
as described in the previous paragraph. Incubation medium 
consisted of 1 mL of tissue suspensions (in HEPES buffer)
_ i
with 50 /zL aliquots of approximately 20 /zCi mL of test
q  q
chemical (e.g. Ni(His)2 > H-proline and H- thymidine) in 
wells of a multiwell plate maintained in a tissue culture
incubator at 37°C.
After the incubation period, the entire sample (1 mL) 
was removed and added to 3 mL of chilled (ice bath) 6 % (v/v) 
TCA (containing /zM quantities of cold incorporation test 
chemicals) to precipitate the macromolecules.
The samples were then spun down and the supernatant 
removed. The precipitates were washed twice in cold 6% TCA 
(see above) and finally resuspended, vortexed and filtered 
onto 25 mm, glass-fibre filters.
Filters were dried by rinsing with absolute alcohol 
followed by a drop of diethyl ether (to remove TCA). The dry 
filters were then placed into the bottom of clean, dry 
scintilation vials and 200 /zL of 0.5 M NaOH added to dissolve 
the precipitate on the filter. These solutions were allowed 
to sit for approximately 2 h before 4 mL of Picofluor 30
scintillant was added. Each vial was then shaken thoroughly 
and left to stand for at least 30 min to ensure low 
chemiluminescence before counting. Each sample was counted 
on an LKB Wallac 1219 RACKBETA scintillation counter (a
9 ,
preset Ni channel or a tritium channel with quench 
correction).
fd^  Simultaneous Isolation of Basolateral
and Brush-Border Membranes
The following procedure derives from Boumendil- Podevin
and Podevin (1983) and is routinely employed by Drs. M.
Taylor and M. Dobrota of the Robens Institute (University of
Surrey) for the isolation of basolateral and brush- border
membranes from rat kidney cortex. This procedure has been
used in a number of studies with gold and cadmium.
The rats (approx. 200g) were anesthetized with ethyl
ether and incision was made in the neck. An i.v. injection
(0.3 mL) was made with ^Ni(His ) 2  (in HEPES; pH = 7.4) so
2+ - lthat each rat was given 6 /zg Ni kg in its jugular vein. 
All rats were sacrificed 10 min after the injection. The 
kidneys were removed and placed in a beaker containing ice 
cold 0.25M sucrose/0.lmM PMSF/2 mM TRIS-HC1 (pH = 7.4). The 
capsule was removed and the cortex was excised from each 
kidney. The cortices were then placed in about 50 mL of 
0.25 M sucrose/0.1 mM PMSF/2 mM TRIS-HC1 (pH = 7.4) that had 
been preweighed. The solution was then weighed so that the 
mass of the cortex could be obtained by difference. The 
cortices were cut up roughly with scissors and then
homogenized with 5 strokes on a Potter Elvehjem, type C 
homogenizer (A. H. Thomas, Philadelphia, Pennsylvania, USA) 
at reduced speed (1000 rev/min). Enough sucrose solution was 
added to make the homogenate up to 10 7o (w/v). The 
homogenate was poured into 50 mL screw cap plastic Oak Ridge 
bottles and centrifuged at 3,700 g«min (2,200 rpm, for 10 
min; Temp = 4°C) on a Beckman TJ6 centrifuge (brake off). 
This pellet was labelled P^ and was later resuspended in 15 - 
20 mL sucrose. The supernatant was transferred to 8x50 rotor 
with 50-mL Oak Ridge bottles and spun at 137,700 g*min(13,500 
rpm, for 15 min) with the brake off on an HS-18 centrifuge 
(MSE, Scientific Instruments, Ltd.). The supernatant was 
carefully removed so that the pellet was not disturbed (this 
supernatant was kept and labelled Sg). The fluffy top of the 
pellet was carefully removed and labelled Pg. The bottom 
part of the pellet (i.e. non-fluffy portion) was labelled Pg- 
The Pg pellet was rehomogenized in 10 to 12 mL of 0.25 M 
sucrose (without PMSF) using the Potter by hand with about 4 
to 5 strokes (on an ice bath).
Subsequently, 100% Percoll was added to the Pg 
suspension to give a final concentration of approximately 
12 % (v/v). After mixing, this self-orienting gradient was 
placed in the 12x35 ml angle rotor (type TFT 50.38) and 
centrifuged at 40,000 g for 35 min _in a Centricon 
ultracentrifuge (Kontron, Zurich, Switzerland). The
resulting gradient was separated and collected into fractions 
with the aid of an MSE gradient extraction unit (Table 4.3).
This resulted in three major bands ranging from low to high 
density: basolateral membrane fraction, brush-border membrane 
fraction and the mitochondrial fraction. The presence of 
these membranes on the Percoll gradient was located by enzyme 
assays. The Na+/K+-ATPase activity was used to identify the 
basolateral fraction and the brush- border fraction was
Q
enriched in alkaline phosphatase. The location of Ni was 
identified by counting on the LKB RACKBETA as described in 
the previous section.
The Na+/K+- ATPase assay is based on that of Forbush 
(1983) where the Na+/K+- ATPase activity is measured in the 
presence and absence of ouabain. The assay mixture (500 //L; 
one set with ouabain and a second set without oubain) and 
sample (100 fJL) were added to a disposable test-tube. This 
solution was incubated (in a water bath) for 17 min at 37°C. 
Solution A (yellow) was added and kept on an ice bath for 10 
min, then 1.5 mL of solution B was added and the mixture 
incubated for 10 min at 37°C. The absorbance of both sets of 
solutions (with and without ouabain) were read at 705 nm on a 
Perkin Elmer Lambda-5 UV/VIS spectrophotometer. The activity 
was measured by the difference in absorbance between the 
ouabain-present and ouabain-absent solutions using a standard 
KI^PO^ curve.
The alkaline-phosphatase enzyme assay mixture contained: 
0.8 mL of buffer + activator - 
0.1 mL of sample
0.1 mL of substrate
This solution was incubated for 20 min at 37°C in a water 
bath and the absorbance was measured on a Perkin- Elmer, 
Lambda-5 UV/VIS spectrophotometer at 405 nm. A standard 
p-nitrophenol curve was prepared. The alkaline phosphatase 
activity was plotted against the appropriate fraction to 
identify the brush-border membranes.
(e) Intravenous Injection Experiments
The method used for tissue homogenisation and 
fractionation had been adapted from that of Boumendil-Podevin 
and Podevin (1983) and Andersen et al. (1987) by Dr. M. 
Dobrota of the Robens Institute (University of Surrey). Male 
Vistar Albino rats (~250g) were anesthetized with i.p. 
injection of Sagatal and an incision was made in the neck 
region. An i.v. injection (0.3 mL/200 g) was made with
Ni(His) 2  (in HEPES, pH 7.4) so that each rat was given 6 /zg 
• 2+  - 1Ni kg in its jugular vein. All rats were allowed to 
recover except for the rats for the 10-min time point. After 
recovery, the rats were permitted free access to Spratts Lab 
Diet No. 1 and water. A blood sample was taken from the vena 
cava after the rats were given an i.p. injection of Sagatal 
or exposed to ether. The kidneys were excised, the capsule 
removed and placed in HEPES buffer (pH = 7.4). Approximately 
4-mm cross section of tissue was taken from the centre of the 
kidneys and placed in 10 % (v/v) formalin for the
autoradiography study. The remainder of the kidney was 
placed in a 100 mL beaker that contained ~50 mL of HEPES
buffer (preweighed). This beaker was weighed again to obtain 
the tissue mass by difference. The kidneys were cut up with 
scissors and then homogenized with 5 strokes on a Potter 
Elvehjem (type C) at a reduced speed of 1000 rpm.
Enough HEPES buffer was added to make the homogenate up 
to 10 7c (w/v). The homogenate was poured into 50- mL 
screw- cap Oak Ridge plastic centrifuge bottles and spun at 
1,115 g-min (1,600 rpm for 3 min) on a Beckman TJ6 (brake 
on). This pellet was labelled N, the nuclear fraction. The 
supernatant was spun at 27,530 g-min (10,000 rpm for 3 min) 
on an HS18 centrifuge (MSE, Scientific Instruments Ltd., 
Crawley, U.K.) with the brake on. The pellet formed was 
labelled the ML fraction (mitochondria/lysosomes). The
supernatant was spun at 137,700 g-min (13,500 rpm for 15 min) 
on an HS18 with the brake off. The supernatant was carefully 
(but quickly) poured off without disturbing the top fluffy
layer of the pellet. The supernatant was kept and labelled 
S^. The fluffy layer was carefully resuspended in HEPES 
buffer by pouring medium in and gently swirling so that the 
pellet below this fluffy coat was not disturbed. The
resuspended fluffy coat was labelled P^ and contained luminal 
and basolateral membrane vesicles of the proximal tubule. 
The supernatant S^ was combined with the pellet below the 
fluffy coat, resuspended and spun at 7,950 ,.000 g-min (40,000 
rpm for 60 min) in the Centricon centrifuge;.:. The pellet was 
labelled MIC (microsomes) and the supernatant was the
cytosol.
The cytosol was passed over a G-75 column using a LKB 
Multirack fraction collector and the elution profile was 
measured with a LKB Uvicord 2 at 254 nm (Table 4.3). Sixty 
2-mL fractions were collected for each sample. The column 
was standardized using the following standards: blue dextran 
(MM = 2,000,000), ribonuclease (MM = 14,000), Cd-thionein (MM
= 7,000), insulin (MM = 5,500), vitamin B-12 (MM = 1,400) and
✓
adenosine monophosphate (5 -AMP) (MM = 365).
All the pellets formed were resuspended in HEPES buffer;
/ ' O
the total volume was recorded and the Ni radioactivity of 
the resulting suspensions was measured on the LKB RACKBETA as 
described previously. The total protein of each fraction 
was measured by the Bio-Rad method described in Chapter 3.
The mass of the other tissues investigated (liver, 
testes, lung, heart, spleen, brain, intestine and thigh 
muscle) were found by difference (weighing was in HEPES 
buffer). The individual tissues were vigorously homogenised 
on an Ultra-Turrex’ (Janke, Kunkel, Staufen, Vest Germany) 
tissue homogeniser in HEPES buffer (pH = 7.4). The volume 
was adjusted so that a 10 7c (w/v) suspension was obtained. 
These suspensions were measured for the presence of Ni 
using the LKB RACKBETA as described previously in 
Section B ii d.
The blood collected was allowed to clot (~ 2 h) , spun 
down (~ 1000 rpm) and the serum removed. The radioactivity 
of the serum was measured using a 25 /zL aliquot in 4 mL of 
Pico-fluor 30.
(f) Incubation with Subcellular Fractions
The pellets (N, ML, Pg, and MIC) were resuspended in 
HEPES (pH = 7.4) and vigorously homogenised on a Turrex
Tissue homogeniser (full speed for 1 min). They were then
spun down at 40,000 rpm on a Centricon centr-ifuge for 1 h. 
This regime was repeated twice more. Finally, the 
appropriate pellets were marked N, ML, P^ and MIC and were
treated as if they were tissue slices. These pellets were
divided into two groups, one of which was resuspended in 
HEPES (pH 7.4) solution that contained ®^Ni^+ (200 /zg L" ^ ) 
and the other was resuspended in HEPES (pH 7.4) that
/ j o  _ -j
contained Ni(His) 2  (200 /zg Ni L" ). They were incubated at 
25°C for 2h, after which they were spun down on a Centricon 
centrifuge for 40,000 rpm for lh (7,950,000 g-min). The 
pellets were then washed with HEPES buffer and spun down as 
before. Subsequently, the pellets were resuspended in HEPES 
and the volume recorded. The radioactivity of the resulting 
suspensions was measured on the LKB RACKBETA as described in 
SectionB ii d. The total protein of each fraction was 
measured by the Bio-Rad method described in Chapter 3.
(g^  Autoradiography
This process involves the generation of an image on 
photographic emulsion by the decay of radioactive substances. 
It is based upon the same principles as photography. In
autoradiography the emulsion is not affected by light 
photons, but registers the radiation emitted by radioactive
decay of atoms. The silver-halide crystals, mostly silver 
bromide, struck by ionizing radiations form an invisible 
image which is transformed into a visible image when the film 
is developed. Autoradiography is said to have high 
resolution when the visible image in the emulsion and the 
radioactive source in the sample are closely aligned; the 
maximum displacement being in the order of a few microns or 
less (Baserga and Malamud, 1969).
The sections of tissues cut from the centre of the 
kidney as described in Section (e) were fixed in chilled 
(4°C) formalin calcium fixative for 24 to 48 h: (47c (v/v)
formaldehyde (BDH) , 17c (w/v) calcium chloride (BDH) ; Bancroft 
and Stevens, 1982). These sections were then washed in 0.1 M 
phosphate buffer (pH = 7.2) for four 30-min periods on a 
rotatory mixer. Fresh buffer was used for each washing. 
Tissue was dehydrated using increasing concentrations of 
aqueous ethanol at 4°C as follows:
50 7c (v/v) ethanol 0.5 h
70 7c (v/v) ethanol 0.5 h
100 7c (v/v) ethanol (anhydrous) 2x1.0 h
These dehydrated kidney sections were then infiltrated with 
JB-4 methacrylate resin using a freshly catalysed 
monomersolution A for 12 h at 4°C. Infiltrated tissue was 
then embedded by placing it in a mould in which there was a 
solution of monomer A and plasticizer B that- had been mixed 
in a ratio of 25 mL to 1 mL. Embedding (polymerization) was 
allowed to occur at room temperature in a vacuum dessicator
under vacuum or nitrogen atmosphere for 2 to 3 h.
Semi-thin sections (~1 to 2 /zm) were cut using glass 
'Ralph' knives on a Bright 5030/WD/MR- CV ultramicrotome and 
were then floated from a water bath (room temperature) onto a 
gelatin coated glass microscope slide. They were then 
allowed to dry onto the slide by being placed onto a hot 
plate at 60°C.
These semi-thin sections were dip-coated with Ilford K-5 
emulsion following the method of Williams (1977) which is 
summarized below.
The following steps were done in a darkroom with a red 
safelight. The molten emulsion was diluted and then tested 
by dipping a clean slide into the emulsion to determine 
whether it gave an even layer that was free from bubbles. If 
there were bubbles present the mixture was allowed to stand 
for a few minutes and then the test was repeated. Two slides 
were placed back-to-back with the tissue sections on the 
outside and the combination was dipped into the melted 
emulsion for ~2 s; the backs were carefully wiped and allowed 
to gel. These slides were placed in plastic light-proof 
slide boxes (~ 10 to 12 slides per box) which were then 
placed in a drying chamber containing dried silica gel 
overnight. The slide boxes were closed, sealed with 
pressure- sensitive black tape and wrapped in two black 
photographic bags. The packages were marked with an 
appropriate code number and date. These packages were stored 
at - 20°C for 3 to 6 weeks exposure after which they were
removed and developed.
The emulsion was developed and fixed without 
interruption at room temperature in a darkroom (red safelight 
only). The emulsion- coated slides to be developed were 
removed from the light-tight box and placed - in a tray and 
developed for 5 min in D19 (Kodak) developer with occasional 
agitation. They were then rinsed for 5 min in distilled 
water and subsequently fixed for 8 min in 30% (w/v) sodium 
thiosulphate fixer with occasional agitation. This step was 
followed with a 10-min rinse with running cold tap water. 
The slides were then allowed to air dry.
Staining was carried out without interruption at room 
temperature. After air-drying, the slides were placed in 
staining dishes and stained with Toluidine Blue (for 1 min) 
as described previously. The presence of nickel was 
identified by the dark spot images of the developed silver 
grains and quantified by a Quantimet 920 image analysis 
system (Cambridge Instruments). This can be used for 
counting, measuring, comparing and classifying images. The 
input to the Quantimet was through a ZEISS Universal optical 
microscope (47-79-01-9901; Carl Zeiss Oberkochen, West 
Germany) employing the 40x objective. These images were 
processed by QUIPS, a Cambridge instruments software package. 
This method converts the field of view of the microscope into 
picture points (630x784 pixels) in each field of view. The 
operator sets a level above which the signal from a picture 
point ( i.e. the light intensity at any picture point)
becomes recognised by the computer circuitry of the system. 
This allows the system to count all the picture points 
brighter than a given intensity; the points brighter than the 
preset level can also be recombined into areas of brightness, 
and the number and size of these areas can be assessed. If 
the slide is viewed under low magnification so that 
individual silver grains are not resolved, it is possible to 
use the Quantimet 920 as a densitometer.
Initial measurements made on the Quantimet 920 involved
its use as a densitometer to count all the grains in specific
regions of the kidney (e.g., outer cortex, inner cortex and
medulla). The QUIPS program was reprogrammed so that the
area of the mask (area of interest) and the occupied area
(grains) were automatically counted and the results were
o
expressed as the area of grains/area of mask (gr//z ). Before 
any measurements were made, the system was standardized using 
one of the 1.5- h slides. One area next to the papilla was 
easily located because of a heavy black deposit which was 
located in the lower left hand of the monitor frame. Five 
areas on the monitor screen were counted and the settings 
were accepted if the results were in the range of 0.0360 to 
0.0378 gr//z using the 40x objective and a projection lens of 
xl.3. If the results were outside this preselected range 
then the sensitivity was adjusted.
The SI, S2, and S3 segments of the proximal tubules, the 
distal tubule and collecting ducts were measured by masking 
the area to be investigated (e.g. a glomerulus) and then
having the Quantiment count the number of grains in the 
masked area, calculating the area enclosed by the mask. The 
results are in turn expressed as gr/// . When >20 of these 
masks were evaluated on one area (e.g. glomerulus) for one 
time point, then the program was instructed to terminate and
the average results were printed out. These mean values
2 2 (gr/ii ) were corrected to a standard of 0.035 gr//z and the
the control value of 0.00974 gr//z was subtracted. The
nickel levels in each segment of the nephron were expressed
as gr/^2 .
(h)_____ Cation Column Chromatography
Solutions of Ni(His) 2  and Ni(His)^ were passed over a
cation exchange resin to identify differences in formal
- 3charge between these complexes. Solutions of 1x10 M 
Ni(His) 2  Q5  were prepared in DDW at pH values of 5.0 
(Ni(His)^) and 8.0 (NifHisJg)? as described in Section B (i)
/> Q
d, except that no Ni or HEPES buffer was used. In this
work the slight excess of histidine (1.0xl0~^ M) was used to
buffer these solutions. The eluting solution consisted of 
- 55.0x10 M histidine made up in DDW and adjusted to the 
appropriate pH.
Bio-Rad analytical-grade cation-exchange resin was used 
in this work. A 1x10 cm column was packe_d with 1.53 g of 
resin and washed with 30 mL of DDW and left ..overnight. The 
column was then washed with 1 M NaCl. One mL of pH 8 eluting 
solution (with 4 drops of bromothymol blue indicator;
Materials and Methods, Chapter 2) was placed on the column
and was observed to come off the column after eluting with
1 mL of eluent. The Ni(His) 2  and Ni(His)^ solutions turned
red when tested with 3 drops of 1% (w/v) dimethylglyoxime
(DMG) in 95% (v/v) ethanol and 3 drops of 1% (v/v) NH^, while
- 3the eluent did not turn red. The 1 mL of 1x10 M Ni(His) 2  
was observed (by DMG/NHg) to come off in the first 2 mL of 
eluent. However, the Ni(His)^ (pH = 5) did not come off the 
column until strontium nitrate (0.5 M) was used to displace 
the nickel-histidine complex.
C RESULTS
m  NiCl2 INJECTION STUDY
fa) Post Injection Status
After i.p. injection, both the rats administered
— 1 1 3 mg Ni kg (intermediate dose) and 6 mg Ni kg” (high dose)
appeared to be extremely relaxed and lethargic. The ears
became red with dilated vessels. After 15 to 20 min., the
_ i
3 mg Ni kg group were beginning to show signs of recovery;
while it took 2 1/2 h for the high-dosed animals to begin
-  1recovery. At a low dose (1.5 mg Ni kg ) the animals did not 
display any of these effects.
fb) Solid and Liquid Balance
The non-histological effects of i.p. injections of NiC^
on male Wistar Albino rats are illustrated in Figure 4.2. 
There appears to be an inverse dose- response relationship 
between amounts of powdered diet eaten by the rats during the 
first 24-h and amount of nickel injected. All of the dosed 
rats in this category showed a significant- drop in diet 
(p<0.005) when compared to the control group. However there 
was no significant difference (p>0.05) between the low and 
intermediate doses while there was a difference between low 
and high dose (p<0.05). The intermediate and high dosed rats 
exhibited no significant difference in food intake (p>0.05). 
The faecal output appears to drop in the first 24-h for all 
animals injected, but not according to dose; only the low- 
and high-dosed rats were significantly different from the 
controls (p<0.005). The decrease in consumption of powdered 
diet is concurrent with a drop in faecal output.
In the second 24-h period, the amount eaten increased
somewhat for all dosed animals and approached the control
level with just a small decrease in food intake for the
nickel-exposed rats (all not statistically significant,
p>0.1). This increase in food intake is also reflected in
the faecal output for the second 24-h period; it has
increased so that there was no significant difference between
2+the controls and the Ni -dosed rats (p>0.05).
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The amount of urine produced in the first 24-h by the 
low-dose group was statistically smaller (p<0.05) than for 
the controls. This observation coincides with the lower 
water intake, which was statistically different (p<0.05) from 
the controls. In the second 24-h collection,- the amount of 
urine produced for the low-dose group is close to the control 
rats (not significant p>0.1) while the water intake is still 
low (p<0.01). This apparent discrepancy is resolved when the 
urine output for both periods is compared. The urine outputs 
of the low-dosed rats for both time periods are not 
statistically different (p>0.05), which agrees with the same 
overall water intake for both time periods (not significant, 
p>0.1). Therefore both the 24-h and 48-h periods are 
characterized by low water intake and urine output. For the 
intermediate and high doses, the amount of urine produced in 
the first 24-h period is higher than the controls, although 
it reaches statistical significance only for the high dose 
(p<0.005). There was no statistical difference between the 
urine output of the low and intermediate doses (p>0.1), while 
there was a difference between the low- and high- dosed rats 
(p<0.005). The water intake for the second 24-h period is 
only significantly greater than controls (p<0.01) for the 
high-dosed group, while for both the intermediate and high 
groups the average urine output is higher .than control with 
only the high dose reaching significance (p<0.005). There 
appears to be a lag between high urine output of the 
high-dosed rats and increasing water intake, since it is not
until the second 24-h period that we see an increase in water 
intake (p<0.01) over controls. This illustrates an increased 
trend to larger urine volumes for the high-dosed rats, while 
the low-dosed rats tend to have a depressed urine output. 
However, both the urine output in the first -collection and 
the increase in water intake in the second apppear to be dose 
related. The urine outputs in the second observation period 
are lower than in the first for the intermediate and high 
injections, with a slight indication of a dose response.
£c} Histology
_ -j
The tissue for the low dose (1.5 mg Ni kg ) pulled away 
from the resin block, making it impossible to cut semi-thin
sections. The results described in this section are limited
-1 - 1 to the high (6 mg Ni kg ) and intermediate (3 mg Ni kg )
dose groups.
There were no characteristic morphological tissue
changes observed in the kidneys, such as a lack of platelets
in the capillaries, cellular disruption and nuclear changes
in the interstitium and collecting duct epithelia of the
papilla. This indicates that there was no renal papillary
_ 1
necrosis (RPN). In the 6 mg Ni kg group, a large number of 
proximal tubules exhibited a significant number of lysosomal 
granules. Cortical morphological alterations were evident in 
the size and shape of the glomeruli. Figures-'4.3a and b show 
control tissue stained with Giemsa with normal appearing 
glomeruli. The capillary spaces are evident, and are defined
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Figure 4.3. Photomicrographs of kidney tissue from rats 
48-h after i.p. injections of NiCl^.
A Control Giemsa- stained tissue with normal appearing 
glomeruli. 100X.
B Control Giemsa-stained tissue with normal appearing 
glomeruli. 400X.
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C Intermediate-dosed (3 mg Ni kg~ ) tissue with increased 
Giemsa staining of the basement membrane of the 
glomeruli and a reduction in the volume of Bowman's 
space. 100X.
1D Intermediate- dosed (3 mg Ni kg ) tissue with increased 
Giemsa staining of the basement membrane of the 
glomerulus and a reduction in the volume of the Bowman's 
space. 400X.
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E 1High-dosed (6 mg Ni kg ) Giemsa-stained tissue with 
majority of the glomeruli within this section solid and 
no evidence of Bowman’s space. 100X.
F High- dosed (6 mg Ni kg Giemsa- stained tissue with a 
solid glomerulus and no evidence of Bowman’s space. 
400X.
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G High-dosed (6 mg Ni kg ) Giemsa-stained tissue with a 
solid glomerulus and proximal tubule profiles with a 
considerable number of protein uptake granules. 250X.
_ i
H High-dosed (6 mg Ni kg ) Giemsa-stained tissue 
illustrating an example of a badly necrosed glomerulus 
with total loss of structural integrity and 
characteristic shape. 400X.
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I Control Giemsa- stained tissue with two examples of 
glomeruli with normal patent capillaries and Bowman's 
space. 400X.
J Control Giemsa- stained tissue illustrating the 
podocyte/capillary membrane region of the glomerulus 
that appear to be most affected by nickel. 1000X.
by podocytes and by Bowman's (capsular) space around the 
glomerulus between the inner or visceral layer (glomerular 
epithellium) and the outer or parietal layer (Fig. 4.3a). 
Under higher power (Fig. 4.3b), details of the glomerulus are 
shown to be normal histologically. There - are wide-open 
(patent) capsular spaces and a well-defined Bowman's area 
around the glomerulus.
For the intermediate-dosed rats, the photomicrograph 
under low magnification (Fig. 4.3c) shows an increase in 
staining of the basement membrane of the glomerulus, with a 
resultant reduction in the number of visible glomerular 
capillaries and a reduction in the volume of Bowman's space 
(compare to Fig. 4.3a). High magnification (Fig. 4.3d) 
reveals further details of the changes in the glomerulus when 
compared with control tissue (Fig. 4.3b). There is evidence 
of increased staining in the basement membrane and a decrease 
in the number of visible capillaries and a shrinking of the 
Bowman's space.
Under low magnification, the tissue from the high-dosed 
rats shown in Figure 4.3e illustrates that the majority of 
the glomeruli within this section are solid with no evidence 
of the Bowman's space (c.f., to Fig. 4.3a and c) . The 
podocytes and capillaries merge together. There is also an 
increase in interstitial staining extending_out from affected 
glomeruli between the proximal tubules-. At 400X
magnification when Figure 4.3f is compared to Figure 4.3b, an 
increase in the thickness and/or volume of the basement
membrane of the glomerular podocytes is evident. In fact, 
there is no Bowman's space in evidence at all. A mitotic 
body is present below the glomerulus in the distal tubule. 
Under a medium magnification of 250X (Fig. 4.3g), tissue from
_ i
the 6 mg kg animals shows a "solid" glomerulus, although 
the proximal tubule profiles also have a considerable number 
of protein uptake granules which might be lysosomal in 
nature. Figure 4.3h shows an example of a
drastically- changed glomerulus with total loss of structural 
integrity and characteristic shape.
The next two photomicrographs again show control tissue. 
Figure 4.3i illustrates at 400X two glomeruli with "normal" 
patent capillaries and Bowman's space. The change that 
occurs in nickel-treated rats is evident when Figure 4.3i 
(control) is compared to Figures 4.3g and h (nickel-treated) 
which show changes in basement-membrane and interstitial 
staining. Under very high magnification (1000X), Figure 4.3j 
illustrates the podocyte and capillary membrane regions of 
the glomerulus that are most affected by nickel. The 
increase in staining, both in thickness and intensity,
suggests increased deposition of glycosaminoglycans
(proteoglycans free of protein) within the cell membrane 
matrix.
Histopathological examination of the_rat kidney also 
revealed alterations restricted to scattered proximal
tubules but occurring along the entire length of the tubules 
altered. The changes included: dilated tubules, loss of
brush border, flattened epithelia, and some regenerative 
activity.
rii^ UPTAKE OF NICKEL IN RENAL SLICES
The uptake curve of p-aminohippuric acid (PAH) by kidney 
slices from male Wistar Albino rats in Tyrodes buffer shows 
an increase in the slice to medium ratio (s/m) of PAH with 
time (Fig. 4.4). There is also a decrease in the s/m for
slices treated with the anion transport inhibitor probenecid
_ A o+
(8x10 M). A similar uptake curve was observed for Ni in
HEPES buffer (Figure 4.5). The results from the uptake of
nickel as its histidine complexes by isolated rat renal
slices were subject to large variations. In an attempt to
compare this data, it was normalized by the slice to medium
ratio (s/m) of various incubation components such as PAH and 
2+Ni (Table 4.4). Studies in the absence of an 
oxygen- enriched atmosphere above the incubation medium 
resulted in a lower slice/medium (s/m) ratios for Ni(His) 2  
and Ni(His)^ relative to Ni^+ (p > 0.01 and p < 0.01,
respectively).
- 4Probenecid (8x10 M) inhibited the uptake of PAH in all 
cases. This reduction was on average 30 + 4% (four runs in 
triplicate) and reached statistical significance at p=0.01. 
The uptake of PAH in dead -tissue (ethariol, boiling and 
2,4-dinitrophenol) resulted in a much lower.^s/m ratio than 
when it was inhibited by probenecid. The average reduction 
observed in three runs (triplicate) was 62 + 9%. and was
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different from the probenecid inhibited uptake (p<0.02).
The picture is not as clear for the inhibition of uptake
n, o I
of Ni or its complexes (Table 4.4). For Ni and the 
2+ 2+Ni /Ca combination, the probenecid-treated slices have 
approximately the same s/m as untreated samples (p > 0.05). 
For the nickel histidine complexes there appears to be an 
increase in the mean s/m value with probenecid that is not
24-
significant (p > 0.05). Relative to Ni , there appears to 
be a nonsignificant decrease in nickel uptake for Ni(His) 2
o I 9+
and Ni /Ca (p > 0.05) compared to a large decrease for 
Ni(His)^ (p < 0.01). Tissue that had been previously treated 
with ethanol or by boiling (i.e. dead tissue) had a larger
2 +  .f.
nickel mean uptake for Ni , Ni(His) 2  and Ni(His)^ than 
nontreated (live) tissue. Only Ni(His) 2  uptake by boiled
24-
tissue slices was significantly different from Ni (live
tissue) (p < 0.01), the remainder appproached significance
with p< 0.05. Tissue treated with DNP appears to have a
24-reduced mean nickel uptake for both Ni (not significant p >
0.05) and Ni(His) 2  (significant p < 0.01) when compared to 
2+
Ni s/m for live slices.
For the one study on the uptake of nickel and PAH while
the incubation medium was continually bathed with
957 02/5% CO2  (v/v) atmosphere, there was a significant
increase (p < 0.01) in the uptake of __PAH compared to
air-exposed slices, but a nonsignificant (p.i> 0.01) change
24-occurred in the s/m for Ni and Ni(His) 2  (Fig. 4.6).
Figure 4.7 illustrates the efflux of PAH from live
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Figure 4.6. The accumulation of ^Ni^+, ^Ni(His)2 and PAH in renal
tissue slices, measured by the slice/medium (s/m) over a 2-h incubation 
period. Each histogram represents the mean + SD of three replicates. 
The uptake without 95% 02/5% C02 (v/v) atmosphere is described in the
text. The uptake with 95% 02/5% C02 (v/v) represents one run where the
slices were treated as described in the text except that the incubation 
medium was kept under an atmosphere of 95% 02/5% C02 (v/v) during the
incubation period.
aNot statistically significant (p>0.05).
^Statistically significant (p<0.01).
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Figure 4.7. The total efflux of PAH and Ni from tissue 
expressed as a percent of that accumulated-during a 2- li 
incubation. The PAH efflux from ethanol-treated tissue 
had the same profile and values as live tissue. The
efflux of Ni(His) 2  from ethanol treated slices
O i
resembled that of Ni in both its profile and amount.
tissue and nickel from live and dead tissues after it had
Q  ^Q o ,
been preincubated with PAH or Ni for 2 h. There is a
rapid increase in the amount of nickel released from the
63n i2+_preincubated tissue slices during the first h. After
1 h, a residual slow release of nickel remained, reaching a
maximum recovery in 3 h of 37 + 1 % compared to 30 + 1% at 1
h. The profile for the efflux of ^3^2+ fr0in ethanol-treated
tissue was very different from the live tissue as illustrated
in Figure 4.7. The largest release still occurs in the first
h, but the 7o efflux is much lower for the ethanol-treated
63slices. The efflux of Ni(His) 2  from ethanol-treated slices
63 2+resembled that of Ni in both its profile and amount (data 
not shown). The release profile of PAH from live tissue was
2 4 -
similar to that of Ni , but with a much higher recovery at 
all time periods (Figure 4.7). The PAH efflux from ethanol 
treated tissue had the same profile and values as live 
tissue.
2+The release curves for PAH, Ni and Ni(His) 2  were found 
to follow first-order kinetics (Table 4.5). The half-life 
for the release of PAH from both live and ethanol-treated 
tissue was relatively short (live tissue 17 ± 2 min and dead
24-
tissue 16 + 3 min). By contrast, the release of Ni from 
live tissue had a much shorter half- life than from dead 
tissue. The half-life for the release of Ni(His) 2  from dead 
tissue (33 ± 3 h) was not significantly different from that 
for the release of Ni^+ (37 + 2 h). Release of Ni^+ by live 
tissue took place more rapidly (^±/2 = ^*9 ±0.2 h).
Table 4.5
FIRST- ORDER KINETIC ANALYSIS OF PAH AND NICKEL 
IN VITRO EFFLUX FROM RAT RENAL SLICESa
r
Substance k ti/ 2  r
Released (h~ (h)
PAH
(Live Tissue)
2.4 ± 0.04 0.29 ± 0.04 0.98-0.99
PAH
(Dead Tissue 
Ethanol)
2.5 ± 0.4 0.27 ± 0.04 0.90-0.95
Ni2+
(Live Tissue)
0.078 ± 0.002 8.9 + 0.21 0.90-0.93
Ni2+
(Dead Tissue 
Ethanol)
0.019 ± 0.001 36.6 ± 2.0 0.97-0.98
Ni(HIS)2
(Dead Tissue 
Ethanol)
0.021 ± 0.002 32.6 + 2.6 0.98-0.99
The efflux of PAH and Ni from tissue illustrated in 
Figure 4.7 expressed in terms of first-order kinetic 
parameters.
b At 25°C.
fiii^ STUDIES VITH ISOLATED PROXIMAL TUBULES
PAH uptake by proximal tubule fragments was shown to be 
inhibited by 200 /M probenecid. The incorporation of 200 and 
400 fig L" Ni as Ni(His) 2  into proximal tubule fragments 
was shown to have a time-dependent change but not to be 
concentration dependent. The incorporation of thymidine, 
proline and histidine into rat proximal tubule fragments was 
studied in the presence of the complex Ni(His)2 * The 
incorporation of histidine was severely inhibited (> 90 7o), 
whereas proline incorporation was lowered to a much smaller 
amount (15 % max). Similarly, thymidine uptake was reduced
_ i
(10%) by 50 fig L Ni, with a subsequent rise to 1007o of
_ i
controls at 200 fig L Ni. UV/VIS spectral analysis
2+suggested that the formation of a Ni -proline complex 
occurred under the experimental conditions (characterized by 
an absorption band at 640 nm), but this was not observed for 
thymidine.
(iv) INTRAVENOUS INJECTION EXPERIMENTS
The simultaneous isolation of the basolateral and 
brush- border membranes from the Pg pellet of 200- g male 
Vistar- Albino rat kidney cortex 10 min after intravenous
/^Q /%Q
injection of 6 fig Ni/kg (as Ni(His)2 ) . into the jugular 
vein showed almost equal amounts of nickel associated with 
both membranes. Nickel was also found to be associated with 
the Pg pellet at 1.5h, 3h and 24h post injection.
/:»q
The 24-h time course after i.v. injections of 6 fig Ni
w /^ q
kg" (as Ni(His)2 ) is summarized in Table 4.6a and Figure
4.8a. Nickel is present in the kidney and liver 10 min after
the injection. The level in the kidney built up to a maximum
1 1/2-h after injection then decreased rapidly reaching
similar levels in all fractions after 24 h. There is a
steady decrease in the percent of injected dose in the plasma
and the liver, which is consistent with the rapid renal 
24-
excretion of Ni (^1 / 2  “ 24h).
The molecular-mass profile of the kidney-cell cytosol 
fractionated by Sephadex G-75 column consistently produced
two peaks: one a high relative molecular-mass (~ 111,000)
fraction and the other of ~ 480 (Fig. 4.9 a-d) . The low 
molecular-mass cytosol fraction (Fig. 4.9d) coincides exactly
£»q
with the peak of authentic Ni(His)2 * This was confirmed 
after calibration with the standard 5'-AMP (MM = 365) which 
came off in the fraction just below nickel. There was no
large peak around fraction 17 where albumin is expected. 
However, the 1.5- and 3-h time points (Figs. 4.9 b and c) do 
not show as dramatic a drop after fraction 15 as the 10-min 
and 24-h time points. Over the initial 3-h period, there are 
increases in the nuclear fraction and the
mitochondria/lysosomes fraction. All the rest of the 
fractions remain relatively constant or show a decrease in Ni 
content (see cytosol and brushborder/basolateral fractions).
/q o
The ratio of low/high molecular-mass ratio for Ni in 
cytosol follows the same profile as the percent retention in

Table 4.7
CYTOSOL PROFILE
Molecular-Mass Profile of Kidney Cell Cytosol 
Determined by Sephadex G- 75 Column Chromatography
Time (h) 
After i.v. 
Injection
Relative 63N. 
of Peak Maxii 
in Fr*
15b
L Radioactivity 
nally Located 
ictions:
34b
Percent of 
Nickel in 
Low- Molecular- 
Mass Component
Ratioa of 63Xi 
Radioactivity 
in Cytosol 
Fractions
34/15b
0.17 1.0 5.0 83 5.0
1.5 1.2 7.3 86 6.1
3.0 1.1 7.1 87 6.5
24 0.22 0.56 72 2.5
a Measured by the area under the curves of the peaks located maximally at 
fractions 15 and 34 (evaluated by a Hughes- Owens polar planimeter).
b High-molecular-mass component occurs maximally in fraction 15.
Low-molecular-mass component occurs maximally in fraction 34.
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Figure 4.9. G-75 Molecular-mass profiles of kidney-cell
cytosol and authentic Ni(His)2 *
(A-D) Molecular-mass profiles of the kidney-cell
cytosol that was passed through a G-75 column.
(E) Profile of the ^Ni(His ) 2  complex on the G-75
column.
Standards: A 2,000,000 (blue dextran); B 14,000
(ribonuclease); C 7,000 (Cd-thionein); D 5000 
(insulin); E 1,400 (vitamin B-12); F 365 
(adenosine monophosphate).
(A ) 10 MIN POST INJECTION
0.10
ID
CM
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0.05
6 3 Ni CYTOSOL
5000
p- 3000
1000
10 3020 5040 60
FRACTION No.
(C ) 3 h POST INJECTION
,* 0.10
in
CM
<  0.05
CYTOSOL
6 3 Ni CYTOSOL
5000
pr 3000
1000
5010 30 40 6020
FRACTION No.
-292-
(D )  24 h POST INJECTION
0.10
CYTOSOL
0.05
6 3 Ni CYTOSOL5000
9-s 3000
1000 *
10 30 504020 60
FRACTION No.
(E )  6 3 NI(HIS)2
7000
50002
Q.O
3000
1000
10 30 40 5020 60
FRACTION No.
the kidney of the injected dose (c.f. data in Tables 4.6 and
4.7). Thus as Ni accumulates in the kidney, the low/high 
ratio of components in the cytosol increases. Subsequently, 
as the percent retention of injected dose decreases (3 h and 
24 h), the low/high ratio also decreases. The
/> Q
Ni/mg(protein) ratio indicates that all kidney fractions 
follow the same trend as the percent retention in the kidney 
of the injected dose.
Table 4.8 illustrates the distribution of injected dose 
of Ni(His) 2  in rat tissues and body fluids. At 3 min after 
injection, 2.457c of the label is present in the bladder 
urine; after 10 min it has increased to 13.47o and decreased 
to 0.3l7o after 24 h. The 24-h urine contained 887o of the 
injected dose illustrating the rapid clearance of Ni(His)2 - 
The tissue with the largest percent of injected dose for both 
the 10-min and 24-h time points is the kidney, with the brain 
being the lowest. Of all the tissues investigated at the 
24-h time point, 93.4% of the injected dose is accounted for. 
This percent does not include the intestine or muscle. When
_ -i
this data is reported in terms of ng nickel g tissue (Table 
4.9), it is evident that the same accumulation order is 
present as in Table 4.8 with the kidney having the highest 
nickel content and the brain the lowest. The excised brains 
of both rats investigated at 24-h time point portrayed a 
subarachnoid haemorrhage. The significance of this
observation is unclear at this time.
The autoradiography data for kidney tissue corresponding
Table 4.8
PERCENT OF INJECTED DOSE IN TISSUES AND BODY FLUIDS 
FOLLOWING A 6  /zg Ni kg' 1 IV INJECTION OF 6 3 Ni(His) 2
Tissue Percent Injected Dose
Percent
Reduction
3 min 1 0  min 24- h 10 min -» 24- h
Seruma 27.8 ± 8 . 6 10.4 ± 1.9 0.36 ± 0.11 96.5
Urine A 
(Bladder)
B
2.45 
__b
13.3')
V 13.4+0.1 
13.4J
0.191
V 0.31+0.17 
0.43J
---
Urine 
(24- h)
-- --- 88.0 ± 9.6 ---
Kidney -- 6.67 ± 0.41 1.25 ± 0.21 81.3
Liver -- 2.50 ± 0.73 0.27 + 0.21 94.3
Testes — 0.77 0.09 86.4
Lung — 0.74 0.07 90.7
Heart . -- 0.41 0.03 91.9
Spleen — 0.17 0 . 0 2 85.2
Brain -- 0.05 0.008 73.3
Intestine0 — 4.4 0.34 94.2
Thigh Muscle0 — 1.92 0.90 53.1
Faeces — -- 3.04 + 2.65 ■■ ■■ ™
aVolume of serum for a 250 g rat was taken to be 7.5 mL. 
^Bladder was empty.
C  "1Expressed as ng Ni g tissue.
Table 4.9
TISSUE CONCENTRATION OF 63NICKEL IN THE RAT 10 min 
AND 24-h FOLLOWING A 6 /jg Ni kg' 1 
IV INJECTION OF 63Ni(His)2
Tissue 10 min 24- h
1 1 (ng Ni g” tissue) (ng Ni g" tissue)
Kidney 66 12.6
Lung 8.3 0.81
Liver 7.5 0.45
Heart 6.8 0.40
Intestine 4.4 0.34
(Small)
Spleen 3.0 0.45
Testes 2.4 0.31
Muscle 1.9 0.90
(thigh)
Brain 0.39 0.11
to the time- course study is in agreement with the subcellular 
fractionation study. Figure 4.10 illustrates typical grains 
observed and masking used in the autoradiographic studies of 
various areas of the kidney. The amount of nickel in the 
cortex for the four time periods in both studies is almost 
identical (compare data in Table 4.10). At 10 min, nickel is 
present in the S3 segment of the proximal tubule, while 
relatively little is present in the other portions of the 
nephron investigated (Fig. 4.11). Vith time (1.5 and 3h), it 
is also present in the glomerulus and in the other segments 
of the proximal tubule, the distal convoluted tubule and the 
collecting duct. After 24 h, nickel appears to be present 
only in the S3 segment of the proximal tubule.
Histopathological examination of the kidneys after the 6 //g 
Ni/ kg dose showed no evidence of a toxic response in any 
segments of the nephron.
The incubation of ®^Ni ■ and ^Ni(His)2 for 2 h with
subcellular fractions indicates that they both have a high
affinity for the mitochondria/lysosome fraction. More 
63Ni(His)2 is associated with both the nuclear and microsomal
Q
fractions than Ni (Fig. 4.8b). Both the results for the
incubated subcellular fractions and the iv injection study 
show a large affinity for the mitochondria/lysosome fractions 
(Table 4.13).
(v) CATION COLUMN CHROMATOGRAPHY
The Ni(His)2 (pH = 8) complex did not have high affinity
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Figure 4.10. Autoradiography of kidney sections, after 
63Ni(His) 2  i.v. injection, illustrating structure and
grains developed. The regions outlined represent 
examples of the masking of specific nephron segments 
identified and selected for counting on the Quantimet 
920 image analyzer.
(A) Outer Cortex X570.
(SI segment of the proximal convoluted tubule)
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(B) Inner Cortex X570.
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(C) Inner Cortex/Medulla Junction X570.
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Figure 4.11. Time-course distribution of nickel along the
nephron identified by Ni autoradiography and 
quantified by image analysis of grains using the
Quantimet 920 analyzer. "Grains/^2" represents the 
ratio (total area of grains)/(total area of nephron 
segment) selected for 30-40 samplings of each specific 
segment.
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for the cation column. This indicates that this complex has 
either a very low positive or a negative charge. By contrast 
Ni(His)^ (pH = 5) complex had extremely high affinity for the 
cation column as indicated by the need to use strontium 
nitrate solution to remove this complex. This incicated that 
the Ni(His)^ complex is positively charged.
D DISCUSSION
(i) NiCl2 INJECTION STUDY 
(ai) Post-Injection Status
-1 -1 Both the high (6 mg kg ) and intermediate (3 mg kg )
i.p. doses resulted in the rats becoming extremely relaxed
and lethargic with dilated blood vessels in their ears about
~5 to 8 min post injection. Although the main thrust of this
chapter is to examine the renal toxicity of nickel, these
observations suggest a rapid, shortlived (15 min - 2.5 h)
pharmacological effect the implication will be briefly
considered. Nickel has been associated with cardiotoxicity
2+in two major ways. Injection of Ni has been shown to 
induce in vivo coronary vasoconstriction in dog heart and in 
perfused isolated hearts (Rubanyi et al. , 1981).
Furthermore, hypernickelemia has been observed in 50 to 75% 
of patients with acute myocardial infarction or unstable 
angina pectoris (Leach et al., 1985). As noted by Nieboer et 
al. (1987a) the mechanisms and sources of nickel released
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into the serum for the above cardiac cases is not
2+established. It is obvious that the direct action of Ni ,
such as in the dog studies, may alter normal haemodynamic
function. Another possibility is that the smooth muscle of
the blood vessels could respond in a similar manner to that
of the isolated uterine strips described by Rubanyi and
7 5Balogh (1982) were low concentrations (10 to 10 M) of
NiC^ increased the basal tone of uterine strips isolated
from 20-day-pregnant Vistar rats, while high concentrations
(10"4 to 10’^ M) of NiC^ depressed spontaneous contractions
2+and decreased basal tone. Large concentrations of Ni in 
the blood might thus result in depressed "spontaneous” 
contractions causing the dilation of the blood vessels 
resulting in the redness observed in the ears. If this 
dilation of blood vessels occurs throughout the vascular 
system, then it could result in at least a short-term 
lowering of blood pressure. Lethargy and weakness are common 
complaints of patients who suffer from chronic hypotension 
(Engelman and Braunwald, 1977), which agree with the observed 
reactions of the rats in the present study.
The transient nature of these post- injection 
observations is consistent with the nickel levels in the 
serum being rapidly lowered with concurrent rapid urinary 
excretion (Table 4.8; 3- and 10-min time points) . This rapid 
removal of nickel from the serum would result in the levels 
of nickel being lowered, allowing the cardiovascular system 
and blood pressure to normalise and recovery after 15 min to
-303-
2.5 h.
The above observations may be due to the interaction of 
2+ 2+Ni and Ca ions. As already indicated, there are a
2+variety of agonistic/antagonistic interactions that Ni can 
24-have with Ca (see Table 1.1). This illustrates that the 
mode of action causing the observed effects may be complex. 
Additional in vivo and in vitro studies are required to 
substantiate and quantify in a systematic manner the way in 
which these stimulatory and inhibitory effects are consistent 
with laboratory behavioral observations.
(b) Relationship between Physiological Function and 
Structural Changes Induced bv Nickel
The most obvious change in the liquid balance is that 
the volume of urine produced is higher than the controls for 
intermediate and high doses (p<0.05), while the volume of 
water consumed is only slightly increased in the second 24-h 
period. By contrast, the low-dosed rats have a urine volume 
lower than controls with a corresponding drop in the volume 
of water consumed (not significant p>0.1). As illustrated in 
the histological study, nickel appears to have a major effect 
on the glomeruli of the nephron for which a dose response 
decrease in the Bowman's space was observed. Although it is 
known that fixation of kidney tissue with formalin may cause 
glomerular swelling (personal communication, Dr. C. Powell, 
Robens Institute), the effect observed in this study was 
dose-dependent and was not observed in control tissues.
Consequently, it is concluded that the observed changes in 
the glomerulus were primarily due to nickel and not to the 
type of fixation. The discussion that follows will first
focus on possible changes in the glomeruli in relation to 
diuresis and proteinuria before considering alternate 
interpretations.
Although it was not possible to obtain histological 
sections of the low-dosed rats, it seems reasonable that the 
effects of nickel would have been less, namely larger 
Bowman’s space than the intermediate dose. This is 
substantiated by the fact that there was no observable change
_ i
in the Bowman’s space in the 6 /ig kg i.v. injection
(autoradiography) study described in Section C (iv) of this
Chapter. It is well established that there is a
dose- response relationship between total protein appearing in
24-rat urine and injection of Ni (Gitlitz et al. , 1975 and
Sunderman et al.,1976b) . Gitlitz et al. (1975) found a dose
response between proteinuria and single i.p. injections of
NiCl2  between 2 and 5 mg Ni^+ kg  ^ (Table 4.11). Therefore,
there appears to be a similar dose- response effect between 
24-the dose of Ni and the amount of protein excreted and the
decrease in Bowman's space.
For each nephron there is a feedback mechanism operating
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Table 4.11
EFFECT OF PARENTERAL NiCl2  UPON EXCRETION OF TOTAL PROTEIN AND AMINO ACIDS
Percent Change of Total Protein and 
Amino Acids in Rat Urinea
Parameter
2.0 mg Ni kg’ * 
as NiCl2
3.0 mg Ni kg’ 1  
as NiCl2
4.0 mg N i kg’ * 
as NiCl2
5.0 mg Ni kg’ * 
as NiCl2
Day 1 Day 2 Day 1 Day 2 Day 1 Day 2 Day 1 Day 2
Total Protein 26 32 84 116 2 2 1 300 337 426
Neutral oAmino Acids
Glycine 0 5 5 26 116 237 205 332
Alanine 0 8 35 146 334 538 630 746
Valine 35 60 240 450 1050 1700 1750 235
Leucine 50 73 109 273 673 1173 1264 1764
Isoleucine 29 43 136 286 6 8 6 1043 1186 1686
Serine 9 13 51 98 307 586 493 760
Threonine 2 6 49 81 230 400 340 506
Phenylalanine - 1 0 -5 25 75 260 375 550 550
Tyrosine 2 1 26 84 147 352 637 689 900
Methionine - 1 0 - 1 0 37 37 160 267 300 400
Cystine 5 -14 29 62 181 352 376 576
Acidic aAmino ILcids
and Amides
Aspartic acid 0 -7 0 1 1—*
■ 
CO 0 0 0 7
Asparagine - 6 -13 - 8 9 79 156 92 54
Glutamic acid 18 - 6 45 79 169 318 437 512
Glutamine 0 31 54 92 277 423 500 623
Basic aAmino A(?ids
Histidine . 1 2 0 6 440 46 800 180 980 280
Arginine 1 2 9 67 91 388 598 737 877
Lysine 14.5 6.7 155 264 627 1136 1118 1700
Ornithine 5 -5 37 58 189 295 279 400
Substituted 
and Miscellaneous 
Amino Acids
/3- Akanine , -5 1.4 - 1 0 -4 - 15 - 14 3 -31
7 - Aminobutyric 1 1 5 - 1 1 1 1 61 17 - 17 - 1 1
1- Methylhistidine - 33 -33 -35 -19 - 1 2 2 62 1 0
3-Methylhistidine 31 4 0 -24 29 - 16 2 2 -4
Sarcosine 
(N- methylglycinc0 11
2 2 -44 -26 -48 -41 -4 -4
Taurine - 2 1 14 2 1 17 -34 - 14 87 3
The percent change, based on 24-h urinary excretion rates (mg/kg/d, protein• 
//mol/kg/d, amino acids) was calculated from the data reported by Gitlitz 
et al. 1975.
between the macula densa segment of the distal tubule and the 
afferent arteriole of the corresponding glomerulus (Bell and 
Navar, 1982). The latter component participates in the 
regulation of the glomerular filtration rate through the 
macula densa cells responding to flow- related alterations in 
the tubular fluid. By affecting changes in the glomerular 
filtration rate, they help control fluid flow along the 
nephron and thus may have an effect on the volume of urine 
produced. Bell and Navar (1982) found, by retrograde 
microperfusion studies in rats, that "cytoplasmic calcium 
within the receptor cells may participate in the transmission
of feedback signals to the contractile cells". If low doses
2+of Ni are able to stimulate the feedback mechanism to the 
afferent arteriole, then there will be a reduction in the 
glomerular filtration rate which, if dramatic enough, would 
result in a measurable reduction in the volume of urine 
produced.
2+If high doses of Ni have the opposite effect on the 
macula densa to low doses (i.e. similar to that observed by 
Rubanyi and Balogh (1982) for uterine contraction), then the 
feedback mechanism between the macula densa and the afferent 
arteriole would be reduced or may not respond normally to 
tubular flow fluctuations. This could result in a larger 
flow of blood through the glomerulus and in a higher
glomerular capillary blood pressure, forcing effective
filtration pressure and glomerular filtration rates to
increase. The result would be an increase in the urine
volume. If this change in pressure were large enough it 
would cause a swelling of the surrounding tissue (i.e., 
edema) and perhaps a reduction in the Bowman's space.
As background for a discussion of tissue swelling in
relation to proteinuria a brief description.of the filtration
barrier is presented. The glomerular filtration barrier in
the glomerulus is composed of "thin endothelial cells, with
large open pores, the hydrated gel of the basement membrane
with its dense network of long fibrillar particles of
proteoglycans and narrow slits between the pediciles of the
podocytes, which are bridged by the slit diaphragm. These
structures are covered by strongly negatively charged cell
coats on both the vascular side and the urinary side of the
filter. Additionally, negative charges are present within
the layers of the basement membrane, especially in both
laminae rarae" (Kriz and Kaissling, 1985). The filter has
been shown to select macromolecules by their charge, size and
configuration under normal flow conditions (Kriz and
Kaissling, 1985). If the observed swelling causes a change
in filtration characteristics (size and configuration) and a
reduction in the charge of the basement membrane by
24-interaction with Ni as noted by Templeton (1987a, b and c) 
in in vitro studies with isolated basement membranes, then 
there will also be an increase in the amount of 
high-molecular-mass proteins being filtered. If the tubular 
maximum for their reabsorption is exceeded, then proteinuria 
would result. Thus structural changes observed in the
histological study can explain both the increased volume of 
urine and the increased proteinuria observed by Sunderman and 
Horak (1981). Section (iv)a of this discussion includes an 
explanation of the decrease in Bowman’s space caused by 
glomerular damage.
The above discussion has been centered on the swelling
of the glomerular tuft. However, it should be noted that
there could also be a change in the tissue surrounding the
Bowman’s capsule. For instance, if there was a swelling in
the proximal or distal tubules and their surrounding tissue
24-due to interaction with Ni , then this could result in a 
decrease in the Bowman’s space surrounding the glomerular 
tuft without a large change in the tuft tissue. If this 
postulated change in the proximal tubules occurs, then it is 
also possible that there is concomitant interference with the 
reabsorption of protein which in turn would lead to 
proteinuria.
It is also feasible to get diuresis by alterations in 
function along the nephron that are not dependent on the 
swelling of the glomeruli. For instance, in the proximal 
convoluted tubule it is known that Na+ reabsorption is 
coupled to the reabsorption of glucose, amino acids and some 
organic anions (e.g. lactate and citrate)(Jones, 1985).
Water is known to pass through the proximal tubulular 
epithelium by osmosis so rapidly that the osmolar 
concentration of solutes on the interstitial side is almost 
the same as the intratubular side. Therefore if there is an
interruption in Na+ or amino acid reabsorption, then it would
cause less water to be reabsorbed resulting in diuresis.
2+Although there is no direct evidence that Ni interferes 
with Na+ reabsorption in the proximal tubule, it is known 
that it causes amino aciduria (Gitlitz et al., 1975;
Sunderman et al.,1976b; and Mathur and Tandon, 1981). Two of 
these studies (Gitlitz et al., 1975; Mathur and Tandon, 1981) 
indicate that there is a concurrent increase in concentration 
of most amino acids measured in the plasma. Thus it seems 
reasonable to speculate that nickel interferes with amino 
acid metabolism which may alter the reabsorption processes in 
the proximal tubule in a manner that produces amino aciduria 
and diuresis.
Proteinuria can also be caused by defects in the
proximal tubule via leakage from damaged cells. This is
presumably the cause of increased excretion of
N- acetyl- (3- D- glucosamiiiidase (NAG) found in rat urine by
Sunderman and Horak (1981) on the second day after i.p.
- 1injection of NiC^ (6 mg Ni kg ) . NAG is an enzyme that is 
associated with lysosomes and hence would presumably require 
cellular damage to cause large amounts of it to appear in the 
urine. This is consistent with the observed damage such as 
dilated tubules, loss of brush border and flattened 
epithelia.
The above discussion illustrates that the mode of action 
2+of Ni in the kidney may be very complicated and that 
further experimental studies are required before the validity
of the various theories presented above can be tested.
fin UPTAKE OF NICKEL IN RENAL SLICES
(a) Comments on Experimental Procedures
A brief review of the literature has shown that there is
no "ideal” composition of incubation media to be employed in
studies with tissue slices. The final composition of the
HEPES incubation medium used here was based on the Tyrodes
buffer solution which had been altered to maximize PAH
accumulation (Cross and Taggart, 1950; Foulkes and Miller;
1959; Chung et al., 1970). The concentration of HEPES buffer
used was lOOmM as recommended by Perrin and Dempsey (1974).
The concentration of PAH used in various studies has
ranged from 67 //M (Chung et al., 1970) to 0.25 mM (Ganote et
al., 1975). The concentration selected for the present work
was that recommended by Ganote et al., (1975). Probenecid
(1x10”^ M) is known to inhibit the uptake of PAH in renal dog
slices (Berndt, 1976). Daley-Yates and McBrien (1982) have
shown by isolated perfused rat kidney studies that probenecid
(0.3 and 3.0 mM) increased the clearance of cisplatin
(cis-dichlorodiammine platinum(II)) to approximately twice
the GFR (i.e., inulin clearance). This indicated that
probenecid inhibited the reabsorption of cisplatin. Because
of this action of probenecid on a metal complex, it was
2+chosen to investigate the transport mechanism of Ni and its 
histidine complexes.
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The incubation time for all the nickel uptake studies
was chosen to be 2 h because this allowed adequate time for
uptake and inhibition of PAH (see Fig 4.4) and the attainment
2+of nearly the maximum s/m ratio for the uptake of Ni (see
Fig. 4.5). This incubation time is at the upper end of the
values (90 to 120 min) usually reported in the literature
(Berndt, 1987). All solutions were incubated at 25°C, since
this temperature seemed to provide better tissue survival
than 37°C. This discrepancy may result from cellular anoxia
due to the combination of increased oxygen consumption at the
higher temperature and a lower oxygen tension (Cross and
Taggart, 1950). The oxygenation of the incubation medium is
usually done at 100% O2  or 95% 0 2 /5 % CO2  (Berndt, 1987) .
2-
Because of the possible interaction of CO2  as COg or HCOg 
2+with Ni (or its complexes), it was decided to oxygenate all 
media only prior to incubation; just one run was done under 
an atmosphere of 95% 0 2 /5 % CO2 . The adopted protocol also 
resulted in a minimum change in the pH of the buffer, 
ensuring that the species distribution of Ni(II)-histidine 
complexes did not change significantly during incubation. No 
runs were carried out with 95% 0 2 /5 % COg being bubbled
constantly through the incubation medium.
Many of the published uptake studies involving renal 
tissue slices have examined the cortex of the kidney only. 
The tissue sampling procedure adopted in the current work 
(see Materials and Methods) assured that uptake was 
investigated for a cross- section of the kidney rather than a
single component. Thus renal slices of rats were used to 
study uptake (i.e., total uptake by the cortex, medulla, 
proximal convoluted tubule and distal convoluted tubule) in a 
manner that closely resembled that of in vivo studies.
(b) Interpretation of Results
Functional integrity of anion-transport processes in
kidney slices was confirmed by the observed 30% inhibition of
PAH uptake by probenecid (Table 4.4). All the s/m ratios for
the uptake of PAH in this study were appreciably larger than
unity. This has been interpreted to indicate active
transport (a s/m value of < 1.0 is usually interpreted to
mean that the compound in the tissue got there by passive
2+means). Similarly, the s/m ratios of Ni , Ni(His) 2  and 
Ni(His)^ in live tissue exceeded unity considerably. In 
fact, they were .all substantially above the s/m value for PAH 
(Table 4.4). However for the uptake of nickel and its 
complexes in dead tissue (ethanol-treated and boiling), the 
s/m was also above that found for live tissue. With slices 
incubated in medium poisoned with dinitrophenol (DNP), the 
uptake of nickel and its complexes was much lower than the 
corresponding live tissue (Table 4.4). The classical 
interpretation of the DNP results is that they indicate an 
active component to the uptake of nickel or its complexes, 
which probably depends on the uncoupling of oxidative 
phosphorylation (White et al., 1973). This inhibition causesATP 
formation to be reduced or abolished on which active ion
transport and also the tubular secretory mechanisms depend.
This is consistent with the PAH results in this study for
boiled ethanol- and DNP-treated medium being lower than those
for the uptake of PAH inhibited by probenecid (Table 4.4).
The high s/m of Ni^+ , Ni(His) 2  and Ni(His)^ for both
live and dead renal slices appear to require another
interpretation. Nieboer et al. (1984c) and Menon and Nieboer
2+(1986) have investigated the uptake of Ni by human
erythrocytes and peripheral mononuclear leukocytes (mostly
lymphocytes) and cultured cells. The presence of lipophilic
ligands such as DDC and APDC enhanced the cellular
24-association of Ni , while more polar ligands such as 
L-histidine, D-penicillamine (D-PEN) and
ethylenediaminetetra- acetic acid (disodium salt) (EDTA) 
prevented uptake. Their observations were interpreted in 
terms of the "Equilibrium" model of metal- ion uptake by cells 
originally proposed by Williams (1981). In this model, no 
active membrane processes are required for metal-ion uptake 
under steady-state conditions (i.e., at fixed pH, redox 
potential, intracellular and extracellular ligand 
concentrations). "The distribution of metal ions among the 
various compartments of a cell is then determined by 
thermodynamic parameters such as the pKa values of ligands, 
the binding constants of the metal-ligand, complexes, their 
solubilities in aqueous and lipid phases (i.e., distribution 
coefficients), and the effective ligand concentrations in the 
various compartments" (Nieboer et al. , 1987a). This
2+perspective suggests that the uptake of Ni is most probably 
passive.
2+The uptake of Ni by boiled, ethanol- or DNP-treated
tissues corresponds to nonsteady-state conditions, because
internal pH, redox potentials and intracellular ligand
concentrations are not maintained and cell membranes are
disrupted. The intracellular proteins and enzymes will be
denatured and perhaps organelles are changed by the above
treatments. This may be expected to make available many more
binding sites than normally found in living tissue. This
phenomenon is known for metal- ion uptake in plant tissues
(Boileau et al., 1985). As shown in the intravenous
time- course study, there is rapid accumulation of nickel in
the kidney (Tables 4.6 and 4.8; Figure 4.8) where in the
cytosol it is probably present as the Ni(His) 2  complex.
2+Therefore, it is not surprising that Ni , Ni(His) 2  and
Ni(His)^ are able to cross cell membranes in live and dead
renal- slices. The large s/m ratio for the dead tissue is
consistent with the postulate of additional extracellular and
intracellular sites to which nickel can bind. Similarly in
live tissue, accumulation of nickel with high s/m ratio can
be interpreted to reflect compartmentalization under
steady-state conditions and not due to active transport.
2+This hypothesis is supported by the efflux, of PAH, Ni and
Ni(His) 2  from live and ethanol-treated tissues. The PAH has
2+a very short half-life when compared to Ni and Ni(His)2 ? 
which implies that there is a small amount of intracellular
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binding for PAH (live and ethanol- treated). Effective
2+intracellular binding for Ni and Ni(His) 2  would result in
much slower release from both live and ethanol- treated
tissues. The distribution of nickel for the in vitro
incubated subcellular fractions and in vivo i.v. injection
study (Table 4.12a and b; Figure 4.8a and b) in a sense
illustrate the "Equilibrium" model. The higher percent of
nickel associated with the mitochondrial/lysomes (M/L) and
nuclear (N) fractions in vitro is an indication of the type
and number of binding sites available intracellarly when
uptake is not restricted by cellular membranes. The passive
2+nature of cellular uptake of Ni has been illustrated in a
number of systems. As noted by Nieboer et al. (1987a), the
2+temperature-dependence of Ni accumulation by Chinese
hamster ovary cells (CHO) is indicative of a passive
(diffusion) process because the estimate of the temperature
coefficient Q^q is near 1.0. Passive uptake has also been
demonstrated by in situ perfusion of rat jejunum by Foulkes
2+and McMullen (1986). There was a biphasic uptake of Ni ,
with the second step (uptake from mucosa) being passive in
nature with ion flow occurring in both directions.
Low s/m values observed in DNP-treated renal slices such 
2+as for PAH and Ni is usually interpreted as an indication
of active transport. A similar effect has also been found in
2+the accumulation of Ni into cultured pneumocytes, which was 
reduced by metabolic inhibitors (NaN^, NaCN, NaAsCy after 
incubation at 37°C in Tyrodes (pH = 7.4) medium (Saito and
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Menzel, 1986). However, treatment of cells as above would
result in loss of the steady- state "equilibrium” condition
2+which could result in a decrease in the uptake of Ni and in
preferential intracellular compartmentalization. For
example, cytoplasmic ligands may be lost to the incubation
2+medium where they can complex with Ni
The change in s/m for renal slices incubated with and
without a 95% 02/5% CO2  (v/v) atmosphere (Fig. 4.6) is
2+statistically significant (p<0.01) for PAH, while for Ni
and Ni(His) 2  there was very little dependence. This
illustrates again that nickel and PAH have very different
transport mechanisms in the nephron. PAH is very dependent
2+on O2  whereas Ni and Ni(His) 2  are not. O2 - independence 
points to passive uptake for the latter.
(iii) UPTAKE OF NICKEL VITH ISOLATED PROXIMAL TUBULES
The uptake of PAH in proximal tubule fragments is 
consistent with the renal-tissue slice work in that it is 
inhibited by probenecid in both instances. This observation 
indicates that the tissue fragment procedure results in 
viable tissue and provides a useful tool to probe 
site-specific absorption along the nephron. For example, it 
facilitates the investigation of effects that may occur only 
in a specific segment (e.g., S3) of the proximal convoluted 
tubule, which would be masked when a cross-sectional slice is 
used.
As pointed out by Davies (1973), there are upper limits 
to both passive and active transport across cell membranes.
If both the 200 fig If* and 400 fig If* Ni(His) 2  are above this 
upper limit for reabsorption of Ni(His) 2  in the proximal 
tubule fragments, then a time-dependent but not a 
concentration-dependent uptake would be expected. Further 
work in this area should be done with a wider range of nickel 
concentrations with particular attention to concentrations
_ i
below 200 fig L to ascertain if the values chosen in this 
study were above the saturation level.
Histidine incorporation into proximal tubule fragments 
appears to be severly inhibited by Ni(His) 2  concentrations
_ i
from 50 to 200 fig L If this occurs in vivo, it would
result in large amounts of histidine appearing in the urine. 
This is exactly what has occurred in rat studies by Gitlitz 
et al. (1975) and Horak and Sunderman (1980). Gitlitz et al. 
(1975) investigated the excretion of total protein, neutral, 
acidic and basic a-amino acids after a single i.p. injection
_ i
of NiClg in dosages from 2 to 5 mg Ni kg . Vhen the data in
the Gitlitz et al. (1975) study is recalculated to express
the percent change (Table 4.11), then it is obvious that
histidine is the only amino acid for which the excretion
increases in the first day, followed by a decrease on Day 2.
This amino aciduria is accompanied by a mean decrease in the
2+histidine present in the plasma. Since the half- life of Ni 
in rats is approximately 24 h, and if its excretion is 
closely associated with the decrease in the reabsorption of 
histidine, then it is expected that histidine excretion would 
increase in the first 24-h period, as observed. This would 
be followed by a decrease in urinary histidine levels in the
2+second 24- h period when the levels of Ni being excreted 
drop, which is again seen. Interestingly, Horak and 
Sunderman (1980) have investigated the excretion of total
protein and amino acids after inhalation of Ni(CO)^ by rats. 
Again histidine is the only amino acid for which excretion 
increases during the first day post-exposure and decreases on 
the second day.
As summarized by Silbernagl (1985), there are six
methods by which amino aciduria can occur. Only a number of 
these are relevant to the present argument. High levels of
one amino acid may inhibit the reabsorption of other amino
acids, possibly by competition or blocking the uptake site. 
The proximal tubule study indicates that the Ni(His) 2  complex 
inhibits the uptake of histidine. This may be due to the 
complex competing with, or blocking, the uptake site of 
histidine prompting its increased excretion. However, it is 
possible that there was ligand exchange in the incubation 
medium of H-His with the His in the Ni(His) 2  complex which 
would alter its uptake. Investigation of the cytosol for the 
presence of Ni( H-His^ would have been useful in 
establishing if ligand exhange occurred. Alternatively, 
reduction of the Na+ gradient could be responsible for the 
hyperexcretion of amino acids, glucose and phosphate and
other compounds that are dependent on Na+ co- transport. Thus
2+ + if Ni is able to interfere with Na reabsorption in the
proximal tubule, possibly by ATP-ase inhibition or disruption
"I”of the brushborder membrane to cause leakiness of Na , then 
it would result in amino aciduria. As already indicated, the
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excretion pattern of all amino acids is not the same
following injection of NiC^. Histidine appears to be the
2+only amino acid whose exretion pattern is in phase with Ni
excretion. Interestingly, the excretion is initially
accompanied by elevated serum histidine levels compared to
controls at 1 h post i.p. injection, being at the control
24-level or below subsequently. Ni appears to have a variety
of effects on other amino acids. Valine has serum
concentrations below controls for the entire 48-h period post
i.p. injection of NiC^? while its excretion has increased
1050% on day one and 1700% on day two (Gitlitz et al., 1975).
The serum concentration of aspartic acid remains relatively
constant throughout the entire 48-h period with no change in
the urine on both days following the NiC^ injection.
Glutamine had serum concentrations below controls for the
entire-48 h period, while its excretion increased 277% on day
2+one and 423% on day two. It appears that Ni has vastly 
different effects on amino acids and suggests that it acts by 
different inhibitory mechanisms of reabsorption to produce 
the reported amino aciduria patterns.
The present proximal- tubule fragment study also suggests 
that Ni(His) 2  inhibits the uptake of proline. However, the 
above-mentioned in vivo studies did not investigate the 
excretion pattern of this amino acid. Therefore it is not 
possibe to comment on whether the observed in vitro 
phenomenon produces a change in the excretion pattern of this 
amino acid. The proximal tubule fragment work suggests that 
this technique can be used to investigate the different
04-
mechanisms underlying the differential effect that Ni or 
Ni(His) 2  have on the uptake of amino acids in the proximal 
tubule.
In the present work with proximal tubules, the uptake of 
thymidine in proximal tubular fragments was,not significantly 
inhibited by the presence of Ni(His)2 * Hui and Sunderman 
(1980) have shown that in vivo incorporation of thymidine 
into liver and kidney DNA of rats was inhibited by i.v. 
injection of Ni(CO)^, while i.m. injection of NiC^ did not 
significantly affect thymidine uptake into liver DNA, but did 
inhibit thymidine uptake into kidney DNA. These differential 
responses are likely related to the lipophilic character of 
Ni(CO)^ and organ-dependent metabolism of this compound.
fiv^ RENAL HANDLING OF IV ADMINISTERED NifHis^
(a) Association of Nickel with Soluble
Intracellular Components
The cytosol from all experimental time points after i.v. 
injection of Ni(His) 2  separated into high- (HMM) and 
low-molecular-mass (LMM) nickel-containing fractions on a 
Sepadex G-75 column (Fig. 4.9). The percent of nickel in the 
ultrafiltrable LMM fraction was between 72 and 87 percent, 
depending on the time after i.v. injection of Ni(His) 2  (Table
4.7). In the. past, there have been several studies that have 
obtained the same results with various renal subcellular 
studies of rats and mice (Sunderman et al. , 1981; Sunderman 
et al. , 1983; Herlant-Peers et al. , 1983; Abdulwajid and
Sarkar, 1983) . Although up to 80 7c of the nickel in the 
renal cytosol was in the low-molecular-mass form, the 
emphasis in the mentioned studies was directed to 
characterizing the macromolecular forms. They were carried 
out between 1 and 24 h after i.p, i.m. or i.v. injections of 
^NiClg or ^Ni(CO)^. It appears therefore, that injection 
of the Ni(His) 2  complex does not induce a drastic change in 
the distribution pattern of nickel between HMM and LMM 
fractions of renal cytosol.
As mentioned in Chapter 1, nickel is transported in the 
serum via both HMM and LMM carriers. The HMM ligand is human
albumin, and possibly a nickel metalloprotein which is
believed to be an alpha-2-macroglobulin, also called 
nickeloplasmin (Sunderman, 1977; Nomoto, 1980; Scott and 
Bradwell, 1983; Nieboer et al. 1987a). The LMM component is 
believed to be a nickel(II)-amino acid complex by in vitro
fjq
Ni-addition experiments (Lucassen and Sarkar, 1979).
M
Oskarsson and Tjalve (1979a) in a study with mice found that 
most of the nickel was associated with the HMM component 
albumin and the remainder with a LMM component. After i.v. 
injection of NiC^ into the mice, the serum was separated 
according to molecular mass by passing it through a G-75 
column. It is interesting to note that the LMM component 
found in the cytosol of both the lung and. kidney cells had 
approximately the same elution pattern as the serum profile. 
These cytosol results are similar to the G- 75 elution 
profiles (Fig. 4.9) of the renal cytsol found after i.v. 
injection of Ni(His) 2  and of pure Ni(His) 2  in the current
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study. In Figure 4.9 it can be seen that the HMM component 
began eluting after fraction 10 which is approximately where 
the standard blue dextran (MM = 2,000,000) eluted, and
stopped eluting at approximately fraction 21 which is where 
the standard Cd-thionein (MM = 7,000) appeared on the column. 
The LMM component had almost the same elution profile as the 
standard 5'- AMP (MM = 365) and ^Ni(His) 2 « Interestingly, a 
recent computer simulation by Cole et al. (1985) predicts 
that plasma LMM complexes are (metal % in parentheses): 
Ni(His) 2  (50.6%), Ni(CYS)(His)' (23.9%), Ni(CYS)|" (11.3%) 
and Ni(His)^" (4.4%). Thus it seems reasonable to postulate 
that the LMM component found in the serum and cytosol of the
»l
current and Oskarsson and Tjalve studies was a Ni(II) amino 
acid complex, such as Ni(His)2 *
The renal cytosol studies by Sunderman et al. (1983) 1 h
63after i.m. injection of NiC^ separated into six fractions 
on using high-performance size-exclusion chromatography with 
TSK-GEL SV-2000 and SV-3000 columns. The largest component 
(fraction F) contained approximately 80 % of the cytosolic
/> Q
Ni eluted near the permeation volume on the SV- 2000 column 
and beyond the total permeation volume on the SV-3000. This 
made it impossible to make a reliable estimate of its MM, 
although from the elution pattern its MM can be predicted to 
be below 7,000 to 10,000. The remaining 20 % divided into 5 
components with molecular masses between ~10,000 and 168,000. 
In a previous study, 0.5 h to 1 h after i.v. injection of
Q
NiC^ Sunderman et al. (1981) found essentially the same 
MMs for the 5 HMM components, but found ~70 % of the renal
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cytosol associated with a LMM component of <2,000. The 
current work is consistent with the high-molecular-mass 
component being between approximately 7,000 and 168,000.
The renal cytosol does not have a large shift in the
ratio of nickel associated with the LMM and HMM components
until the 24-h time point where the percent of nickel in the
LMM component has been lowered from a maximun of 87 to 72
(Table 4.7). This can be interpreted as either
corresponding to an increase in the HMM fraction
(compartmentalization) or a decrease in the LMM fraction
(cellular clearance). The increase in HMM components may
represent the association of nickel with cytosolic proteins
such as those found by Sunderman et al. (1983). If transport
across the celluar membrane of LMM cytosolic component such
2+as Ni(His)2 ? or Ni is by diffusion, nickel could be rapidly 
released across the epithilial- cell membrane to the tubular 
lumen as the nickel levels in the serum are lowered.
As pointed out by Abdulwajid and Sarkar (1983), many
proteins with a similar MM can elute together under the peaks 
found in their own work and that of Sunderman et al. (1981, 
1983). This depends on the nature of the proteins and may 
result in a change in the apparent MMs that have been cited. 
Recently, Templeton and Sarkar (1985) investigated the 
composition of the LMM nickel component of. renal homogenate 
after centrifugation at 105,000g for 60 min (cytosol). In 
this fraction, they found two major components; one is
consistent with a MM of 4000, the second was found in a 
region rich in carbohydrate. They also investigated bovine
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kidney homogenates incubated with excess NiClg (containing
Q
Ni) , which showed the same cytosolic G-75 and LMM pattern 
as the in vivo study. It is interesting that the UV/visible 
absorption spectra of this LMM component collected off a G- 75 
column has spectral characteristics very close to that 
obtained for the Ni(His)9 complex at pH + 7.5 (A = 626 nm;
^  l i l d X
- 1 - 1a626 = 2.9 cm M ) prepared in the present study. As
Templeton and Sarkar (1985) lowered the pH to 4.0, the
2+appearance of the Ni^gO)^ spectrum was observed. Similarly
when the pH of the Ni(His) 2  complex was lowered to 5.5
(present work), spectrum assumed the characteristic features 
2+of the Ni^gO)^ species. It is interesting to note that the
/> Q
G-75 profile of Ni(His) 2  was the same as the LMM-species of 
rat cytosol. As already indicated (Section (iv) a; of this 
discussion), there are more components in the LMM fraction of
o
plasma than just Ni(His)2 « The G-75 column would not
distinguish between such species because of similar MMs.
The levels of nickel injected into rats in both the
sbove studies (Abdulwajid and Sarkar, 1983; Templeton and
Sarkar, 1985) were ~20 times that used in the present
fractionation/autoradiography work and that by Oskarsson and 
n
Tjalve (1979b). No abnormallity was found in the glomerulus 
for the latter conditions. Since the HMM nickel complexes 
described by Sunderman and Sarkar have not been identified in 
the serum, they may result from the toxic interaction with 
tissue during glomerular filtration. The bulk of nickel was 
found to be associated with oligosaccharide fractions. The 
source of these oligosaccharides may be from damage to
cellular membranes such as the capillary endothelium, 
epithelial cell foot process or the basement membrane. If 
such damage occurs, it may also cause a change in the cell 
membrane permeability allowing accumulation of fluid inside 
these tissues resulting in a swelling of the glomerulus and a 
decrease in the Bowman’s space. This model potentially 
provides an explanation of the delay in the glomerular damage 
noted in the fusion of the foot processes 48 h post injection 
and the observation that at 96 h after injection there was no 
evidence of this change (Gitlitz et al., 1975). The delay 
may be due to the slow buildup of fluid in the tissue that 
reaches a maximum ~48 h post-injection, after which the cell 
membrane is presumably repaired (or regenerated) with a slow 
concomitant removal of the fluid which is complete after 96 h 
(see Chapter 5 for a further discussion).
fb) Mechanisms of Uptake
From the present time- course study and in vitro work
(Sections (ii) and (iii)), it is impossible to conclude the
exact mechanism by which nickel is absorbed from the tubular
fluid into the cytosol. Among the possibilities are the
transfer across the cell membrane as the Ni(His) 2  complex,
partial dissociation into and transport of the Ni(His)^
24-complex, or complete dissociation to Ni before crossing the 
cell membrane. The cation-exchange chromatography work 
reported in Section C (v) is consistent with the expectation 
of a neutral charge for Ni(His) 2  and 4-1 for Ni(His)^. Figure 
4.12 summarizes the different posssible processes based on
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Figure 4.12. ’’Equilbrium" model for the transport of 
nickel across a biological membrane. Processes 1-6 
denote various modes of transporting ligands,
metal ions such as Ni2+ or their complexes across 
biological membranes: 1, cation diffusion, ion
exchange or ion channel; 2, ligand diffusion or 
exchange; 3, partitioning via neutral, 
lipid-soluble protonated ligand; 4, partitioning 
via a neutral lipid-soluble metal complex; 5, 
exchange by extraction; and 6, receptor-mediated 
transfer. Process 7 represents the diffusion of 
Ni(His) 2 across the membrane. Symbols: M,
represents Ni2+ or Ni(His)Jh; L, ligand; HL is a 
neutral protonated ligand molecule; ML is a neutral 
metal-ligand complex; and R denotes a receptor. 
Charges on L, HL, and ML and M/ligand stoichiometry 
are omitted for convenience. Under "steady-state” 
conditions the processes summarized in this figure 
do not require additional energy input and thus may 
be considered as "passive". Adapted from Menon 
(1985) .
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the "Equilibrium" model for the transport of nickel across a 
biological membrane. The diffusion of Ni(His) 2  across the
cell membrane (Fig. 4.12; process 7) is probably less 
effective than more lipid-soluble complexes such as Ni(DDC)2 * 
Since the cell membrane is lipophilic in character, 
lipid- soluble metal complexes are taken up more readily than 
hydrophilic (polar) complexes such as those of amino acids. 
Interestingly, administration of DDC to mice 10 min prior to
/>n
NiClg dosing increased the amount of nickel associated with
n
the lung, liver, and brain (Oskarsson and Tjalve, 1980). By
contrast, when DL-penicillamine (which forms a polar complex 
2+with Ni ) was administered similarly, tissue levels of
nickel were lowered in all tissues including the kidney.
Based on the in vivo and in vitro work in this thesis,
it is impossible to conclude if the ultrafiltrable Ni(His) 2
complex outside the renal cells in the tubular fluid retains
the same histidine ligand when taken up into renal cytsol
(i.e., diffusion across the membrane). Putting it another
way, to what extent do the processes depicted in Fig 4.12
take place? Dual labelling might be the way to explore this.
63 i a
For example if Ni( C-His^ were injected, then it would be
possible to trace both the nickel and the histidine entities.
This would permit an assessment to establish if the Ni(His) 2
complex isolated from the renal cytosol has the same
14 63radioactivity ratio ( C/ Ni) as the serum ultrafiltrate. 
Such an experiment should, in principle, indicate if the
Ni(His) 2  complex has crossed the renal-cell membrane by
diffusion without change or if ligand exchange is involved
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and may give information as to how Ni(His) 2  inhibits 
L-histidine uptake in the nephron.
Cellular uptake by phagocytosis has been illustrated for 
particulates of crystalline (relatively insoluble) nickel 
compounds (e.g., NigS2 ; Costa and Mollenhauer, 1980; Nieboer 
et al., 1987a, b). Pinocytosis might be expected for
dissolved nickel compounds . Fluid-phase endocytosis is 
indeed an important uptake process in the kidney (Moffat, 
1982). Subsequent to pinocytic uptake, subcellular
redistribution would be expected to occur after release of
O i
Ni or Ni(II)-complexes (e.g., Ni(His)^) from acidified (pH 
~ 5) fused lysosomal/endosomal structures.
fc) Tissue Distribution of Nickel
The distribution of Ni in various tissues tested after 
i.v. injection of Ni(His) 2  is given in Tables 4.8 and 4.9. 
This is essentially the same distribution found in a number 
of reports in the literature, prior to 1979, that describe 
the tissue accumulation of divalent nickel following i.p., 
i.v. or s.c. injection of nickel salts (EPA, 1986). Although
Rq
there appear to be differences in the distribution of Ni 
which are dependent on the type of animal (mouse, rat, guinea 
pig, rabbit) and protocol used, the EPA (1986) review came to 
the following conclusions. The highest accumulation of 
nickel is "in the kidney, endocrine glands, lung and liver. 
Relatively little nickel is lodged in neural tissue, which is 
consistent with the observed low neurotoxic potential of 
divalent nickel salts. Similarly, there is relatively slight
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uptake into bone, consistent with other evidence that nickel 
is rather rapidly and extensively cleared from organisms, 
with little retention in soft or mineral tissue” (EPA, 1986).
n
Oskarsson and Tjalve (1980) found the same order as in Table
63 2+4.9 for mice tissues 4 h after i.v. injection of 7 fig Ni 
kg . Sunderman et al. (1976b) also found the same order as 
in Table 4.8 for rat tissue 6 h after i.p. injection of 5.9
1 ^JO
mg kg" of NiC^. From this short review, it appears that
f* o
i.v. injection of the Ni(His) 2  complex does not drastically 
alter the distribution of nickel in tissues observed
f* o
following injection of NiC^. This is probably due to a
9 4 -
fast in vivo conversion of the injected Ni to the Ni(His) 2  
complex.
fd^  Distribution of Ni in Different Regions of the Nephron 
Figure 4.10 illustrates the change in distribution of 
nickel along the nephron at various time points after i.v.
_ i
injection of Ni(His) 2  (6 fig Ni kg ). Over the 24-h period, 
only the S3 segment of the proximal tubule appears to have a 
large retention of nickel. Most importantly, the S3 segment 
also shows the highest proportion after 10 min and all the 
subsequent time points, suggesting that the uptake in this 
region is very rapid and that Ni is most strongly bound and
retained. Interestingly, uptake by the S3, segment has also
been related to the nephrotoxic action of cisplatin 
(Daley-Yates and McBrien, 1982). The nickel associated with
all other segments of the nephron reached a maximum and then
decreased over the 24-h period. For example, there is an
increase in the accumulation of nickel in the glomerulus at
the 1.5- h time point after which it rapidly decreases. This
2+accumulation is probably due to Ni binding to the
glomerular-basement membrane (Templeton, 1987a; Templeton, 
1987b). It should be noted that the glomeruli in the 
time-course study were normal, with no indication of a 
decrease in the Bowman's space. This is due to the much 
lower levels (~250 - 1000 fold) of nickel used in the i.v.
study than in the histological study.
It is interesting to speculate why there is rapid 
accumulation and large retention of Ni(His) 2  in only the S3 
segment of the nephron. In the rat, the brush border 
microvilli of the S3 segment are the longest and most densely 
packed compared to the SI and S2 segments of the proximal 
tubule (Kriz and Kaissling, 1985). Therefore, the high 
surface area associated with the S3 microvilli would allow 
the largest and quickest movement of nickel across the cell 
membrane from the lumen to renal cytosol.
(e) Serum and Intracellular Distribution of Ni
The subcellular fractions in the in vivo time- course 
experiments following i.v. injection of Ni(His) 2  (Fig* 4.8a 
and Table 4.6a) correspond to the same tissue as used in the 
autoradiography study (Fig. 4.10). There . was a continuous 
decrease in the percent of injected dose found in the serum 
and liver. The nickel content peaked at 1.5 h in the kidney 
and its subcellular fractions. This profile illustrates the 
rapid accumulation of nickel in the kidney and subcellular
fractions followed by rapid clearance. It appears that 
nickel is removed less rapidly from both the 
mitochondria/lysosome (M/L) and nuclear fractions (see Fig. 
4.8a). This is also illustrated when the percent loss of the 
maximum content at 1.5 h is calculated at the 24-h time point 
using the data in Table 4.6a. The average reduction for P^, 
cytosol and microsomes was 92.9 + 1.3 % (based on both cpm 
and cpm/mg protein), while for the M/L fraction it was 79.1 + 
0.2 %; for the nuclear fraction it was 83.8 ± 1.8 %.
Therefore, it appears that nickel is preferably 
compartmentallized intracellularly within the nuclear and M/L 
subcellular fractions. In the absence of direct histological 
evidence of endocytosis mediating nickel uptake, the observed 
retention in the M/L fraction can only be taken as 
circumstantial evidence of this pathway. Since
nickel(II)-phosphate complexes are of relatively low 
solubility, localization within lysosomes as insoluble 
phosphates may occur by analogy to the trivalent metal ions 
(Al3+, Ga3+, In3+) (Galle, 1983).
(f) Relationship Between Distribution and Toxicity
In Chapter 1, it was pointed out that the major
postulate of nickel carcinogenesis and other toxic effects of
2+nickel is that the Ni ion is the ultimate putative agent 
(Sunderman, 1984b). However, as pointed out by Nieboer et 
al. (1986) consideration must be given to a number of factors 
that may mediate or modify the nickel-ion hypothesis. Among
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2+these are: the concepts of the bioavailability of Ni , mode
2+of entry and delivery of Ni or Ni (II)-complexes to cells
and the nucleus of the cell, the biological residence time of
nickel and its compounds and the balance between the
2+intracellular compartmentalization of Ni and its
extracellular transport/excretion. The species that enters
2+renal cells from the tubular fluid is likely to be Ni or a
LMM complex such as Ni(His)2 ? which are able to pass quickly
into the renal cytosol (e.g., 6.7 % of injected dose in 10
min). The only indication of compartmentalization within the
cell is the slower release from both the M/L and nuclear
fractions. However, only 1.25 % of the injected dose is
present in the kidney 24 h after injection. This illustrates
that the biological residence time of nickel within the
kidney is short in comparison to that of more insoluble
compounds in the lung which have been associated with cancer
development. This observation illustrates the relevance of a
2+balance between intracellular compartmentalization of Ni
and its transport/excretion favours excretion. The long
biological- residence time associated with deposits of
nickel- containing particulates in the lung presumably
2+provides a vehicle for continuous availabliity of the Ni ion
to cells and their nuclei over a long period of time.
However, such particulate nickel compounds do not reach the
2+kidney, only the Ni ion or its complexes do. Therefore, 
insoluble nickel compounds that workers are exposed to impact 
on the kidney in a manner similar to soluble nickel compounds
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which is characterized by rapid subcellular clearance. This 
perspective implies that the incidence of renal cancer in 
humans exposed to insoluble nickel compounds will be low (see 
Chapter 5 for a further discussion). Indeed, renal cancers 
are not associated with industrial exposure to nickel 
compounds.
At this point it is interesting to compare the
2+ 2+subcellular action of Ni to Cd , a known nephrotoxin. 
2+Cd is largely excreted in the tubular fluid as its
metallothionein complex (CdMT). The CdMT complex is
reabsorbed, which is believed to be decomposed within the
2+lysosomes with release of Cd (Nieboer and Sanford, 1985 and
references therein). Perturbation of the homeostasis of Zn
and possibly Cu may also be involved since metallothionein
not induced by cadmiun contains both Zn and Cu. There is
24-evidence to suggest that the Cd ion impairs cell function
by interfering with the function of lysosomes and the
nucleus, resulting ultimately in tubular loss of LMM protein
and suppression of amino acid transport (Fowler, 1983;
Foulkes, 1983). In Table 4.13 a comparison is made of
subcellular fractions found in the present study and after a
single i.v. injection of ^^^CdMt into rats (Squibb et al. ,
1979). From this it is apparent that there is more rapid
association of cadmium with the nuclear and M/L fractions
than for nickel. After 0.5 h, there appears to be a transfer
of cadmium from the M/L fraction to the cytosol, which is
24-consistent with the toxic action of Cd . This transfer is
Table 4.13
RENAL SUBCELLULAR FRACTIONATION STUDIES
^Ni(His) 2  (iv injection; 6 fig Ni kg_1)a 
Percent of Total Ni Present in Kidney.
Subcellular
Fraction
10 min 1.5 h 3 h 24 h
P3 3.2 5.3 4.8 3.3
Cytosol 56.5 56.8 48.0 32.9
Mitochondrial/
Lysosomes
18.9 25.6 28.3 48.3
Nuclear 9.2 11.9 11.9 18.7
Microsomes 10.8 13.8 9.8 10.2
■^^CdMT (iv injection; 
Percent of Total 1(^ Cd
0.17 mg Cd kg" 1)b 
Present in Kidney.
Subcellular
Fraction
0.5 h 3 h 24 h
Cytsol 25.6 61.8 70.4
Mitochondria/
Lysosomes
38.6 6.2 6.1
Nuclear 33.2 
(plus large 
cytoplasmic bodies)
30.2 22.4
Microsomes 2.5 
(plus small
mitochondria and lysosomes)
1.7 1.0
£LData taken from present study. 
bData taken from Squibb £t al. 1979.
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2+not seen for Ni . The comparison of these studies indicates 
a different compartmentalization profile, lower 
bioaccumulation and shorter cellular or subcellular residence 
time of nickel in comparison to cadmium. Therefore it 
appears that these properties of nickel account for its 
relatively low nephrotoxicity.
It is interesting that even at the 3-min time point,
f\0 O  i
~2.5% of the injected Ni dose occurs in the bladder urine
of rat (Table 4.8), while at 10 min it is up to 13%. It is
unlikely that biliary nickel content would contribute to the
excretion of nickel in rats at these time points because it
has been shown to be less than 0.5% of the injected dose over
a 24-h period (Marzouk and Sunderman, 1985). In the current
work, it was possibe to account for 93% of the injected dose
24 h post- injection (w.ithout including muscle or intestine).
This illustrates that it is unlikely that there are other
pools in the body with large retention of nickel. The two
tissues (brain and thigh muscle) with the lowest nickel
2+accumulation were most reluctant to release Ni during the 
24-h post-injection observation period (column 5, Table 4.8), 
but did not induce any serious tissue damage. Previous 
animal studies reviewed above have established that the brain 
is not a primary target organ for inorganic forms of nickel, 
which is in direct contrast to the lipophilic compound 
Ni(CO)^ that does impact serverly on the central nervous 
system in man and animals.
The work reported in this chapter illustrates that high
doses of NiC^ result in toxic responses in all segments of 
the rat nephron. By contrast for low doses of Ni(His)2 ? the 
initial accumulation of Ni is followed by rapid subcellular 
clearance, with the rat renal tissue having no histological 
evidence of nephrotoxicity in any segment of the nephron. 
These findings will be discussed further in Chapter 5 within 
the context of the results reported in Chapter 3 for the 
survey of elecrolytic nickel-refinery workers.
CHAPTER 5 GENERAL DISCUSSION AND CONCLUSIONS
A RENAL CLEARANCE OF NICKELfin AND IMPLICATIONS 
FOR BIOLOGICAL MONITORING
The amount of serum nickel(II) associated with the 
low-molecular-mass (ultraf iltrable) fraction i-n si-x
electrolytic nickel workers was found to be 0.24 + 0.06 
(Chapter 3). Evaluation of this parameter allowed nickel 
clearances and fractional clearances to be calculated. 
Clearly nickel is reabsorbed in the human kidney. The 
average renal clearance of nickel (volume of serum from which
available nickel is removed per min) was estimated from the
-1 -1 slope of Fig. 3.3 to be 42 mL min compared to 120 mL min
for creatinine. From this it was possible to estimate that
about 65% of the nickel in the glomerular filtrate is
reabsorbed in the nephron. The shape of the fractional
clearances curves closely resembled that of urea whose
tubular reabsorption occurs by passive diffusion. The renal
excretion of the metabolite creatinine is the only known
endogenous substance for which the clearance approximates the
glomerular filtration rate (Duarte et al., 1980; Epstein,
1977). This means that creatinine is not reabsorbed in the
nephron (in fact it is thought to be slightly secreted).
Total solutes assessed as p-1 in the urine depend to a large
extent on the amount of substances such as~~Na , amino acids
and urates that are reabsorbed in the nephron. From the
current work it can be seen that the excretion pattern of
nickel(II) resembles that of total solutes more closely than
of creatinine. This indicates that normalization of spot 
voids employing specific gravity (p ) rather than creatinine, 
allows flow-dependent variations in urinary nickel to be 
compensated.
The close relationship between total solutes and nickel 
excretion is clearly illustrated in Figures 2.31, 2.33, 2.34 
and 2.35. When the creatinine normalization of 24-h nickel 
was examined in detail, two curves were found when Uj^/U ^ 
was plotted against (Fig. 2.31). For the same data set,
Un i/U^  ^  versus yielded a single straight- line
relationship (Fig. 2.34). However, when Uj^/U e ^ was 
plotted against the excretion rate (F^^ = Uj^V) a straight 
line was observed (Fig. 2.33). These relationships 
demonstrate the presence of a residual, uncompensated 
flow-rate dependence for creatinine adjustment of urinary 
nickel concentrations, which is not present for solute 
correction. Thus specific gravity normalization is more 
appropriate than creatinine adjustment.
In Chapter 2, a rationale was developed for the volume 
correction of nickel in spot-urine voids. This approach can 
be used to generate protocols for other substances. It was 
based on Equation 2.1, which was first proposed by Araki 
(1980) and centered on the evaluation of the power 
coefficient b^ of the urine flow rate. Evaluation of b^ for 
any analyte of interest (e.g., nickel) and bref f°r a 
reference analyte (e.g., creatinine or total solutes) is a 
prerequisite. If the analyte of interest (i) and reference
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metabolite (ref) have the same mathematical dependence on 
urine flow rate, then = bre£ (e.g., bj^ = b ^). This 
equality forms the basis for selecting the most appropriate 
reference substance. The evaluation of the reported b^^
values relied on a large variation in the natural flow rate
-1 -  1 (at least AV > 1 mL min , although AV > 2 mL min was
preferable) and an adequate number of timed urinary voids
(eg. n > 4) . Also, an even distribution of V values
throughout the range studied was mandatory. These criteria
resulted in a rejection of the data for a number of donors in
this study. To circumvent these limitations, water-loading
or restriction is advisable. Such practice would allow the
above requirements for the evaluation of b^ values to be
fulfilled more readily.
The curves in Figures 2.25 to 2.30 were interpreted as 
belonging to a family of theoretical curves depicted in 
Figure 2.38. A generalized form of Equation 2.6 namely 
Equation 2.25 which incorporates the mathematical function 
describing this family of curves, was employed in urinary 
analyte normalization.
U,
U
2
1 (2.25)
where, Ab = l>2- b^ and b^ refers to the analyte being
normalized and l>2 to the reference analyte. Further 
modification of Equation 2.25 was based on the 95% confidence
limits of Ab (i.e., the confidence interval Ab ± t(SD/VTT )) 
for the normalization of nickel by total solutes taking into 
account the size (n) of the volunteer group. This provided a 
rationale for the establishment of boundary values for 
urinary specific gravity and creatinine (Tables 2.11 and 
2.12) as determined by a preselected confidence level of Ab
and an acceptable error in (the uncompensated flow
factor). For example, for a group of 20 volunteers, 95% of
AIdthe time the error in the residual flow factor V will not
exceed + 10% if p falls in the range 1.010 to 1.039. This
approach permits an investigator of nickel- exposed 
individuals to measure the specific gravity of a urine sample 
on a work site with a hand-held refractometer. If p falls 
within the range predetermined by the acceptable error and 
confidence limits, the specimen can be accepted for further 
processing (e.g., nickel analysis). When the measured p is 
outside this range, then the specimen should be rejected and 
another obtained (providing the dip stick levels of other 
metabolic and nephrotoxic indicators such as glucose or 
protein are acceptable). For individuals or small groups, 
the use of the standard score for Ab and a percentile table 
permits the recommendation that if the specific gravity of a 
urine specimen is between 1.015 and 1.026 then 95% of the
A * u  ^
time the deviation of V from unity would not exceed 30%.
The use of a 24-h specimen would reduce the rejection rate
based on this criterion.
As illustrated in the above discussion, the approach to
-342-
normalization summarized in Equation 2.25 is general and can 
be employed for any analyte (metallic or organic). For 
example, this is important when a worker is exposed to metals 
such as lead, for which it is necessary to evaluate urinary 
levels of biochemical metabolites such as coproporphyrin and 
(^aminolevulinic acid in the urine (Lauwerys, 1983). Both of 
these compounds have had their b^ values evaluated by Araki 
(1980). This concept of flow-rate correction of spot urine 
samples is also applicable to exogenous exposure to organic 
compounds such as trichloroethylene. Major portions of the 
latter are metabolized to trichloroethanol and 
trichloroacetic acid, which are excreted in the urine 
(Lauwerys, 1983). In this case, the b^ coefficients for 
these metabolites of trichloroethylene would have to be 
measured and the appropriate concentration boundaries 
selected relative to a suitable reference analyte before an 
appropriate rationale for biological monitoring can be 
established. As illlustrated, biological monitoring
utilizing spot urine specimens can be based on sound 
scientific principles and thus the choice of protocol should 
not be left to the arbitrary discretion of an individual 
investigator.
In Chapter 3, it was shown that the evaluation of the 
clearance and fractional clearance of nickeL_was important in 
establishing that nickel is reabsorbed in the nephron. 
However, the concept of clearance may have toxicological 
application for well-established nephrotoxins such as
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cadmium. It could serve as a reliable indicator of renal
damage. Cadmium is known to be reabsorbed in the proximal
tubules as the metallothionein complex, where it is
catabolised within lysosomes (Nieboer and Sanford, 1985 and
2+references therein) and the released Cd .is thought to
attach to de novo synthesized metallothionein in the kidney
(Lauwerys, 1983). The current hypothesis is that saturation
2+of this renal scavenging process releases free Cd allowing 
its toxic action to occur. This critical event could result 
in a dramatic change in the clearance of cadmium. Before 
there is renal dysfunction, the CdMt complex is being 
reabsorbed in the kidney and thus has a clearance less than 
creatinine. When early dysfunction occurs, cadmium may be 
expected to be released from proximal-tubule cells into the 
tubular fluid, which would dramatically increase the cadmium 
clearance. An investigation of Cd clearances as an early 
indicator of renal damage is currently being conducted at 
McMaster University.
It is interesting to note that in the past some 
investigators have recommended the rejection of very dilute 
urine samples (specific gravity < 1.010 or creatinine
_ i
concentration < 0.3 g L ; Lauwerys, 1983) and p < 1.012
(Bernacki et al., 1978). They advise that analyses should be 
repeated on a more concentrated specimen__if the specific 
gravity is less than these values. Using specific gravity 
adjustment of urinary nickel spot voids (Chapter 2D (v)) for 
20 workers exposed to nickel, the upper and lower limit for
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acceptable specific gravity measurements would be 1.010 and 
1.039 for 95% confidence level in Ab and =1.0 + 0.1.
This would have resulted in 15% of the specimens in the 
electrolytic nickel refinery study (Chapter 2) being 
rejected, all of which were below 1.010 and none above 1.039. 
Thus the recomendation by Lauwerys (1983) appears to be a 
reasonable first approximation to the problem for selection 
of spot voids for nickel analysis. However, as pointed out 
in Chapter 2D (v), as the group size gets smaller or Ab 
larger (Fig. 2.38), then the range of acceptable specific 
gravity values becomes narrower. The choice of the lower 
specific gravity limit of 1.010 and no upper limit of 
Lauwerys (1983) represent boundary values that are widely 
separated and would result in accepting urine specimens that 
should be rejected.
The value of solute normalization was illustrated by 
calculating (estimated from Eqn. 2.6 or Uj^ adjusted to a 
mean p value during the 24- h observation period) . values
generally increased during the shift with a subsequent 
decrease in the post-shift period (Figs. 3.6 - 3.10) and also 
correlated with job category (Table 3.11). However, it would 
be more appropriate to establish a relationship between 
breathing zone levels of nickel measured by personal sampling 
and levels throughout a 24- h periocL The observed
variation in during the 24-h collection period (Figs. 3.6 
-3.10) might reflect some diurnal variation in the excretion 
pattern of nickel for electrolytic refinery workers.
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Circadian rythms involving the kidney have long been
recognized. For example, the low urine flow at night is an 
classical observation and is of obvious practical 
convenience. Disturbances of the usual urinary rhythms 
underly some cases of bed-wetting (Mills, 1976). It is also 
known that sodium and potassium excretion undergo a circadian 
change (Elliott et al., 1972 and Mills, 1976). A person’s 
inherent rhythms can be changed by the intake of coffee and 
tea that influence the excretion of water, sodium and
chloride. Alterations may also derive from time shifts such
as those found in transatlantic flights (Elliott et al., 
1972). In the present work, the systematic increase of 
during the 24- h time period including an 8- h shift is
consistent with exposure to soluble nickel and not due to a 
circadian rhythm. It may be possible for nickel excretion to 
follow a circadian rhythm in nonexposed healthy adults, which 
would of course be masked by exposure during a work shift. 
Because working on the afternoon and midnight shifts involves 
a time shift and a change in body rhythms, a circadian 
component might be included in the design of future
biological monitoring programs.
B ABSORPTION AND TOXIC EFFECTS OF NICKEL IN RAT KIDNEY
The renal slice work, the isolated. proximal-tubule 
fragments experiments and i.v. time-course studies all 
illustrate that nickel can be absorbed in the rat kidney,
likely by the S3 segment of the proximal tubule. Nickel was
also found to be reabsorbed in the kidneys of electrolytic 
refinery workers (Chapter 3). It appears therefore that 
nickel is absorbed from the glomerular filtrate through the 
brushborder membrane into the epithelial cells of the 
proximal tubule, eventually passing through the basolateral 
membrane to the blood capillary. Indeed, nickel was 
associated in almost equal amounts with the basolateral and 
brush-border membranes isolated from rat kidney after i.v.
/>o
injection of Ni(His) 2  (Section 4C (iv)). Such reabsorption
/jo
of Ni would afford an opportunity for some intracellular 
accumulation of nickel such as in the M/L and nuclear 
fractions. All the animal work reported in this thesis is 
most consistent with a passive absorption process (e.g, fluid 
phase endocytosis), although some contribution from active 
components can not be ruled out. The largely passive nature 
of uptake of nickel in the rat studies agrees with the 
urea- like reabsorption of nickel in man described in Chapter 
3F (iii). As pointed out in Chapter 1C (i) , homeostatic 
control of a substance by contolled reabsorption in the 
kidney is partial evidence of its essentiallity. Further 
evidence of homeostatic regulation are the narrow ranges of 
nickel concentration observed in human body fluids of 
non-exposed individuals (Chapter 1C (ii) and Nieboer et al. , 
1987a). -
_ i
In the histological study, high (6 mg Ni kg ) and
_ -j
intermediate doses (3 mg Ni kg ) of nickel appear to have a 
major effect on the glomeruli of rats. A dose response
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decrease in the Bowman's space was observed. However, in the
_ -t
low i.v. injections (6 jig Ni kg ) employed in the
subcellular fractionation study there was no change in the
Bowman's space observed. A number of mechanisms have been
proposed to explain the observed changes in -the glomerulus
and the associated nephrotoxic observations of proteinuria,
amino aciduria and polyuria. They are: (i) enlargement of
the glomerular capillaries due to an increase in renal
capilliary pressure and filtration rate with associated
2+edema; (ii) interaction of Ni with the negative charge 
located on the filtration barrier; (iii) formation of immune 
complexes in the glomerular basement membrane (GBM) and (iv), 
cellular or tissue damage with decreased reabsorption of 
amino acids and proteins in the proximal convoluted tubule 
(possibly the S3 segment). The common explanations for 
proteinuria are the reduction in surface charge and the 
formation of immune complexes in/on the GBM (Hook and Hewitt, 
1986). However, the available data does not permit exclusion 
of the other explanations. It may be that the four 
mechanisms described are not mutually exclusive and all 
contribute to the observed effects.
The time- course rat study indicates that there is quick
63 ”1clearance of nickel of the injected label (6 jig Ni kg” ) 
from all subcellular fractions, with only a flight indication 
of retention in the M/L and nuclear fractions. If the rat 
kidney handles high-dose injections simiarly. which result in 
nephrotoxicity characterized by increased total proteinurea,
amino aciduria and N- acetyl- p- D- glucosaminidase (NAG), then
such effects might be expected to be transient. There are
two studies that support this hypothesis. The first
demonstrates a dramatic rise in urinary total protein and 18
of 20 amino acids the first day after i.p. injection of 5.9 
_ 1
mg Ni kg , which reach maxima on the second day post­
injection (Sunderman et al., 1976b). Subsequently, these 
excretions diminish systematically so that on day 4 they have 
returned to control values. Histidine follows a slightly 
different pattern as first pointed out by Gitlitz et al. 
(1975). It reaches a maximum on the first day after 
injection, after which it continually decreases until on the 
Day 3 and 4 there is no statistical difference when compared 
to control rats. This excretion pattern of histidine very 
closely resembles that of nickel which has a half- life of 
about 24 h, suggesting concurrent excretion as the Ni(His) 2  
complex. Gitlitz et al. (1975) found that fusion of the
foot processes of epithelial cells occurred in renal
2+ - lglomeruli 48 h after i.p. injection of 4 mg Ni kg . This 
focal lesion was not seen in the glomeruli from any of the 
control rats or exposed rats 24 or 96 h after the injection, 
indicating reversibility. Thus as in the published 
histological study, the major change occurred in the 
glomeruli which reached a maximum 48 Ji post- injection 
(Chapter 4). Interestingly, the maximum in the urinary 
excretion of total proteins and most amino acids is also seen 
on the second day after injection (Sunderman et al. , 1976b).
This supports the argument that the severe glomerular damage 
described in Chapter 4C (i) (a) is a major contributing
factor to the excess excretion of total protein.
C KIDNEY FUNCTION STATUS IN ELECTROLYTIC REFINERY WORKERS
The time- course subcellular- fractionation results permit 
an understanding of how the human kidney handles exposure to 
soluble nickel. As depicted in Figure 3.1 and 3.6 to 3.10, 
there is a significant drop in urinary nickel levels after 
each work shift. Thus if the human kidney acts in a manner 
similar to the rat kidney, then after each shift and weekend 
it is expected that there will be at least partial 
subcellular clearance. It is common to see a gradual 
increase in the urinary nickel levels during a work week 
(Fig. 3.1), although weekends allow restoration of urinary 
and subcellular levels of nickel closer to background values. 
One month after being layed off work the urinary nickel 
levels were 36 to 70% lower than the pre- layoff values and 
were still well above the concentrations expected for healthy 
adults (see Chapter 3F (iii) for details) . This has been 
interpreted to indicate that there is a slow release of 
nickel from pools stored in the body. In the Port Colborne 
operation, most of the donors also worked, mostly in the 
past, in operations generating nickel-containing particulates 
(e.g., in smelting and calcining, anode scrap washing, 
nickel- anode casting). This constitutes mixed exposure to 
both aerosols of dissolved nickel (as chloride or sulphate)
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and less soluble forms (e.g., nickel sulphides and oxides and 
nickel metal). The data depicted in Figure 3.7 corresponds 
to an individual who had such mixed exposure over 25 y of 
employment, while that in Figure 3.6 is for a younger worker 
employed for only 4.5 y in the electrolytic -refinery. The 
data suggests the presence of respiratory nickel deposits in 
the former, which would give a slow continous release of
nickel with a longer half- life than asociated with dissolved 
nickel salts.
The work in this thesis emphasizes the importance of
utilizing animal and human studies to obtain a better
understanding of the renal handling of a potential
2+nephrotoxin such as Ni . This requires that animal studies 
be designed to simulate human exposure. Experiments with
animals readily demonstrate nephrotoxicity due to elevated
_ i
acute doses (e.g., 6 and 3 mg Ni kg ). These may have no
real counterpart in humans because they are never exposed to
2+correspondingly high single doses of Ni . Nevertheless,
such doses are sometimes valuable in illustrating an
intrinsic response, but in this instance it appears that this
animal data cannot be readily extrapolated to man. By
contrast,single-dose, non-acute microgram-level animal
studies do allow an understanding of the dynamics and
mechanisms that may be important in human exposure. This can
be illustrated by employing the time-weighted-average (TWA)
- 3of 0.1 mg Ni m recommended by the American Conference of 
Governmental Industrial Hygienists (ACGIH, 1986) for soluble
3
nickel compounds. Assuming that 20 m of air is breathed
daily, it is possible to estimate the hypothetical nickel
intake during an 8-h shift at the TWA level. Under such
conditions, approximately 0.7 mg of nickel is inhaled
(assuming 100% deposition). For a typical worker of 83 kg 
(mean of the electrolytic workers surveyed in Chapters 2 and
_ -j_
3) , this would represent a dose equivalent to 8 fj,g Ni kg
_ i
This is much less than the range of 2 to 6 mg Ni kg that is 
usually injected into rats. For comparision, the exposure 
for one year can be approximated by estimating the work year 
to be 240 days. This would result in an equivalent dose of 2
_ i
mg Ni kg . Thus the amount of a single injection usually 
administered to rats appears to be equivalent to one year of 
accumulated exposure by a worker exposed to soluble nickel at 
the TWA level.
It is interesting to note that there have been two
reported cases of proteinuria in man resulting from nickel
carbonyl poisoning (Sunderman, 1977). This type of poisoning
in humans is characterized by a sharp increase in urinary
nickel levels following exposure (see Fig. 2.1). This
2+probably results in a large and quick release of Ni into 
the body from the lungs so that it simulates the acute animal
_ i
injections (2 - 6 mg Ni kg ) which are associated with
proteinuria and amino aciduria in rats.
Throughout the in vitro and animal work, all incubations 
and injections were designed to simulate the uptake and 
distribution of low-molecular-mass (ultrafiltrable)
components of nickel (Ni(His) 2  and Ni(His)^). The in vitro
63 2+work of Chapter 4 demonstrated the uptake of Ni ,
^Ni(His) 2  and ^Ni(His)^ in renal slices and ^Ni(His ) 2  in
2+proximal tubular fragments. The efflux of Ni from live
renal slices was much less than PAH indicating that there is
more tissue compartmentalization and retention of nickel than
PAH. This retention is reflected in the high affinity that 
2+Ni and Ni(His) 2  have for the M/L and nuclear incubated
fractions (Table 4.6b and Fig. 4.8b) and the retention of
nickel in the ML fraction of the kidney after i.v. dosing
(Table 4.13). The PAH uptake in renal slices was
significantly increased by a 95% 02/5% CO2  (v/v) atmosphere, 
24-while Ni and Ni(His) 2  was not. All the nickel uptake 
studies were interpreted to involve a passive mechanism that 
can be explained in terms of a steady state "Equilibrium" 
model in which uptake is regulated by thermodynamic parmeters 
such as the pK values of ligands, the binding constants of
cl
the nickel-ligand complexes, their solubilities in aqueous 
and lipid phases, and the effective ligand concentrations in 
the intracellular and extracellular compartments. However, 
as already indicated the data presented in this thesis does 
not eliminate a contribution of active processes. Injection 
of Ni(His) 2  into the jugular vein of rats demonstrated rapid 
renal cellular and subcellular uptake on nickel but, did not 
alter the distribution of nickel in tissues (Tables 4.8 and 
4.9) relative to those reported for NiC^ (EPA, 1986;
n
Oskarsson and Tjalve, 1980; Sunderman et al. , 1976b). As the
serum nickel levels declined, so did the renal cellular and 
subcellular levels which is consistent with passive diffusion 
back into the lumen. The G-75 high- and low-molecular-mass 
elution profiles after injection of Ni(His) 2  did not differ 
much from NiC^ studies (Table 4.7 and Fig. 4.9). Therefore, 
to unravel the uptake and excretion processs both the in 
vitro and in vivo work described in Chapter 4 has been 
helpful.
In conclusion, it can be seen from the work in this 
thesis that the incidence of nephrotoxicity found in
electrolytic refinery workers was found to be minimal in 
comparison to the known nephrotoxic metal Cd. This 
differential response can be explained by the relatively 
rapid extracellular, cellular and subcellular clearance of 
nickel in contrast to the very long biological half- life of 
cadmium (10 - 30 y). Clearly to obtain a consistent picture 
between animal and human studies, it is necessary to design
experiments that pertain to doses and routes of
administration that simulate human exposure. In addition, 
carefully chosen in vitro and in vivo approaches need to be 
employed in a complementary fashion to obtain a model of 
renal retention, nephrotoxicity or detoxification of a
potential toxic industrial metal such as nickel.
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